0001144204-11-059553.txt : 20120117 0001144204-11-059553.hdr.sgml : 20120116 20111026171609 ACCESSION NUMBER: 0001144204-11-059553 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20111026 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PREMIER BIOMEDICAL INC CENTRAL INDEX KEY: 0001515740 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 272635666 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1362 SPRINGFIELD CHURCH ROAD CITY: JACKSON CENTER STATE: PA ZIP: 16133 BUSINESS PHONE: 814 786 8849 MAIL ADDRESS: STREET 1: 1362 SPRINGFIELD CHURCH ROAD CITY: JACKSON CENTER STATE: PA ZIP: 16133 CORRESP 1 filename1.htm Unassociated Document
 
 
October 26, 2011


United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, D.C.  20549
Attn: Laura Crotty

 
Re: 
Premier Biomedical, Inc.
Amendment No. 3 to Registration Statement on Form S-1
File No. 333-174876

Dear Ms. Crotty:

On behalf of Premier Biomedical, Inc. (the “Company’), we herein provide the following responses to the Commission Staff comment letter dated October 13, 2011, regarding the above-listed Registration Statement on Form S-1 for the Company.  We have summarized the Staff’s comments in bold and italics followed by the Company’s response.

General

1.           Please revise your financial statements to present audited financial statements for the period ended December 31, 2010, and unaudited financial statements for the period ended June 30, 2011.  Rule 3-02 of Regulation S-X requires the presentation of statements of income and cash flows for the interim period between the latest audited balance sheet and the date of the most recent interim balance sheet being filed, and for the corresponding period of the preceding fiscal year.  However, presenting balance sheets for the interim period between the latest audited balance sheet and the date of the most recent interim balance sheet being filed is not required.

The financial statements have been revised as requested.

2.           Please ensure that you label all financial statements and notes that you revised as restated.  For example, the audited balance sheet for the audited period ended December 31, 2010 on page F-19 should be labeled as restated.

Respectfully, the financial statements had been labeled as restated at the top of the statement as both periods presented had been restated.  The Company has carried it to the top of each column now as well to avoid confusion.
 
 
 
 
 
 
 
Laura Crotty
U.S. Securities and Exchange Commission
Division of Corporation Finance
October 26, 2011
Page 2
 
 
3.           We acknowledge your revised disclosures in response to prior comments 13, 14, 15 and 16.  Throughout your document you state that you established the fair value of certain warrants based on an independent valuation.  This disclosure appears to infer that the values allocated to warrants were taken directly from a report provided by a third party appraisal firm or that management determined the value of the warrants based on data in a third-party valuation report.  Please clarify for us.  If you continue to include this disclosure, you must name the appraisal firm and provide their consent in any ’33 Act filing that includes this reference.  On the other hand, if you determined the valuation of the warrants and in doing so considered or relied in part upon a report of a third party appraisal firm, and the disclosure so states, or the disclosure attributes the valuation to the registrant and not a third party appraisal firm, then there would be no requirement to comply with Rule 436 with respect to the valuation figures.  Please refer to the answer to question 233.02 of Compliance and Disclosure Interpretations related to Securities Act Rules that can be found on our website.

The Company determined the fair value of the warrants based upon information it received from a third party appraisal firm.  Management accounted for the warrants and in doing so considered or relied in part upon a report of a third party expert.  As such, it will remove the reference to a 3rd party valuation within the disclosures to clearly attribute the valuation figures to the registrant, rather than the third party expert.  As a result, there won’t be a requirement to comply with Rule 436 with respect to the valuations as the fair values are attributed to the registrant.

License Agreements, page 21

4.           We note the information provided in your supplemental response letter in response to our prior comment 6 regarding the definition of PCT.  Please add this information to your registration statement, where applicable.

The following disclosure was added in the Description of Business section, the first place reference to PCT is made:

PCT stands for the Patent Cooperation Treaty (PCT), which is an international patent law treaty which was concluded in 1970.  It provides a unified procedure for filing patent applications to protect inventions in each of its contracting countries.  A patent application filed under the PCT is called an international application, or PCT application.

Feldetrex, page 29

5.           We note the disclosure added to pages 6 and 29 in response to our prior comments 2 and 4.  Please revise your disclosure in the “Regulation” section starting on page 26 to separately discuss the specific regulatory pathway to be followed for each of the indications for which you expect to market Feldetrex.  Also, please consider and address in the disclosure the fact that, despite the fact that Feldetrex contains an approved drug combined with vitamins, the company intends to market the product for indications for which efficacy has not been previously demonstrated in clinical trials submitted to the FDA and for which approval has not been obtained.  In that regard you should also consider the appropriateness of the disclosure added to page 6 under the risk factor “The FDA might not approve our product candidates for marketing and sale.”  If you still believe that this disclosure is appropriate in light of the revisions made in response to this comment, you should provide a substantive legal analysis supporting your conclusion that FDA approval of Feldetrex can be obtained using an ANDA despite the fact that Feldetrex will be used for currently unapproved indications of Naltrexone.

Management of the Company believes that it will most likely license a product such as Feldetrex to a larger pharmaceutical company, and thus any regulatory pathway that must be navigated will be done by them.  The disclosure in the referenced locations, as well as several other locations in the prospectus, has been revised accordingly.
 
 
 
 
 
Laura Crotty
U.S. Securities and Exchange Commission
Division of Corporation Finance
October 26, 2011
Page 3
 
 
Potential for Feldetrex, page 32

6.           Please define “endogenous enkephalins” where first used on page 32.

The company’s first reference to, “endogenous enkephalins” was on page 29, rather than 32.  The Company has revised its disclosure on page 29 to define, “endogenous enkephalins” as follows:

Feldetrex™ utilizes a low dosage of Naltrexone which has been shown in multiple medical articles, in the medical literature, to increase endogenous enkephalins (endogenous enkephalins are pain-relieving pentapeptides produced in the body, located in the pituitary gland, brain, and GI tract. Axon terminals that release enkephalins are concentrated in the posterior horn of the gray matter of the spinal cord, in the central part of the thalamus, and in the amygdala of the limbic system of the cerebrum. Endogenous Enkephalins function as neurotransmitters that inhibit neurotransmitters in the pathway for pain perception, thereby reducing the emotional as well as the physical impact of pain).

Financial Statements as at December 31, 2010, audited
Notes to Financial Statements
Note 7 - Stockholders’ Equity, page F-29

7.           We acknowledge your revised disclosures in response to prior comments 15 and 16.  Please clarify for us and revise your disclosure to state, if true, that you allocated the proceeds received in the financing transactions on a relative fair value basis.

The Company did in fact allocate the proceeds received in the financing transactions on a relative fair value basis, and will revise its disclosures throughout to state that the proceeds received were allocated between the common stock and warrants on a relative fair value basis.

8.           Please consider disclosing the narrative disclosure made in response to prior comment 15 in tabular form.  Similar disclosure should be made in an appropriate section of your MD&A and should be updated for any new equity issuances up until the time of effectiveness of your registration statement.  Please also disclose the expected term of each of the common stock and warrant issuances.

The Company has added tables as supplemental information to Note 7 and the MD&A as requested.
 
 
 
 
 
Laura Crotty
U.S. Securities and Exchange Commission
Division of Corporation Finance
October 26, 2011
Page 4
 
 
9.           Please provide us with an analysis that supports the fair value of each common stock and warrant issuance.

Please see the two valuation reports related to the financing transactions dated June 21, 2010 and February 28, 2011.

Financial Statements at June 30, 2011, Unaudited

10.           Please update the unaudited financial statements and related disclosures based on the comments related to the audited financial statements as at December 31, 2010 as applicable.

The Company acknowledges the Commission’s request and has carried all applicable revisions to the unaudited period, as well as the audited period presented.

Company Statements

 
· 
The Company is responsible for the adequacy and accuracy of the disclosure in the filing;

 
· 
Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and

 
· 
The Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

The letter attached hereto indicates the Company’s agreement and affirmation of the above “Company Statements.”

Please do not hesitate to contact me if you have any questions.  Thank you for your time and attention to this matter.

Sincerely,

/s/ Brian A. Lebrecht, Esq.

Brian A. Lebrecht, Esq.

 
 
 
 
October 26, 2011


United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, D.C.  20549
Attn: Laura Crotty

 
Re: 
Premier Biomedical, Inc.
Amendment No. 2 to Registration Statement on Form S-1
File No. 333-174876

Dear Ms. Crotty:

Premier Biomedical, Inc. (the “Company”) hereby affirms and agrees with the following statements related to the comment response for the above-mentioned filing to be filed with the Commission on October 26, 2011:

Company’s Statements

 
· 
The Company is responsible for the adequacy and accuracy of the disclosure in the filing;

 
· 
Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and

 
· 
The Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Please do not hesitate to contact me if you have any questions.  Thank you for your time and attention to this matter.

Sincerely,

/s/  William A. Hartman

William A. Hartman
Chief Executive Officer

 
 
 
 
 
 
 
 
 
Premier Biomedical, Inc.
Exhibit 1, Page 1
Black-scholes Calculation - Common Stock Warrant
  
(Actuals)
Valuation as of June 21, 2010
 
 
                         
Common
Stock Warrants
    
                               
   
Black-scholes Calculation
                    
(1)    
Underlying price
                 $0.00032    
     
Exercise price
                 $0.00001    
(2)    
Time to expiration (days)
                 3,647    
(3)    
Volatility
                 105.00 %  
(4)    
Risk-free interest rate
                 3.26 %  
                                 
      d1                     2.797    
      d2                     (0.522 )  
     
Output:
                 $0.00031    
                                   
   
Black-scholes value of common stock warrant
           $0.00031    
   
Discount for lack of marketability
       25.0%       ($0.00008 )  
                                     
   
Common stock warrant fair value - non-marketable
             $0.00023    
                                     
   
Common stock warrant fair value - non-marketable (rounded)
       $0.00023    
                                     
                                     
Notes:
(1)  
Price per share of common stock. See Supplemental A, Page 1. Summary values per the option-pricing method to allocation as follows:
                               
         
Per share Values
                    
     
Common Stock
     $0.00032                    
     
Common Stock Warrants
     $0.00031                    
     
Preferred Stock Warrants
     $0.00032                    
     
Preferred Stock
     $0.00128                    
                               
(2)  
Calculated as follows:
                          
               
Days to expiration
                    
           
Current date
     6-21-2010                    
           
Expiration date
     6-15-2020                    
           
Days
     3647                    
                         
(3)  
See Exhibit 2, Page 1 for volatility data.
                    
(4)  
Continuously compounding risk-free rate of return associated with a 120 month term. Source: U.S. Treasury.
(5)  
See Exhibit 3, Page 1. We conducted an Asian put option calculation to determine the discount for lack of marketability.
 
 
 
 
 
Premier Biomedical, Inc.
  
Exhibit 1, Page 2
Black-scholes Calculation - Preferred Stock Warrant
    
(Actuals)
Valuation as of June 21, 2010
 
 
                         
Preferred Stock
Warrants
    
                               
   
Black-scholes Calculation
                    
(1)    
Underlying price
                 $0.00128    
     
Exercise price
                 $0.00100    
(2)    
Time to expiration (days)
                 3,647    
(3)    
Volatility
                 105.00 %  
(4)    
Risk-free interest rate
                 3.26 %  
                                 
      d1                     1.832    
      d2                     (1.487 )  
     
Output:
                 $0.00119    
                                   
   
Black-scholes value of preferred stock warrant
           $0.00119    
   
Discount for lack of marketability
       25.0%       ($0.00030 )  
                                     
   
Preferred stock warrant fair value - non-marketable
             $0.00089    
                                     
   
Preferred stock warrant fair value - non-marketable (rounded)
       $0.00089    
                                     
                                     
Notes:
(1)  
Price per share of common stock. See Supplemental A, Page 1. Summary values per the option-pricing method to allocation as follows:
                                   
         
Per share Values
                    
     
Common Stock
     $0.00032                    
     
Common Stock Warrants
     $0.00031                    
     
Preferred Stock Warrants
     $0.00032                    
     
Preferred Stock
     $0.00128                    
                               
(2)  
Calculated as follows:
                          
               
Days to expiration
                    
           
Current date
     6-21-2010                    
           
Expiration date
     6-15-2020                    
           
Days
     3647                    
                         
(3)  
See Exhibit 2, Page 1 for volatility data.
                    
(4)  
Continuously compounding risk-free rate of return associated with a 120 month term. Source: U.S. Treasury.
(5)  
See Exhibit 3, Page 1. We conducted an Asian put option calculation to determine the discount for lack of marketability.
 
 
 
 
 
Premier Biomedical, Inc.
Exhibit 2, Page 1
Volatility Calculation Summary - 10.0 Years
  
(Actuals)
Valuation as of June 21, 2010
 
 
           
21-Jun-2010
  
           
Historical
  
   
Guideline Company
      
Volatility (1)
  
               
   
BioCryst Pharmaceuticals, Inc.
  
 NasdaqGS:BCRX
  
93.9%
  
   
Enzo Biochem Inc.
  
 NYSE:ENZ
  
62.5%
  
   
Entest Biomedical, Inc.
  
 OTCPK:ENTB
  
266.1%
  
   
Intellect Neurosciences, Inc.
  
 OTCPK:ILNS
  
223.8%
  
   
Lexicon Pharmaceuticals, Inc.
  
 NasdaqGS:LXRX
  
83.0%
  
   
Osiris Therapeutics, Inc.
  
 NasdaqGM:OSIR
  
65.4%
  
   
Cytori Therapeutics, Inc.
  
 NasdaqGM:CYTX
  
75.7%
  
   
DURECT Corporation
  
 NasdaqGM:DRRX
  
87.1%
  
   
Dyax Corp.
  
 NasdaqGM:DYAX
  
84.8%
  
   
Zalicus Inc.
  
 NasdaqGM:ZLCS
  
109.7%
  
               
               
         
Minimum:
62.5%
  
         
Lower (First) Quartile:
77.5%
  
         
Median:
85.9%
  
         
Average:
115.2%
  
         
Upper (Third) Quartile:
105.8%
  
         
Maximum:
266.1%
  
               
               
         
Selected
105.0%
  
               
               
Notes:
            
Source:  Historical stock prices extracted from Capital IQ, a division of Standard & Poor's.
               (1) Historical volatility calculated using daily prices from June 23, 2000 through June 21, 2010.
 
 
 
 
 
Premier Biomedical, Inc.
Exhibit 3, Page 1
Discount for Lack of Marketability (DLOM)
  
(Actuals)
Valuation as of June 21, 2010
 
 
       
Common Stock and Preferred Stock Warrants
    
      (1)  
Holding Period
    
12.0 month term
    
         
Current Price
       $1.00    
         
Dividend Yield
       0.0 %  
         
Strike Price
       $1.00    
         
Maturity (years)
       1.00    
      (2)  
Risk-free Rate
       0.29 %  
      (3)  
Volatility
       115.00 %  
          V2T       0.492    
         
vT
       0.701    
                       
      (4)  
Asian Put Value
       0.274    
                       
         
DLOM - Common and Preferred Warrants
       27.0 %  
                       
                       
                       
         
Concluded DLOM
 25.0 %  
                       
                       
Notes:
(1)
  
Based on the estimated holding period required to divest the warrant positions.
(2)
  
Continuously compounding risk-free rate of return associated with a 12 month term. Source: U.S. Treasury.
(3)
  
See Exhibit 3, Page 2. The calculated volatility relies on data from the previous 12 months.
(4)
  
We used an Asian or "average" put option where the payoff depends on the average price of the underlying asset during the life of the option. Traditional put options can overstate the marketability based on the fact that a restricted stock and a put option combined provides the owner 100.0 percent downside protection and 100.0 percent upside participation. However, the owner of a marketable security does not have 100.0 percent downside protection.
 
 
 
 
 
Premier Biomedical, Inc.
Exhibit 3, Page 2
Volatility Calculation Summary - 1.0 Year
  
(Actuals)
Valuation as of June 21, 2010
 
 
           
21-Jun-2010
  
           
Historical
  
   
Guideline Company
      
Volatility (1)
  
               
   
BioCryst Pharmaceuticals, Inc.
  
 NasdaqGS:BCRX
  
85.7%
  
   
Enzo Biochem Inc.
  
 NYSE:ENZ
  
63.8%
  
   
Entest Biomedical, Inc.
  
 OTCPK:ENTB
  
266.1%
  
   
Intellect Neurosciences, Inc.
  
 OTCPK:ILNS
  
205.4%
  
   
Lexicon Pharmaceuticals, Inc.
  
 NasdaqGS:LXRX
  
92.1%
  
   
Osiris Therapeutics, Inc.
  
 NasdaqGM:OSIR
  
67.0%
  
   
Cytori Therapeutics, Inc.
  
 NasdaqGM:CYTX
  
72.6%
  
   
DURECT Corporation
  
 NasdaqGM:DRRX
  
59.7%
  
   
Dyax Corp.
  
 NasdaqGM:DYAX
  
62.5%
  
   
Zalicus Inc.
  
 NasdaqGM:ZLCS
  
121.5%
  
               
               
         
Minimum:
59.7%
  
         
Lower (First) Quartile:
64.6%
  
         
Median:
79.1%
  
         
Average:
109.6%
  
         
Upper (Third) Quartile:
114.2%
  
         
Maximum:
266.1%
  
               
               
         
Selected
115.0%
  
               
               
Notes:
Source:  Historical stock prices extracted from Capital IQ, a division of Standard & Poor's.
               (1) Historical volatility calculated using daily prices from June 21, 2009 through June 21, 2010.
 
 
 
 
 
Premier Biomedical, Inc.
Supplemental A, Page 1
Option-pricing Method to Allocation - Option Value by Capital Structure
  
(Actuals)
Valuation as of June 21, 2010
 
 
     
Breakpoints (1)
            
 
from
     $0.0000       $1,000.0000       $1,000.0010       $1,120.0010            
 
to
     $1,000.0000       $1,000.0010       $1,120.0010       n/a            
                                             
     
Value to Allocate (1)
            
        986.4891       $0.0010       $115.1810       $14,815.3289  
=
     $15,917.0000    
                                               
     
Participation (2)
              
 
Senior debt
     100.0 %     0.0 %     0.0 %     0.0%              
 
Common Stock
     0.0 %     0.0 %     83.3 %     20.6%              
 
Common Stock Warrants
     0.0 %     0.0 %     0.0 %     75.3%              
 
Preferred Stock Warrants
     0.0 %     0.0 %     16.7 %     4.1%              
 
Preferred Stock
     0.0 %     100.0 %     0.0 %     0.0%              
        100.0 %     100.0 %     100.0 %     100.0%              
                                               
     
Summary Values (3)
              
 
Senior debt
     $986.4891       $0.0000       $0.0000       $0.0000  
=
     $986.4891    
 
Common Stock
     $0.0000       $0.0000       $95.9841       $3,054.7069  
=
     $3,150.6911    
 
Common Stock Warrants
     $0.0000       $0.0000       $0.0000       $11,149.6803  
=
     $11,149.6803    
 
Preferred Stock Warrants
     $0.0000       $0.0000       $19.1968       $610.9414  
=
     $630.1382    
 
Preferred Stock
     $0.0000       $0.0010       $0.0000       $0.0003  
=
     $0.0013    
                                               
                                          $15,917.0000    
                                               
      Total Value     Outstanding Shares (4)      
Value
Per
Share (5)
                      
                                               
 
Senior debt
     $986.4891       n/a       n/a                      
 
Common Stock
     $3,150.6911       10,000,000       $0.00032                      
 
Common Stock Warrants
     $11,149.6803       36,500,000       $0.00031                      
 
Preferred Stock Warrants
     $630.1382       2,000,000       $0.00032                      
 
Preferred Stock
     $0.0013       1       $0.00128                      
                                               
        $15,917.0000       48,500,001                              
                                               
                                               
Notes:
(1)
See Supplemental A, Page 2. Breakpoints represent strike prices used in the Black-Scholes calculation. Value to Allocate represents the result of the Black-Scholes calculation for each breakpoint.
(2)
See Supplemental B, Page 1. Participation results from the capital structure and preferences related to such securities.
(3)
Summary Values are the product of Participation and Value to Allocate.
(4)
See Supplemental B, Page 1.
(5)
The per share values reflect the unadjusted values.
 
 
 
 
 
Premier Biomedical, Inc.
Supplemental A, Page 2
Option-pricing Method to Allocation - Breakpoint Summary
  
(Actuals)
Valuation as of June 21, 2010
 
 
   
Description
  
Strike Price,
Breakpoint (1)
    
Black-Scholes
Calculation (2)
    
Incremental
Value (3)
    
                               
   
Base value to be allocated
     $0.0000       $15,917.0000       n/a    
   
Senior debt obligation fulfilled
     $1,000.0000       $14,930.5109       $986.4891    
   
Preferred stock achieves liquidation preference and preferred stock warrants exercise
     $1,000.0010       $14,930.5099       $0.0010    
   
Common stock warrants exercised
     $1,120.0010       $14,815.3289       $115.1810    
   
The common option
     n/a       n/a       $14,815.3289    
                               
                          $15,917.0000    
                               
                               
Notes:
(1)  
The Strike Price is the Critical Value; a value which was calculated after an analysis of the quantity, relative seniority, and economic characteristics of the equity classes.
(2)  
The Black-Scholes Calculation inputs are as follows:
   
I. Implied Market Value of Invested Capital - $15,917 (represents aggregate of cash, debt, and patent registration fees)
   
II. Strike Price (Exercise Price) - varies; as determined by the critical value analysis
   
III. Time Until Expiration - 12 month term
   
IV. Volatility - 115.0 percent (see Exhibit 3, Page 2)
   
V. Risk Free Interest Rate - 0.29 percent, continuously compounding
   
VI. Dividend Yield - 0 percent
(3)  
The incremental value is the value which is to be allocated as prescribed by the option pricing method. After all incremental value is allocated, the common option must be allocated on a fully diluted basis.
 
 
 
 
 
Premier Biomedical, Inc.
Supplemental B, Page 1
Capitalization Details - Diluted Shares
  
(Actuals)
Valuation as of June 21, 2010
 
 
             
21-Jun-2010
    
                         
   
Diluted Shares
                    
(1)  
Common Stock
           10,000,000       20.62 %  
(2)  
Common Stock Warrants
       36,500,000       75.26 %  
(3)  
Preferred Stock Warrants
       2,000,000       4.12 %  
(4)  
Preferred Stock
           1       0.00 %  
                             
   
Total
           48,500,001       100.00 %  
                             
                             
Notes:
(1)  
Balance calculated as follows:
                    
         
Common stock
                    
     
Founders
     10,000,000                    
     
Issued
     0                    
            10,000,000                    
         
(2)  
The common stock warrants' weighted strike price is $0.000010 per share.
(3)  
The preferred stock warrants' strike price is $0.001000 per share.
(4)  
No preferred stock existed as of the Valuation Date. We assumed one share of preferred stock existed with liquidation preference and pro-rata participation with common stock for purposes of valuing the preferred stock warrant.
 
 
 
 
 
 
 
 
 
 
TODD G. POLING
President, Vantage Point Advisors, Inc.

EMPLOYMENT HISTORY
 
2005 – Present
 Vantage Point Advisors, Inc.
President

Vantage Point Advisors specializes in corporate valuation and related financial advisory services. The firm provides purchase price allocation and goodwill impairment studies in connection with SFAS 141R and 142, stock option and stock plan valuations in connection with SFAS 123R and IRC 409A, fair value studies in connection with SFAS 133 and 157, ESOP valuations, fairness opinions, valuation opinions for gift and estate planning purposes, valuation opinions for marital dissolutions, intangible asset and intellectual property valuations, and valuations for other general corporate purposes. Financial advisory services include assisting clients in developing value creation, growth, and exit strategies.
 
1996 – 2005
  CBIZ Valuation Group, Inc.
Managing Director

Mr. Poling managed large and complex valuation consulting engagements focusing heavily in the transaction arena. He participated in numerous engagements involving corporate restructurings, initial public offerings, mergers and acquisitions, ESOPs and fairness opinions. He gained significant experience providing valuation consulting in litigation support situations and provided testimony as an expert witness in both deposition and trial settings. In addition to his consulting responsibilities, Mr. Poling was responsible for the creation and implementation of the strategic plan and held senior leadership positions in the firm’s Dallas, San Diego, and Los Angeles offices.
 
1993 – 1995
  ADR, Inc.
General Manager

Mr. Poling was the number two executive responsible for the company’s operating activities for this start- up drapery hardware manufacturing company located in Dallas, TX. He and his staff quickly established core business operating systems, including manufacturing, sales, personnel, information technology and finance. Under his direction, the company achieved and maintained profits amidst significant growth in sales and employment. During his tenure the company grew from a staff of two employees with no revenue to approximately 60 employees with full product line installations at over 175 retail stores across the United States.  Today, ADR, Inc. is viewed as a leader in its industry and is a thriving, international business with over 150 employees.
 
1988 – 1991
Arthur Andersen & Co.
Staff Accountant

Mr. Poling performed numerous auditing and small business consulting engagements for companies in several different industries, including healthcare, restaurant, construction and oil and gas. He gained significant business and accounting experience through planning, supervising and actively participating in these client engagements.
 
FORMAL EDUCATION
 
•  
MBA, Marketing, Finance and Entrepreneurial Studies – 1993  Southern Methodist University, Dallas, Texas
•  
BA, Accounting – 1988
 
University of South Dakota, Vermillion, South Dakota
 
 
 
 
 
 
 
ACADEMIC HONORS AND AWARDS

•  
Selected by SMU Cox School of Business Faculty to participate in Dean’s Leadership Class, Spring 1993
•  
SMU Cox School of Business Dean’s Scholarship, 1991-92 and 1992-93
•  
University of South Dakota Outstanding Male Student Athlete, 1988; Mortar Board; Omicron Delta Kappa; Deans List

ACCREDITATIONS, LICENSES AND CONTINUING EDUCATION

•  
CPA – State of Texas (inactive)
•  
Associate Member, Business Valuation, American Society of Appraisers
•  
Principals of Business Valuation – BV 201, 202, 203, 204, offered by American Society of Appraisers
•  
Valuation of Intangible Assets for Financial Reporting Purposes – BV 301, offered by American Society of Appraisers
•  
Cost of Capital course, offered by Center for Advanced Valuation Studies (CAVS)
•  
ESOP Valuation course, offered by Center for Advanced Valuation Studies (CAVS)
•  
Real Options Valuation and Monte Carlo simulation course, offered by Center for Advanced Valuation Studies (CAVS)

BOARDS AND OTHER CIVIC ACTIVITIES

•  
San Diego Rotary Club 33
•  
Board of Directors – Association for Corporate Growth (ACG), San Diego Chapter
•  
Board of Advisors – Entrepreneurial Management Center (EMC), San Diego State University
•  
Board of Directors – University of South Dakota Alumni Association, Vermillion, SD
•  
Trustee – University of South Dakota Foundation
•  
Past Volunteer – Big Brothers and Junior Achievement

PROFESSIONAL ASSOCIATIONS AND OTHER CREDENTIALS

•  
Member, American Institute of Certified Public Accountants
•  
Candidate, American Society of Appraisers

SELECT LECTURES AND APPEARANCES

•  
“Staying in or Getting Out- Exploring Exit Strategies and Liquidity Options” – presentation with Allen Matkins and Northwestern Mutual Financial Network – The Entrepreneurial Management Center (EMC) Retreat – February 2009.
•  
“The Nuts and Bolts of M&A” – presentation with Duane Morris, LLP – The Entrepreneurial Management Center (EMC) Roundtable Panel – September 2008.
•  
“How to Go Up in a Down Market”, panel presentation – BioCom CFO Series, San Diego, California – May 2008.
•  
“Valuation Workshop”, panel presentation – The Entrepreneurial Management Center (EMC) Third Annual Family Business Retreat, San Diego, California – February 2008.
 
 
Todd Poling Vantage Point Advisors, Inc.        Page 2
 
 
 
 
 
•  
 “Valuation of Early-Stage Enterprises,” panel moderator – Early Stage Investing Conference, San Francisco, California – October 2004.
•  
“Valuation Workshop,” – Arizona Venture Capital Conference, Phoenix, Arizona – April 2003.
•  
“Valuation and Accounting Touchpoints,” panel presentation – CBI Energy Conference, Monterey, California – July 2002.
•  
“Financial Due Diligence,” panel presentation – Mid-Market Investment Conference, Chicago, Illinois – October 2001.
•  
“Valuation Implications of Built-In Capital Gains Taxes” – Internal Revenue Service, Western Region, San Diego, California – September 2000.
•  
“Valuation Analysis and Executive Compensation” – Valuation Roundtable of San Francisco, San Francisco, California – April 1999.
•  
“Intercompany Transfer Pricing Analysis” – Primedia Workplace Learning Accounting and Financial Television Network, Dallas, Texas – July 1998.

EXPERT WITNESS TESTIMONY

•  
Sun City RV vs. Damon Corporation (No. 2000-009246), Superior Court of Arizona, Maricopa County. Deposition testimony in May 2003 as to the value of a recreational vehicle retailer.
•  
Jerry S. Payne vs. Commissioner (No. 12473-99), United States Tax Court. Trial testimony in December 2001 as to the valuation of certain intangible assets for a Houston area nightclub.
•  
Ralph Pipkin Trucking Inc., a California corporation (No. 00-04613-A11), United States
 
Bankruptcy Court for the Southern District of California. Deposition testimony in January 2001 as to the value of a trucking company.
•  
Gold Car, Inc. vs. Bradshaw, Smith & Company, (No. A367516), Clark County, Nevada.
 
Mediation testimony in July 2000 as to the value of a rental car company.
•  
F. Scott Salyer vs. Salyer American Fresh Foods, et al. (No. 115481), Superior Court of California, County of Monterey. Deposition testimony in August 1999, and trial testimony in September 1999, as to the value of a grower/shipper of fresh produce.
•  
Kimberly-Clark Tissue Co. vs. United States, (No. 97-C-0134), Eastern District of Wisconsin.
 
Deposition testimony in August 1998 as to the value of certain intangible assets.
•  
Eugene M. Oliver and Anna Oliver vs. WFAA-TV, INC.; and Robert Riggs; Charles James Harman, SR.; and Wilma Harman, (No. 3-96-CV-3436-G), United States District Court for the Northern District of Texas Dallas Division. Deposition testimony in July 1998 as to the value of certain insurance contracts.
•  
Geotex, Inc. d/b/a Delta Concepts vs. Delta Concepts, Inc. D. Michael Tiedeman and Joseph
 
Weintraub, (No. 94-11624), 68th Judicial District Court, Dallas County, Texas. Trial testimony in December 1997 as to the value of a plastics manufacturer.
•  
Douglas W. Fugate, S. Mark Rippley, James Masters, and Cable Advertising Networks vs. Mark
 
Weisbart; Michael Curran; Akin, Gump, Strauss; Hauer & Feld, L.L.P.; Jonathan V. Leaver; and
 
Cable Advertising Concepts, (No. 17-158151-95), 17th Judicial District, Tarrant County, Texas.
 
Deposition testimony in February 1997 as to the value of a cable advertising company.
 
 
Todd Poling Vantage Point Advisors, Inc.        Page 3
 
 
 
 
 
SELECT CORPORATE FINANCE AND FINANCIAL REPORTING ENGAGEMENTS

•  
Rendered a fairness opinion to the board of directors of a publicly held title company in connection an acquisition.
•  
Served as financial advisor to a software development company and assisted in negotiating the sale of the company to a publicly held strategic buyer.
•  
Served as financial advisor to a software development and marketing company for purposes of implementing an executive incentive stock plan.
•  
Rendered a fairness opinion on behalf of the trustee of an agricultural chemical manufacturer in conjunction with the formation of an employee stock option plan.
•  
Served as financial advisor for a sports equipment manufacturing company prior to its initial public offering.
•  
Served as financial advisor to an Internet education company. Our analysis was used as the basis for a major venture capital investment.
•  
Rendered a fairness opinion to the board of directors of an oil and gas company in connection with a reverse merger.
•  
Served as valuation advisor to an investment company with respect to due diligence and deal consulting related to a major investment in a publicly held aircraft parts distribution company.
•  
Served as financial advisor to the board of directors of an optical lens manufacturing company with respect to a proposed sale of the company.
•  
Served as financial advisor to a developer of interactive games for purposes of implementing an incentive stock plan.
•  
Served as financial advisor to a manufacturer and wholesaler of decorative fountains for purposes of assisting management with a pending sale of the company.
•  
Valued the intangible assets acquired in a merger between two national electronic stock exchange companies in connection with SFAS 141.
•  
Valued the intangible assets of two biotech firms with multiple pharmaceutical compounds under development in connection with SFAS 141.
•  
Valued the acquired intangible assets of a development stage pharmaceutical company in connection with SFAS 142.
•  
Served as valuation advisor to an international sports apparel manufacturing and marketing company with respect to the value of certain intangible assets for collateral purposes in connection with a major debt-financing event.
 
 
Todd Poling Vantage Point Advisors, Inc.        Page 4
 
 
 
 
 
 
 
 
 
 
Premier Biomedical, Inc.
Exhibit 1, Page 1
Black-scholes Calculation - Common Stock Warrant
  
(Actuals)
Valuation as of February 28, 2011
 
 
                         
Common
Stock Warrant
    
                               
   
Black-scholes Calculation
                    
(1)    
Underlying price
                 $0.00225    
     
Exercise price
                 $0.00195    
(2)    
Time to expiration (days)
                 3,395    
(3)    
Volatility
                 105.00 %  
(4)    
Risk-free interest rate
                 3.27 %  
                                 
      d1                     1.741    
      d2                     (1.461 )  
     
Output:
                 $0.00206    
                                   
   
Black-scholes value of common stock warrant
           $0.00206    
   
Discount for lack of marketability
       25.0%       ($0.00052 )  
                                     
   
Common stock warrant fair value - non-marketable
             $0.00155    
                                     
   
Common stock warrant fair value - non-marketable (rounded)
       $0.00155    
                                     
                                     
Notes:
(1)  
Price per share of common stock. See Supplemental A, Page 1. Summary values per the option-pricing method to allocation as follows:
     
         
Per share Values
                    
     
Common Stock
     $0.00225                    
     
Common Stock Warrants
     $0.00109                    
     
Preferred Stock Warrants
     $0.01065                    
     
Preferred Stock
     $0.01164                    
                               
(2)  
Calculated as follows:
                          
                                   
               
Days to expiration
                    
           
Current date
     2-28-2011                    
           
Expiration date
     6-15-2020                    
           
Days
     3395                    
     
(3)  
See Exhibit 2, Page 1 for volatility data.
(4)  
Continuously compounding risk-free rate of return associated with a 108 month term. Source: U.S. Treasury.
(5)  
See Exhibit 3, Page 1. We conducted an Asian put option calculation to determine the discount for lack of marketability.
 
 
 
 
 
Premier Biomedical, Inc.
Exhibit 2, Page 1
Volatility Calculation Summary - 9.3 Years
  
(Actuals)
Valuation as of February 28, 2011
 
 
           
28-Feb-2011
  
           
Historical
  
   
Guideline Company
      
Volatility (1)
  
               
   
BioCryst Pharmaceuticals, Inc.
  
 NasdaqGS:BCRX
  
90.3%
  
   
Enzo Biochem Inc.
  
 NYSE:ENZ
  
59.5%
  
   
Entest Biomedical, Inc.
  
 OTCPK:ENTB
  
266.1%
  
   
Intellect Neurosciences, Inc.
  
 OTCPK:ILNS
  
223.8%
  
   
Lexicon Pharmaceuticals, Inc.
  
 NasdaqGS:LXRX
  
79.6%
  
   
Osiris Therapeutics, Inc.
  
 NasdaqGM:OSIR
  
65.4%
  
   
Cytori Therapeutics, Inc.
  
 NasdaqGM:CYTX
  
75.7%
  
   
DURECT Corporation
  
 NasdaqGM:DRRX
  
86.1%
  
   
Dyax Corp.
  
 NasdaqGM:DYAX
  
82.4%
  
   
Zalicus Inc.
  
 NasdaqGM:ZLCS
  
109.7%
  
               
               
         
Minimum:
59.5%
  
         
Lower (First) Quartile:
76.7%
  
         
Median:
84.3%
  
         
Average:
113.9%
  
         
Upper (Third) Quartile:
104.9%
  
         
Maximum:
266.1%
  
               
               
         
Selected
105.0%
  
               
               
Notes:
Source:  Historical stock prices extracted from Capital IQ, a division of Standard & Poor's.
               (1) Historical volatility calculated using daily prices from November 12, 2001 through February 28, 2011.
 
 
 
 
 
Premier Biomedical, Inc.
Exhibit 3, Page 1
Discount for Lack of Marketability (DLOM)
  
(Actuals)
Valuation as of February 28, 2011
 
 
         
Common Stock Warrants
    
      (1)    
Holding Period
    
12.0 month term
    
           
Current Price
       $1.00    
           
Dividend Yield
       0.0 %  
           
Strike Price
       $1.00    
           
Maturity (years)
       1.00    
      (2)    
Risk-free Rate
       0.25 %  
      (3)    
Volatility
       115.00 %  
            V2T       0.492    
           
vT
       0.701    
                         
      (4)    
Asian Put Value
       0.274    
                         
           
DLOM - Common Stock Warrants
       27.0 %  
                         
                         
                         
           
Concluded DLOM
       25.0 %  
                         
                         
Notes:
(1)
  
Based on the estimated holding period required to divest the warrant positions.
(2)
  
Continuously compounding risk-free rate of return associated with a 12 month term. Source: U.S. Treasury.
(3)
  
See Exhibit 3, Page 2. The calculated volatility relies on data from the previous 12 months.
(4)
  
We used an Asian or "average" put option where the payoff depends on the average price of the underlying asset during the life of the option. Traditional put options can overstate the marketability based on the fact that a restricted stock and a put option combined provides the owner 100.0 percent downside protection and 100.0 percent upside participation. However, the owner of a marketable security does not have 100.0 percent downside protection.
 
 
 
 
 
Premier Biomedical, Inc.
Exhibit 3, Page 2
Volatility Calculation Summary - 1.0 Year
  
(Actuals)
Valuation as of February 28, 2011
 
 
           
28-Feb-2011
  
           
Historical
  
   
Guideline Company
      
Volatility (1)
  
               
   
BioCryst Pharmaceuticals, Inc.
  
 NasdaqGS:BCRX
  
85.7%
  
   
Enzo Biochem Inc.
  
 NYSE:ENZ
  
63.8%
  
   
Entest Biomedical, Inc.
  
 OTCPK:ENTB
  
266.1%
  
   
Intellect Neurosciences, Inc.
  
 OTCPK:ILNS
  
205.4%
  
   
Lexicon Pharmaceuticals, Inc.
  
 NasdaqGS:LXRX
  
92.1%
  
   
Osiris Therapeutics, Inc.
  
 NasdaqGM:OSIR
  
67.0%
  
   
Cytori Therapeutics, Inc.
  
 NasdaqGM:CYTX
  
72.6%
  
   
DURECT Corporation
  
 NasdaqGM:DRRX
  
59.7%
  
   
Dyax Corp.
  
 NasdaqGM:DYAX
  
62.5%
  
   
Zalicus Inc.
  
 NasdaqGM:ZLCS
  
121.5%
  
               
               
         
Minimum:
59.7%
  
         
Lower (First) Quartile:
64.6%
  
         
Median:
79.1%
  
         
Average:
109.6%
  
         
Upper (Third) Quartile:
114.2%
  
         
Maximum:
266.1%
  
               
               
       
 
Selected
115.0%
  
               
               
Notes:
Source:  Historical stock prices extracted from Capital IQ, a division of Standard & Poor's.
               (1) Historical volatility calculated using daily prices from February 28, 2010 through February 28, 2011.
 
 
 
 
 
Premier Biomedical, Inc.
Supplemental A, Page 1
Option-pricing Method to Allocation - Option Value by Capital Structure
  
(Actuals)
Valuation as of February 28, 2011
 
     
Breakpoints (1)
            
 
from
     $0.000       $3,489.000       $3,489.001       $22,980.607       $48,805.518            
 
to
     $3,489.000       $3,489.001       $22,980.607       $48,805.518       n/a            
                                                     
     
Value to Allocate (1)
            
        $3,468.232       $0.001       $16,793.587       $15,392.977       $54,963.971  
=
     $90,618.768    
                                                       
     
Participation (2)
              
 
Senior debt
     100.0 %     0.0 %     0.0 %     0.0 %     0.0%              
 
Common Stock
     0.0 %     0.0 %     0.0 %     84.9 %     22.2%              
 
Common Stock Warrants
     0.0 %     0.0 %     0.0 %     0.0 %     73.8%              
 
Preferred Stock Warrants
     0.0 %     0.0 %     100.0 %     15.1 %     4.0%              
 
Preferred Stock
     0.0 %     100.0 %     0.0 %     0.0 %     0.0%              
        100.0 %     100.0 %     100.0 %     100.0 %     100.0%              
                                                       
     
Summary Values (3)
              
 
Senior debt
     $3,468.232       $0.000       $0.000       $0.000       $0.000  
=
     $3,468.232    
 
Common Stock
     $0.000       $0.000       $0.000       $13,064.798       $12,228.259  
=
     $25,293.057    
 
Common Stock Warrants
     $0.000       $0.000       $0.000       $0.000       $40,556.607  
=
     $40,556.607    
 
Preferred Stock Warrants
     $0.000       $0.000       $16,793.579       $2,328.177       $2,179.104  
=
     $21,300.859    
 
Preferred Stock
     $0.000       $0.001       $0.008       $0.001       $0.001  
=
     0.012    
                                                       
                                                  $90,618.768    
                                                       
     
Total
Value
    
Outstanding
Shares (4)
    
Value
Per
Share (5)
                              
                                                       
 
Senior debt
     $3,468.232       n/a       n/a                              
 
Common Stock
     $25,293.057       11,223,200       $0.00225                              
 
Common Stock Warrants
     $40,556.607       37,223,200       $0.00109                              
 
Preferred Stock Warrants
     $21,300.859       2,000,000       $0.01065                              
 
Preferred Stock
     $0.012       1       $0.01164                              
                                                       
        $90,618.768       50,446,401                                      
                                                       
                                                       
 
Notes:
                                              
(1)
See Supplemental A, Page 2. Breakpoints represent strike prices used in the Black-Scholes calculation. Value to Allocate represents the result of the Black-Scholes calculation for each breakpoint.
(2)
See Supplemental B, Page 1. Participation results from the capital structure and preferences related to such securities.
(3)
Summary Values are the product of Participation and Value to Allocate.
(4)
See Supplemental B, Page 1.
(5)
The per share values reflect the unadjusted values.
 
 
 
 
 
Premier Biomedical, Inc.
Supplemental A, Page 2
Option-pricing Method to Allocation - Breakpoint Summary
  
(Actuals)
Valuation as of February 28, 2011
 
 
   
Description
  
Strike Price,
Breakpoint (1)
    
Black-Scholes
Calculation (2)
    
Incremental
Value (3)
    
   
Base value to be allocated
     $0.0000       $90,618.7680       n/a    
   
Senior debt obligation fulfilled
     $3,489.0000       $87,150.5356       $3,468.2324    
   
Preferred stock achieves partial liquidation preference until preferred stock warrants exercise
     $3,489.0010       $87,150.5346       $0.0010    
   
Preferred stock and excised preferred stock warrants achieve full liquidation preference
     $22,980.6067       $70,356.9475       $16,793.5871    
   
Common stock warrants exercised
     $48,805.5182       $54,963.9709       $15,392.9766    
   
The common option
     n/a       n/a       $54,963.9709    
                               
                          $90,618.7680    
                               
                               
Notes:
  (1)  
The Strike Price is the Critical Value; a value which was calculated after an analysis of the quantity, relative seniority, and economic characteristics of the equity classes.
  (2)  
The Black-Scholes Calculation inputs are as follows:
     
I. Implied Market Value of Invested Capital - $90,619 (represents aggregate of cash, debt and patent registration fees)
     
II. Strike Price (Exercise Price) - varies; as determined by the critical value analysis
     
III. Time Until Expiration - 12 month term
     
IV. Volatility - 115.0 percent (see Exhibit 3, Page 2)
     
V. Risk Free Interest Rate - 0.25 percent, continuously compounding
     
VI. Dividend Yield - 0 percent
  (3)  
The incremental value is the value which is to be allocated as prescribed by the option pricing method. After all incremental value is allocated, the common option must be allocated on a fully diluted basis.
 
 
 
 
 
Premier Biomedical, Inc.
Supplemental B, Page 1
Capitalization Details - Diluted Shares
  
(Actuals)
Valuation as of February 28, 2011
 
             
28-Feb-2011
    
                         
   
Diluted Shares
                    
  (1)  
Common Stock
           11,223,200       22.25 %  
  (2)  
Common Stock Warrants
       37,223,200       73.79 %  
  (3)  
Preferred Stock Warrants
       2,000,000       3.96 %  
  (4)  
Preferred Stock
           1       0.00 %  
                               
     
Total
           50,446,401       100.00 %  
                                 
                                 
Notes:
  (1)  
Balance calculated as follows:
                    
                               
         
Common stock
                    
       
Founders
     10,500,000                    
       
Issued
     723,200                    
              11,223,200                    
           
  (2)  
The common stock warrants' weighted strike price is $0.001953 per share.
    
  (3)  
The preferred stock warrants' strike price is $0.001000 per share.
            
  (4)  
No preferred stock existed as of the Valuation Date. We assumed one share of preferred stock existed with liquidation preference and pro-rata participation with common stock for purposes of valuing the preferred stock warrant.
 
 
 
 
 
 
 
 
 
 
TODD G. POLING
President, Vantage Point Advisors, Inc.

EMPLOYMENT HISTORY

2005 – Present
Vantage Point Advisors, Inc.
President

Vantage Point Advisors specializes in corporate valuation and related financial advisory services. The firm provides purchase price allocation and goodwill impairment studies in connection with SFAS 141R and 142, stock option and stock plan valuations in connection with SFAS 123R and IRC 409A, fair value studies in connection with SFAS 133 and 157, ESOP valuations, fairness opinions, valuation opinions for gift and estate planning purposes, valuation opinions for marital dissolutions, intangible asset and intellectual property valuations, and valuations for other general corporate purposes. Financial advisory services include assisting clients in developing value creation, growth, and exit strategies.
 
1996 – 2005
 CBIZ Valuation Group, Inc.
Managing Director

Mr. Poling managed large and complex valuation consulting engagements focusing heavily in the transaction arena. He participated in numerous engagements involving corporate restructurings, initial public offerings, mergers and acquisitions, ESOPs and fairness opinions. He gained significant experience providing valuation consulting in litigation support situations and provided testimony as an expert witness in both deposition and trial settings. In addition to his consulting responsibilities, Mr. Poling was responsible for the creation and implementation of the strategic plan and held senior leadership positions in the firm’s Dallas, San Diego, and Los Angeles offices.
 
1993 – 1995
ADR, Inc.
General Manager

Mr. Poling was the number two executive responsible for the company’s operating activities for this start- up drapery hardware manufacturing company located in Dallas, TX. He and his staff quickly established core business operating systems, including manufacturing, sales, personnel, information technology and finance. Under his direction, the company achieved and maintained profits amidst significant growth in sales and employment. During his tenure the company grew from a staff of two employees with no revenue to approximately 60 employees with full product line installations at over 175 retail stores across the United States. Today, ADR, Inc. is viewed as a leader in its industry and is a thriving, international business with over 150 employees.
 
1988 – 1991
Arthur Andersen & Co.
Staff Accountant

Mr. Poling performed numerous auditing and small business consulting engagements for companies in several different industries, including healthcare, restaurant, construction and oil and gas. He gained significant business and accounting experience through planning, supervising and actively participating in these client engagements.
 
FORMAL EDUCATION

•  
MBA, Marketing, Finance and Entrepreneurial Studies – 1993 Southern Methodist University, Dallas, Texas
•  
BA, Accounting – 1988
 
University of South Dakota, Vermillion, South Dakota
 
 
 
 
 
 
ACADEMIC HONORS AND AWARDS

•  
Selected by SMU Cox School of Business Faculty to participate in Dean’s Leadership Class, Spring 1993
•  
SMU Cox School of Business Dean’s Scholarship, 1991-92 and 1992-93
•  
University of South Dakota Outstanding Male Student Athlete, 1988; Mortar Board; Omicron Delta Kappa; Deans List

ACCREDITATIONS, LICENSES AND CONTINUING EDUCATION

•  
CPA – State of Texas (inactive)
•  
Associate Member, Business Valuation, American Society of Appraisers
•  
Principals of Business Valuation – BV 201, 202, 203, 204, offered by American Society of Appraisers
•  
Valuation of Intangible Assets for Financial Reporting Purposes – BV 301, offered by American Society of Appraisers
•  
Cost of Capital course, offered by Center for Advanced Valuation Studies (CAVS)
•  
ESOP Valuation course, offered by Center for Advanced Valuation Studies (CAVS)
•  
Real Options Valuation and Monte Carlo simulation course, offered by Center for Advanced Valuation Studies (CAVS)

BOARDS AND OTHER CIVIC ACTIVITIES

•  
San Diego Rotary Club 33
•  
Board of Directors – Association for Corporate Growth (ACG), San Diego Chapter
•  
Board of Advisors – Entrepreneurial Management Center (EMC), San Diego State University
•  
Board of Directors – University of South Dakota Alumni Association, Vermillion, SD
•  
Trustee – University of South Dakota Foundation
•  
Past Volunteer – Big Brothers and Junior Achievement

PROFESSIONAL ASSOCIATIONS AND OTHER CREDENTIALS

•  
Member, American Institute of Certified Public Accountants
•  
Candidate, American Society of Appraisers

SELECT LECTURES AND APPEARANCES

•  
“Staying in or Getting Out- Exploring Exit Strategies and Liquidity Options” – presentation with Allen Matkins and Northwestern Mutual Financial Network – The Entrepreneurial Management Center (EMC) Retreat – February 2009.
•  
“The Nuts and Bolts of M&A” – presentation with Duane Morris, LLP – The Entrepreneurial Management Center (EMC) Roundtable Panel – September 2008.
•  
“How to Go Up in a Down Market”, panel presentation – BioCom CFO Series, San Diego, California – May 2008.
 
“Valuation Workshop”, panel presentation – The Entrepreneurial Management Center (EMC) Third Annual Family Business Retreat, San Diego, California – February 2008.
 
 
Todd Poling Vantage Point Advisors, Inc.        Page 2
 
 
 
 
 
•  
 “Valuation of Early-Stage Enterprises,” panel moderator – Early Stage Investing Conference, San Francisco, California – October 2004.
•  
“Valuation Workshop,” – Arizona Venture Capital Conference, Phoenix, Arizona – April 2003.
•  
“Valuation and Accounting Touchpoints,” panel presentation – CBI Energy Conference, Monterey, California – July 2002.
•  
“Financial Due Diligence,” panel presentation – Mid-Market Investment Conference, Chicago, Illinois – October 2001.
•  
“Valuation Implications of Built-In Capital Gains Taxes” – Internal Revenue Service, Western Region, San Diego, California – September 2000.
•  
“Valuation Analysis and Executive Compensation” – Valuation Roundtable of San Francisco, San Francisco, California – April 1999.
•  
“Intercompany Transfer Pricing Analysis” – Primedia Workplace Learning Accounting and Financial Television Network, Dallas, Texas – July 1998.
 
EXPERT WITNESS TESTIMONY
 
•  
Sun City RV vs. Damon Corporation (No. 2000-009246), Superior Court of Arizona, Maricopa County. Deposition testimony in May 2003 as to the value of a recreational vehicle retailer.
•  
Jerry S. Payne vs. Commissioner (No. 12473-99), United States Tax Court. Trial testimony in December 2001 as to the valuation of certain intangible assets for a Houston area nightclub.
•  
Ralph Pipkin Trucking Inc., a California corporation (No. 00-04613-A11), United States
 
Bankruptcy Court for the Southern District of California. Deposition testimony in January 2001 as to the value of a trucking company.
•  
Gold Car, Inc. vs. Bradshaw, Smith & Company, (No. A367516), Clark County, Nevada.
 
Mediation testimony in July 2000 as to the value of a rental car company.
•  
F. Scott Salyer vs. Salyer American Fresh Foods, et al. (No. 115481), Superior Court of California, County of Monterey. Deposition testimony in August 1999, and trial testimony in September 1999, as to the value of a grower/shipper of fresh produce.
•  
Kimberly-Clark Tissue Co. vs. United States, (No. 97-C-0134), Eastern District of Wisconsin.
 
Deposition testimony in August 1998 as to the value of certain intangible assets.
•  
Eugene M. Oliver and Anna Oliver vs. WFAA-TV, INC.; and Robert Riggs; Charles James Harman, SR.; and Wilma Harman, (No. 3-96-CV-3436-G), United States District Court for the Northern District of Texas Dallas Division. Deposition testimony in July 1998 as to the value of certain insurance contracts.
•  
Geotex, Inc. d/b/a Delta Concepts vs. Delta Concepts, Inc. D. Michael Tiedeman and Joseph
 
Weintraub, (No. 94-11624), 68th Judicial District Court, Dallas County, Texas. Trial testimony in December 1997 as to the value of a plastics manufacturer.
•  
Douglas W. Fugate, S. Mark Rippley, James Masters, and Cable Advertising Networks vs. Mark
 
Weisbart; Michael Curran; Akin, Gump, Strauss; Hauer & Feld, L.L.P.; Jonathan V. Leaver; and
 
Cable Advertising Concepts, (No. 17-158151-95), 17th Judicial District, Tarrant County, Texas.
 
Deposition testimony in February 1997 as to the value of a cable advertising company.
 
 
Todd Poling Vantage Point Advisors, Inc.        Page 3
 
 
 
 
 
SELECT CORPORATE FINANCE AND FINANCIAL REPORTING ENGAGEMENTS

•  
Rendered a fairness opinion to the board of directors of a publicly held title company in connection an acquisition.
•  
Served as financial advisor to a software development company and assisted in negotiating the sale of the company to a publicly held strategic buyer.
•  
Served as financial advisor to a software development and marketing company for purposes of implementing an executive incentive stock plan.
•  
Rendered a fairness opinion on behalf of the trustee of an agricultural chemical manufacturer in conjunction with the formation of an employee stock option plan.
•  
Served as financial advisor for a sports equipment manufacturing company prior to its initial public offering.
•  
Served as financial advisor to an Internet education company. Our analysis was used as the basis for a major venture capital investment.
•  
Rendered a fairness opinion to the board of directors of an oil and gas company in connection with a reverse merger.
•  
Served as valuation advisor to an investment company with respect to due diligence and deal consulting related to a major investment in a publicly held aircraft parts distribution company.
•  
Served as financial advisor to the board of directors of an optical lens manufacturing company with respect to a proposed sale of the company.
•  
Served as financial advisor to a developer of interactive games for purposes of implementing an incentive stock plan.
•  
Served as financial advisor to a manufacturer and wholesaler of decorative fountains for purposes of assisting management with a pending sale of the company.
•  
Valued the intangible assets acquired in a merger between two national electronic stock exchange companies in connection with SFAS 141.
•  
Valued the intangible assets of two biotech firms with multiple pharmaceutical compounds under development in connection with SFAS 141.
•  
Valued the acquired intangible assets of a development stage pharmaceutical company in connection with SFAS 142.
•  
Served as valuation advisor to an international sports apparel manufacturing and marketing company with respect to the value of certain intangible assets for collateral purposes in connection with a major debt-financing event.
 
 
Todd Poling Vantage Point Advisors, Inc.        Page 4
 
 
 
 
GRAPHIC 2 header.jpg GRAPHIC begin 644 header.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`.4MO&5U>ZEJMO9>&-3O; M>QNC;"ZM9;?9(RJ-W^LD0Y#$J0,CCKG@9NB_%.T\1:I?Z;I7AO7;B[L&*W,? M^BIY9#%>K3@'D'H37;6=E;:?;_9[2%(8M[/M08&YF+,?J22?QKQ3X-`#XH^/ M0.GVE\?]_GH`]3\-^)QXBGU6+^S;JPDTZY%M)'=%-Y;:&)^0LN.>,,<]:I>, M_'MKX&MUN]3TC5)K%G6,75JL+)O()"D&0,/NGG;CWKHX+"UM;JZN8(52:[=7 MG:`.Z\->(!XETJ/4HM,OK*V MF19(#=B,&5&&0P".V!C'7%/3;=&,>BWDBDB-1PRQ$,/0@D&O/_$NHPZK^ MT;X4GM8[J-1!$I%S:RVS'#2Y^615)&#UQCM0![Q:S/<6L4TEO+;.ZAC#*5+H M?0[21GZ$BN*\0_$^S\,:M9Z;J?A_6XY[V0QVA06[+,=P7((FXY(^]@\\XKNJ M\.^.DBP^-/`@&23[#F@#U!O$>IJI8^#-=P!GB6R)_+[1 M5GPQXCM?%>@PZO9P7,$,K.GE72!)%*.5(8`D#E3WK(U;Q]96<%O]FL]4,T]W M!;+]ITJZ@C'F2*A)=T51P3CGKBNGL[&UT^%XK2%88WE>9E7H7=BS'\22?QH` ML4C$JI(4L0,A1U/MS2T4`<`_Q7LH_%O+K,GW;8K;<_*6SN\[;C`)Z MUWL;%XD=HVC9E!*-C*GT."1GZ$UX=JG_`"=;I/\`U[?^V\E>YT`17,KP6TDL M=O+&H/#6NMJ]LI>6V(M1M``.=QGV MGAAT/>N\KP:PU/VF_$%Q<)=.GV7;BVM9;ALF.+^&-6;'OC%`'I6L^.Y?# M^E3:GJ?A+7X;.``R2*;23:"<9(2V,UON4%$V@2*I.=YS@''%=:JA$"J,*HP!0!PNM_%*Q\/\`B.TT M&^T#6EOKV18[54%N5FW/L4AO.P`3_>Q[XJQ?_$C3M$U"VM?$6EZKHB7)VQ75 MXD30%LCY2\4C@'G/.!@')KSGXOR-#\9_`\J0R3NDENRQ1E0SD7'W1N(&3TY( M'J14_P`8=0DU_P#L/1]U`'N( M(8`@@@\@BN+\9?$JP\"R1_VOH^K&WE?9#ZCI76V"PIIU MLMM+YL`B01R;MV]<#!SWR.]>+?M*G_B0:$.?^/J3M_LB@#O=5^)-CX>>U/B' M1M7TBVN6V)=7"0R1!NN"8I'(.,GIV-=A!/%=6\<\$B2PR*'1T.593R"#W%>) M?%SQ5:>)='L?!>C6EW+K%[/$Z175L]IM49QCS@O)(P.W7FO4_!6B3^&_!FDZ M/=2K+<6MN$D93D;NI`/H,X'L*`*WB[QK#X,LY+^_T;5)]/CV[[NU\ED4L<`8 M:0/UQ_#CGK3--\9W.L:9;:C8>$M99KN4]#@W`(_&L3XY?\DEU; M_?@_]')3?`GB[3M/^'&B1RVVL.T%@FXQ:/=.IPO9Q&5(]P<>]`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`61FSD'MCCK7/?$;Q1IU[\.]>MH[;5P\EHP4S:-=QH#[LT05?J2*?\` M`[/_``J32,_WY\?]_GH`Z37/%#:1K>FZ5;:3=ZG86;:.5G('/')%=N+.W%\UZ M(E^TM&(C)WV`D@?F37B7Q="_\+C\!'C<;B#/T^T+_P#7H`]'/C::/Q3HNA77 MAO4[*75&F"374D!0".-G./*D?)X`P<=<]L5UM5;G3K2\N[*ZGA#SV4C2V[Y( MV,R,A/'7Y688/KZ@5:H`*IZIJVGZ)I\M_J=W%:6D7WY96P!Z#W/M5RO!?BG/ M-XC^,_A?PI.V=,C>&22$])"S$N2.A^5<#TR?6@#U"#QL;ZP74=,\-:[?V#IO MCN(HX8Q(OJJ22HY'H=O/;-7_``UXLTGQ9:W$^ER3-]FE,$\W]AI%F;F_N[:RM4PIEGD6-%SP!DD`5D:+JGA*YU:\.B:KI-Q?WI$MPEI= MI(\A4!=Q56/08&<4`:&M:J^C:<]ZNFW=\D8+2):F(,B@$ECYCJ"..@)//2N3 MT3XIVOB31[C5M'\,Z_=V=NYCE=%M@P8`,0%,VX\,.@-=9X@./#>J$YXM)>@S M_`:\-^#'C/2?"'PVU:ZU1;T(FH,^Z&RE=#F.,!3(%V*2>S,.H]10![)X4\9Z M'XST]KS1;OS5C(66)U*R1$]F4_S''O6_7BGP(\-:G#!W[OXIZY=>'?AOK&H63%+D1K%&ZG!0NZIN'N`Q-`%V3Q MGI\FJ7&F:5;W>L7UL/W\5@JE8N>C2.RQAO\`9W9]J9;^.=*_MB'1]3BN]'U* M?)AM]015\WG'R.K-&Q]@V:Y;X!V<%O\`#"WGC0"2YN)GE;NQ#;1^BBJ_[0.G M17/P\2_.5GL+N-XW7J`WRD9].0?J!0!ZO7#>)_B?8>$M8MM-U/0]9\V[,/`I&,BY?&?\`KI%0![+#?W,NEM=OI-[%.H8BR=X3*V.@!$A3GMEOKBL[ M0?$[:]=7<*Z'JEDMK(T,LMV8`HD7:2F$E9B<,#G&/>M^N8\*@)K7B^,=1K`? M\[2W-`&KKFK/HNFO>KIE[J"1Y,D=GY9=5`)+8=UR..@R>>E6]NVR1E6V4AL9P%:8$\>@-=IJ"[M-NE]87'Z&O!O@CXITKPG\/\` M6-0UB:2&V&H!=Z0O)\QC7`.T'&<8R<#)ZT`>P^$O&VB>-+.6?2)W,D!"W%O, MFR6%B.C+^!&1D9!YXKH:\-^!VE:E<^*O$GBR6UN+/3-0+?9TE7:)=\GF!@.X M4<9Z?,<9YQ[E0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!4U'4[#1[)[ MW4KR"TM4QNEGD"*">@R>]>`_!WQ#I-M\3/%.?M":UIB^"ET@WD#:D]W%(+82`R*N&.XKU`[9/K7L=%`')_ M#?5M.U+P#H<5C?6]S):Z=;17"12AFB<1@%6`Y4Y!Z^E>0^-/%&B7/Q^\-:K; M:I9SZ?;11)-A M!KP7XS^(=&N_'/@\VVJ6DXT^[;[68I0_D8DB)W8Z?=/Y&OH"B@#E;_QCX%O; M,QWGB70YH5=)=GV^,G&2::1(XHU+N[L%55`R22>@`I]%`'SWJ/B' M19/VF-,U5-8L&TU(-KW@N4,*GR)!@OG;U('7J:]-\2?%7PGH6BW%Y!KFGW]R MJ'R;:UN%E:1^P.TG`SU)KMZ*`,^UU%5\/V^I:G+!;`VR37#LVR.,E06Y8\`> MYKPS0O$^A)^T=K6K2:O9)IT]L4CNWF58F/EQ<;B!=+ M@.MOK6FWMW:0R)`EI=)+*P?:2BJI/4JO)X&,Y%=/H=U=WV@:?=W\<<=W/;QR MS)'G:K,H)`SSQG%:%%`'SW\5/$.CS_&/P=+#J-K+'I]Q";N2.566'%P"0S`X M!&TY!Z5TOQ<\0:9XJ\(_\(]X;F37=3NYXRD>FD7`B"MDL[+D*.W)[^@->OT4 M`8?@S2+G0?!FCZ5>,&N;6U2.7:<@,!R`>X'3\*\<_:0U.PN;?1K&"^MI;NVG ME\^".56DBRJXW*#E<^]>_P!%`'BWQ?TZP\7^!K?Q7X=OX;NYT63+3V:#;77B M/2()XK...2*:]C1T8#!!4D$5Z+10!Q'AGQ?I&I>)E\,^%S;S:3IECNFGB)9% M;*K''&V<$`;B3SV`/6M;QQX8C\8^$+_1&D$3SH#%(>B2*=RD^V1S[9KH:*`/ M+?AOKP\(>&4\,^,2-'O-.D:**>\.R"="2RE)3\AQDC&<\?7&Y_PL.VU3Q9IN MB>&X_P"U(9)6^W7\*E[>W0(6QYB_*6)`[XY[Y%=M10!6U#4;+2;*2]U&[@M+ M6/&^:>0(JY.!DGU.!7@WP<\0:/;?$7Q@]QJ5I`NH76;0RRA1-F5\!23R?F'' M?-?05%`'"?%O6M,T_P"'^KV5W?00W5Y:.MO"[@/*>/NCJ>M9'P'U?3[CX=66 MEQ7D#7]L9GEMPX+HIE8@D=0.17J5%`!7SA\4O$^B:C\6_"5[8:K:7-M920&> M>&0/''B?</\`Q;\&:O)XBTGQQX>MGN[S3&0SVL9.]U1MRE0.O4@@R"*=&[H8VPQ/T'/;-.FTGM7OM%`' MS_\`"/Q.W@?Q-JO@+Q%=)!%'.QM99FVJ),@;^>YKVCQ5H$'BGPOJ M&BW!"I=Q%`Y&=C#E6Q[,`?PK8HH`\>^%^I3?#[3KKPKXSVZ68;AI+.\G(6VF M1NRRGY< M*2?EKURB@#-\/:+;^'/#UAH]J2T-G"L2LP&6QU8X[DY/XUYE\=?#&KZI;Z'K MFD6DEX^E3.TL$2[GVG:P8#J0"F#@'K[&O7Z*`.;TOQYX9U>"-K?5[7[2RY:S M9P+A".JF+[^1T/':K'ARQEAEU;49HWB?4[W[2L3C#(@C2)3T/2O>:*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHJ.XN(;6!Y[B:.&&,;GDD8*JCU)/`H`DHHK&O M/%WAK3[N2TO?$6DVUS&QHZGKRI;(H`V:*S+CQ'H=II\.H7&LZ=#93G$ M-S)=(L`>E+IGB'1=:>1-*UC3[]XP"ZVMRDI4'H3M)Q0!I450U+7 M-(T94;5-4L;$/PINKA(MWTW$9Z&I9]3L+;3VU"XOK:*R4!CX214.,\E20..:`+]%95KXG\/W]O>7(.%'!Y/H:ETS7M'UOS?[)U:QO_`"L>9]EN$EV9SC.TG&<'\C0!H45F MP^(M$N-1;3H-9T^6^7K;)=(T@_X"#GN/SI\VNZ1;ZI'ID^JV,6H2X\NU>X19 M7STPA.3T/:@"_15'4]:TK14C?5=3LK!)"0C75PL08CJ!N(S5B2ZMX8XY);B) M(Y&5$9G`#,QPH![DD\>M`$U%4M2UC3-&A2;5-1L[&)VV*]U.L2LV,X!8C)XJ M6QO[/4[-+RPNX+NUDSLFMY!(C8.#AAP<$$?A0!8HK/U/7M'T0Q#5=6L;`RY\ MO[5,/#$BED\1Z0P$9ERM]$?D!P6^]T!!&:V(Y$EC62-U>-P M&5E.0P/0@T`.HK*;Q-H"ZE_9K:YIHOPVW[*;N/SU6M0U33])MOM M&I7UM9P`X\VYF6-<_5B!0!;HJM:ZA97UF+RTO+>XM2-PGBE5T(ZYW`XK,@\: M>%;F=((/$VC2RN=J1QW\3,Q]``W-`&Y169J7B/0]&F2'5-:TZQE==ZI=721, MRYQD!B,C(-3Z=JVFZO`9],U"TO80<&2VF610?3*DT`7**S1XBT1M3.F#6=/. MH`X-J+I/-!ZXV9S^E+J>OZ-HK1KJNK6%@903&+JY2+?CKC<1G&1^=`&C15'3 M=9TO68GETK4K.^C0[7>UG64*?0E2<&K+75NEU':M/$MQ(C.D)_7K:KW:GZEK.EZ-$DNJ:E9V,;MM1[J=8@QZX!8 MC)H`NT4U'26-9(V5T8!E93D$'H0:=0`4444`%%%%`!1110`4444`%%%%`!11 M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5Q7Q)6'4M$7P_,UXL>H*Y ME:SM9IY%1%R#MB5CCS#'G(QC([UVM9RZ)9+JSZF#=?:G0QDF[E*;3V";MH]L M#CM0!SWPN\0R>(O`EE)=;QJ%GFSO$D&'66/@[AV)&#^-9WB`W"?&30GM(89; MG^R+K8DTAC5CN7`+!6('X&NFT7P?HWAZ]N+O3(KN.:Y8O.9+^>42L<99E=R" MW'WB,^])=>#M%O?$$>NSQ7AU*,`),FH7"!%X^4*KA0IQRH&#SD')H`\^U[PQ M<>$?@GXKBO;E))[V5[MXX"3%`9)%^1,@':/7`^E/TG[3JOQ:T0:Q'%I5WIFE M>9:);2-*-01UPV9"J\)_=QUSV&:](U[P]IGB;3CI^K12S6C$%HDN)(@_LVQA MN'?!R,X-4;CP/H%VFFB>VN'DTPL;2I@OJJZN]NYE'S)`H_=H/1?O8[&H?!_GV_B;XB:;;(!HD$P:!5'R1S-&3 M(J]ASC(_QKN-0\*Z/J5\;Z:":*[90CW%I=2VTCJ.@9HF4L!Z'-2CPYI2:+)I M$%LUM92$ETM9GA9B3DG>A#9)ZG//.+J[>`*-G&-L;Y_2N MZ\/>&=*\*V!L='@EM[7.X0M+5[M&D`Z`D2C@=AT':@#'U'2+[5_!=DEI>6>F^)&GMKZ5)_\`5O>!%8HZ M]L[4/!:20J,#&*`.8\(ZAKP\776G^*M#L;;5GLA)'J-@Y M,5U%&^,$'D%3(.N.IX`Q7`K?7]I^SEJMSI+RQR-?3!GB&&6)KC#'CIP<$^E> MS6WA[3[2VF@B^U_OD\MYI+V9YMOH)6RTRUE2TG_ M`-9!-+;Q0QVMKIZRV;(`/+8`&-E M/8YQR/6JUYH"^-/"WA2U\2I+'?S6WF-,AV2PS"($.#V(/..E=/#X'\/0-&%L M9&AB8-':R74KV\9!R"L+,8UP1QA>*NZCX>T_5-1M;^Z^U_:+0YA,5[-$JGGG M:CA3G)!R#D<'B@#S6;Q)J6GFT\'^,$635(M0LGL;[&(]1A%S&">>D@4G*]^? MQT/BYYFIZ>VFVS:@+FRA_M"`V5I--FX5OW2L44JH.)/O8&<'M7?:IHFFZT+4 M:C:1W'V6=+F`MD&.13E6!'(Y'X]#Q447AZPADO9$:]#WJ[)F^WSDD?[/S_(> M>"N"/PH`X+QKK\7BC]GR]UF$C%U:1,X!^ZXE0,OX,"*]#L)XH-&L6FE2-6BB M0%V`!9@`HY[DD`#N37/CX8>%%TM]+%I?C3Y"2]H-5N_*8DY.4\W!YYZ=:NP^ M"-#BN;2X*ZA,]FXD@6XU2ZF2-AT(1Y"O'TH`Y_XR#_BB8/\`L)VO_HP5W\DT M431K)(B-(VQ`S`%FP3@>IP"?P-9.O^%=(\3QQ1:O#<311-N6-+R:)=P.02J, M`2".">1VJHW@30GNH;F7^U)9X,F&275[MVC)&"5+2G!()''8F@#SV]U\:?\` M$[2_%"F_6UOKF32KKS;*=(5@R%@99"H1LNI?@GA_RZ/QC;P:%XPT[Q!,@_LS M5H_['U92."KY\IS]#E2?0UT-[X'T'4="MM$N[>[FTZV.8X6O[CL8?#P"2WO\`PG=2 M22WEI,+2,SXR=,.9%;&!PZG:?]Y<],5VWQ-O-0L/AMKMSI;,MTEL<.C%6120 M'8$="%+'\*WXM(L(=8FU:.V5;Z:%+>28$Y,:DE1CIU8]O3T%7&574JRAE88( M(R"*`.5T+1_#[?#?3;)X;9]'-C&[,Q`4C8"7+=CWW9!!K`T29[OXZ^(4U+#/ M:V$/]EJYR%A8`R,@]VP"1]*Z8>`O#:D*MA(+8/O%F+N86H/_`%PW^7_X[UYK M0U7P[I6M30SWMLQN801%<0RO#-&#R0LB$,`<=`:`.)M?.LOC_=6NG*5L;K1U MN+^.,83SMY"NV/XB`.>I!KSF[N[D>&O'5G)9VW]CWWBJ6"YU"1B[6>Z08D\K M`!`X^;>"">E>_P"G:#INDPSQV5N8VN#F>4R,TLIQC+2$EV..Y.:R['P#X;T^ MTU*T@LIC;ZEN^V137DTJS%OO,0[GYC_>'/O0!R/Q)MDM-)^']O%,;A8=>L8T MF8Y,@"D!B??&:J^*=`\0:'I'COQ<$=O3MBNFC@CCMEM\,\:H$ MQ(Q=')@':XBW!P3_$&YSUS7+Z]> M:I0QV%C@D94`DX/7I7HD?@'PS$/+33B+7?Y@LOM M$IM0V5+9Q)$D=W-"JN.C81E!([$\CM0 M!Q7@\2ZE\6_$FI:DJ:;JMI;1VC:;"Q=)8B0RS[RJ[\]!\HQWZUE>-_$']F^, M;'Q5$+WR])OQ83?Z+-]G-JPVRMYNSR]PD)7&[.5'?BO0[OP1H-[J%OJ$T%TM M];VXMDNX;^XBF,8[-(CAG^K$DTZY\&:)=Z$^BW$5Y)I\DAE>)M0N/F)Z@MOW M%><[<[<\XS0!+KMO;#P_K5[$B&6>PD#2CDLH1MHSZS'E-GE%]+;P_\`V&PO#I^-NS[?/OV_W?,W[]O;;G&.,4[2 MO#.F:)H[Z3IZW4-DZE!']MF8Q@C&$9G+)_P$C!YZT`>1QWFH67P-\7W.D%TG M_M6ZR\?#+&9E#D8Z?*3SVKL_$ECHY^"%R+:.`6<&D^?:.F,*ZQ[HV4_WMV.> MO-=+H?A+1?#EONWFF(O@KQB?-NDNK6;3-2=?DOXTN(VP?208P1W_`!&?2M4\.:;K M-W9W5XMT9K-B\!AO)H0C8(SA'`)P2,GL2.AJ75M#TS788(M3M([A8)DN(MV0 M8Y%.58$<@_S&0>#0!H4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`WTJ2*^DT]A/'Y+2T_LT-)J\%^EB;B1;>TCC*'RHV\LD@E/[J@;B<<8(! MV5KXALKW5+FVM[JQFM[>V2>2>*\1RN[)`9`1#,MTA223^XK9P6]AS7+7?A;7SK&MW=A;Z);17.E0V=BCNTBQR1,S*6 MC\K;M^Y,[B M>,8H`]!LM0LM3@,]A>6]W"&*&2"59%##J,@XR/2L>^\5V]AXRTWP])`Y-[&Y M%SD[4D`)6,\8RRJYZC&T>HI/#FD:CINJ^(KJ\2T6/4;X7-NL,S.0HC2/YLHN M"=@/&>N.V3RVM^!]=UF!]3\JS@\1+J4=W`XUBY-O$J8"G9Y84MM&P_(,@D[A M]V@#TNN;LO$=]=>.-0\//IMO'!9P1W!NA=LS.KE@O[ORP`-]6UVVL-&EAN[ M>*VCCDU*5&"QLY#G$!Y(;[O;'4T`=9=:II]E,+>_U+4=-U#[)87EK?M90PF[#-^!M2NKG4[<2V7V M+4=5AU)YR[>=!Y1CPJKMPQ81_>W#&X\&@#L+?7='O&G6VU6QG:WW><(KA&,6 MW[V[!XQD9STS2Q:YI,^EOJD.J64FG("6NTN$,2@=^\;65GK&C1+)8S:3J44\G]I+>+L MB\I=Q)XVE??<,)M"MWT])=8L5.HD"SS.O\`I&>FSGD'C!'4D#J17/W7 MAS5Y?$'A_4X+#1H8[`W4MQ;QSN@,DRX."(OF^;DL0I.3Q5;P_P"#]8TJV\)B M;^SQ)HQN(IDBG5K:..2<(3&DCE%9L<`L` M2!GO@X]#7':%XN\0Z[9?;8M`TN.`74EJ5;5W\PM&Y5MH,`!^Z2`6&?:M_2]4 MO=3T::Z_LY(+M7E2.&2XS'(5)"GS%4_*V`<[21GH<5PNB>!]=T:"62/0?"_] MKMB?VMIO]J?V7_:%I_:&S?]D\Y?-V M^NS.<>^*2#5],NKN2TM]1M);F)MDD,36)IMO+X=\2>"O#^IW&F?:;2&Y MB@>&<^9.GEX#LA4%"2#P"V2#S0!ZA1573OM_]GP_VG]F^V[?WOV;=Y>?]G=S MCZU:H`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`" MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`** M**`"BBB@`HHHH`****`"BBB@`HHHH`RO$6OVWAO2&O[E))_%5(=TC*RED38<'.>1P>?5WB[PV/ M$^CQVJ7`M[FWN([NUF*[E26,Y71UJI=VWBW4[.]M[F+1[:)[.6%(X M;F23SI6&`S,8U\M1UP`Q.>O'(!K/XCT./3AJ+ZSIRV)(7[2UT@CR0"!NSCH1 M^8I$UNVEUTZ;%-:2;+7[1(RW2%T&1MS'][:0<[NG'O7)0^#M;C\*:)I"1Z/! M+;V7-: MWTKV*01W-CJ0O(H(8B-L3%88PI^?(R68\Y.!70^,/"LWB)]+N+*[%G>65QS. M,@FW<;9D!'.2IR/<"@#3\.ZE?:MI$=]?V,%FTQW1)#N,=, M<\X'.:MXXU73=9UNR30[&6#2;1;V69M3,;/"V[HIAQN^0\%@.GS5U=NE_'J5 MPCBT73%BC%L(]WFA_FW[OX=N-F,>^>U<-J_@K5-3\9ZGJ\VC>'[V"XMH[:V: MZN7\VWV%CYJ_N3AOFZ!A]T?-Z`'7P>)]'DM89I[^WLY)+-;YH+J58Y8H2!\S MJ3E0"<$GC-++XET<36EM#JEA)=WT1DLHC7GGRQD$#&XXW8Y`-W2/%UA>>&M+UC4YK72CJ"C9#<72CYSG MY%8XW'CL*TXM9TJ;49-.BU*SDOHSA[99U,BG&>5SD<`GZ5YW!\.=6:RT1=06 MRN'L[*2PN;>+4KFWC>-V#%U>-0QSC!C88/'/%:D&A:GX:U[7=>%AIEU:_8;= M+-6O&656@1EY+H=NX.1G<2,=\\`'4>)M6N-!\-ZAJUO:17364#W#PR3&(,B` MLV&"MS@'`QSZBJ&AZYKVJ+IES<:-IL%G?0B?=%JC22QH4W`E#"H/)53AN-W> MIO$EIJ&O^"+ZRL8(8[O4;)H=EW*8Q%YB$')56.5STQSCJ*PO#/A;5="&G00: M#XWME<,TMPJKSE/(0$LP!R6)&3@\T`==:ZSI=]]I^QZE9W'V5BMQ MY,ZOY)&OI3]/U73M6A\[3;^UO(NN^VF61>I'52>X(_`UP%M\/-47 M1=2T_P"U0VD%]+\2-:'4HYG-I)YD/ESO'M;^\-I&&&.&&&'.",G.S0`444 M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`! M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%% M%%`!1110`4444`%%%%`!14,-U;W$DT<-Q%))`^R94<,8VP#A@.AP0<'L126M MY:WT;26ES#<(KM&S1.'`93AE)'<'@CM0!/144MU;P2PQ33Q1R3L4B1W`,C`% MB%!ZG`)P.P-2T`%%03WEK:R01W%S#"\[^7"LCA3(V"=J@]3@$X'I4]`!14%Q M>6MH\"7-S#"T\GE0K)(%,CX)VKGJ<`G`]*EDDCAB>65U2-%+,['`4#J2>PH` M=134=)8UDC971@&5E.00>A!JE>ZYI&FW4%K?ZI96MQ.<0Q3W"(\ASCY03D\G M'%`%^BJ]U?V=CY'VR[@M_/E6"'SI`GF2-]U%SU8X.`.34?\`:^F%[5/[1M-U MV2+8>>N9B.H3GYL8/2@"Y114^#CT-244`>:Q^#_%]I=:G-9W]JIU:W4W M;->LK13AV8B(I`I"$,4W$[P"#D[`#')X-\8;9DM+N&S3R;DPE-68V M?]V-^PHPRV2P;D=17IU%`'"-X:\4F[11J(%G]MDF*G5+@N(7MO+*9VY.)29! MD_+@8QVSYO`GB,6KI9ZK+:R/IUK:_NM8N-RM&[F4*[(V`P97(QR6\PA6S\N`.:O:MH/B" MZ\02W=KJ&RT8?(/MLT>U?+*F+RU!7YF^;S<[E["NNHH`\VM?"7BV"VB@O;V* MZ@7["TK/JEQ))OB1A/(A,9*LQ*X4'^'/!-:VAZ)J@\'7RO>7LNHW=N88)+J] MN(SM52D4A#9:%V&';:H.3R,BNSHH`X/3/#GBR#7+74+O4$V+>"2:%=4N)4\C M[,(V0(R!23*/,&0,>HR:N3^'-5M_$>LWEG#I5]:ZPL0F&H,VZ#8NW:%"D2(> MNTE,$MSS7844`>;ZEX3\7W.H7%PEU:7$,E];7*6]SJ4VU!#<&4%?W1"%EV(0 MJ@#:#\QR2?\`"'^*W6&4WD4=VFGK:O*NKW+%RL^\KG8"-T?R^9]]2<@'`)]( MHH`\WE\'^+I;*>%M5;S&L9X[>1=:ND-O,SN8LX7]Z$5@-[?,V!D<"KEMX<\5 MVNJ^:E\K6@GFD17U:=V1'@5`N'C(;]Z"XW9"YX')%=Y10!P]AX%DU&PCB\5N BUS+;79N;4PZC/)Y>57/S-A@0P;:PY`/RE GRAPHIC 3 footer.jpg GRAPHIC begin 644 footer.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V>^T:_N[R M2>'Q-JME&V,001VI1,`#@O"S<]>2>OIQ5?\`X1[5/^ASUS_OS9?_`"/7044` M<_\`\(]JG_0YZY_WYLO_`)'H_P"$>U3_`*'/7/\`OS9?_(]=!10!S_\`PCVJ M?]#GKG_?FR_^1Z/^$>U3_H<]<_[\V7_R/7044`<__P`(]JG_`$.>N?\`?FR_ M^1Z/^$>U3_H<]<_[\V7_`,CUT%%`'/\`_"/:I_T.>N?]^;+_`.1Z/^$>U3_H M<]<_[\V7_P`CUT%%`'/_`/"/:I_T.>N?]^;+_P"1Z/\`A'M4_P"ASUS_`+\V M7_R/7044`<__`,(]JG_0YZY_WYLO_D>C_A'M4_Z'/7/^_-E_\CUT%%`'/_\` M"/:I_P!#GKG_`'YLO_D>C_A'M4_Z'/7/^_-E_P#(]=!10!S_`/PCVJ?]#GKG M_?FR_P#D>C_A'M4_Z'/7/^_-E_\`(]=!10!S_P#PCVJ?]#GKG_?FR_\`D>C_ M`(1[5/\`H<]<_P"_-E_\CUT%%`'/_P#"/:I_T.>N?]^;+_Y'H_X1[5/^ASUS M_OS9?_(]=!10!S__``CVJ?\`0YZY_P!^;+_Y'H_X1[5/^ASUS_OS9?\`R/70 M44`<_P#\(]JG_0YZY_WYLO\`Y'H_X1[5/^ASUS_OS9?_`"/7044`<_\`\(]J MG_0YZY_WYLO_`)'H_P"$>U3_`*'/7/\`OS9?_(]=!10!S_\`PCVJ?]#GKG_? MFR_^1Z/^$>U3_H<]<_[\V7_R/7044`<__P`(]JG_`$.>N?\`?FR_^1Z/^$>U M3_H<]<_[\V7_`,CUT%%`'/\`_"/:I_T.>N?]^;+_`.1Z/^$>U3_H<]<_[\V7 M_P`CUT%%`'/_`/"/:I_T.>N?]^;+_P"1Z/\`A'M4_P"ASUS_`+\V7_R/7044 M`<__`,(]JG_0YZY_WYLO_D>C_A'M4_Z'/7/^_-E_\CUT%%`'/_\`"/:I_P!# MGKG_`'YLO_D>C_A'M4_Z'/7/^_-E_P#(]=!10!S_`/PCVJ?]#GKG_?FR_P#D M>C_A'M4_Z'/7/^_-E_\`(]=!10!S_P#PCVJ?]#GKG_?FR_\`D>C_`(1[5/\` MH<]<_P"_-E_\CUT%%`'/_P#"/:I_T.>N?]^;+_Y'H_X1[5/^ASUS_OS9?_(] M=!10!S__``CVJ?\`0YZY_P!^;+_Y'H_X1[5/^ASUS_OS9?\`R/7044`<_P#\ M(]JG_0YZY_WYLO\`Y'H_X1[5/^ASUS_OS9?_`"/7044`<_\`\(]JG_0YZY_W MYLO_`)'H_P"$>U3_`*'/7/\`OS9?_(]=!10!S_\`PCVJ?]#GKG_?FR_^1Z/^ M$>U3_H<]<_[\V7_R/7044`<__P`(]JG_`$.>N?\`?FR_^1Z/^$>U3_H<]<_[ M\V7_`,CUT%%`'/\`_"/:I_T.>N?]^;+_`.1Z/^$>U3_H<]<_[\V7_P`CUT%% M`'/_`/"/:I_T.>N?]^;+_P"1Z/\`A'M4_P"ASUS_`+\V7_R/7044`<__`,(] MJG_0YZY_WYLO_D>C_A'M4_Z'/7/^_-E_\CUT%%`'/_\`"/:I_P!#GKG_`'YL MO_D>C_A'M4_Z'/7/^_-E_P#(]=!10!S_`/PCVJ?]#GKG_?FR_P#D>C_A'M4_ MZ'/7/^_-E_\`(]=!10!S_P#PCVJ?]#GKG_?FR_\`D>C_`(1[5/\`H<]<_P"_ M-E_\CUT%%`'/_P#"/:I_T.>N?]^;+_Y'H_X1[5/^ASUS_OS9?_(]=!10!S__ M``CVJ?\`0YZY_P!^;+_Y'H_X1[5/^ASUS_OS9?\`R/7044`<_P#\(]JG_0YZ MY_WYLO\`Y'H_X1[5/^ASUS_OS9?_`"/7044`<_\`\(]JG_0YZY_WYLO_`)'H M_P"$>U3_`*'/7/\`OS9?_(]=!10!S_\`PCVJ?]#GKG_?FR_^1Z/^$>U3_H<] M<_[\V7_R/7044`<__P`(]JG_`$.>N?\`?FR_^1Z/^$>U3_H<]<_[\V7_`,CU MT%%`'/\`_"/:I_T.>N?]^;+_`.1Z/^$>U3_H<]<_[\V7_P`CUT%%`'/_`/"/ M:I_T.>N?]^;+_P"1Z/\`A'M4_P"ASUS_`+\V7_R/7044`<__`,(]JG_0YZY_ MWYLO_D>C_A'M4_Z'/7/^_-E_\CUT%%`'/_\`"/:I_P!#GKG_`'YLO_D>C_A' MM4_Z'/7/^_-E_P#(]=!10!S_`/PCVJ?]#GKG_?FR_P#D>C_A'M4_Z'/7/^_- ME_\`(]=!10!S_P#PCVJ?]#GKG_?FR_\`D>C_`(1[5/\`H<]<_P"_-E_\CUT% M%`'/_P#"/:I_T.>N?]^;+_Y'H_X1[5/^ASUS_OS9?_(]=!10!S__``CVJ?\` M0YZY_P!^;+_Y'H_X1[5/^ASUS_OS9?\`R/7044`4]-LI[&W:*XU.[U!RY82W M2Q*P&!\H\M$&.,],\GGI@JY10`4444`8=EXFCOO%-_H`TV^BFLHUEDGD\KRB MK$[",.6YVM_",8YQQ6-/\2K"TN[V*[T;5H(;*[2SN+EEA9(Y'QLX64N00R]% M/7G%7-,T?6+;Q_K.LW,5B+"]MX8(O+N7:4>46P2IC`YWGHW&.^>.5N?AWK=Q MKNJZ]'#HT&K'48K_`$ZY\YW("J$:*0F($*R@GC.">!QF@#L]<\61:#K.EZ;- MI6H7!U*3RH)X/*\KS.258M(I!`&>G/;)R*FL_$$EZNJ%-%U%?[/D:,;C#_I+ M`9(C(DQZ?>V]<=00*OBK0+OQ1X1:T;R+75DV7%M(LA=(+E#N0ABH)&>,[>A/ M':K]CIT^E>'1:6JPSWBQL[%V,:2S,2SLQ"DCM`&7#XYMKCP,WBZ/2= M3-@L;3^5B'S3$HR9,>9C``/&<\=*:_C_`$UO#<.MV=G?7L+W"6LD$*QK-;RL MP0)(KNNT[V"D9/7/3FL^P\+:[:?""7PFR:>#G@FM;1]4.K6CSM87=D M4D,9CN=A)P`<@HS*PYQD$\@CM7)>-?".I^(_%OA_48]-T6_T[2EN#):ZC<,! M<-*@7!7R7`"E0P/.3V&,UTWAVUOK+33:WECIUC'$^VVMK"9Y4CBP,`LR)SG= MP%``Q0`NM^(K/0WLX)4FN+R]C^);75[ZZ MTYK:ZL=2M0K36=VJAPC?=<%6964^JL?0X-9_B?PO=:EK^A>(=,FA74=':79# M<$K%,DB;64L`2I]"`>_!HT;PW>_\)?=^*]8^S1ZA+9K8Q6]I(TD<4(?>"RN)";;$&/!,UMXAU;6->TC1FNKJ M^^VVUS;S-+-`=JKLW-$AV\$\'G)XI^N>#[K7OB!:ZGJ&E:-?:+!:-:^7=2L\ MAW%6,@0Q%0P((`W<@YR.E`&KJOC"'2?#]EK$NDZE)%=R1QB&,1>9&TA"J&W2 M`CT5E66FRV_B+5-0:&U6.Z2%4DC9S*^P,#O!.T M8SQM]\]JU:`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`" MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`** M**`"BBB@`HHHH`****`,+7_%=EX?NK.SEAFN;V\$C06\+1JSA,;L&1T4D;AQ MG)[`X-7WU2&'1#JMQ'-!"MO]H>.5,2(-N[:5_O=L>O%8WB[0[C7A:VIT71-5 ML`',T>HRO&Z/\NUHV5'QQOST)XY'-0S^'-2'A[1?#\9BN;&'REOYWOIK>8HF M"/+**6SD`\LOW<9YR`#:T?7+77O#MKK>G))+!

=''\H<\?6L(E>)1=>7N8HQ5B-CMP&!'..GIS6)X.\/Z]X4AU:P2 MWT^33&GEN--0W\K/&6P1&Y:+.TG'-(M]*-GH31"\>: M:X^WS,1')*78*GDC+`,0,L!D4`7]4\;OI&H16MQX;U>07-Y]CM)HC!MG?!/` M>56'W6Y(`XX)R*Z#2[V;4-/2YGL9[&1F<&WGQO3#%1G&1R`#P2.>"1S7/>,M M%UO5]0T&?2H=/>/3;T7CBZNGB+D*R[!MC?\`O9S[=*ZP9P,@`]\4`8.' MQA!X;.FWS7$T!N5N%\KR?+!`).7W<$@8VYY].:U;Z\ATZPN+VX)$,$;2/@9. M`,\#N?:N4U/2/$A^($/B"PL])FMK>Q>S2.>_DB=][*Y8XA8+@J1C)SUR.E6= M0T_Q%K.F6%EJ%MIH22YWZA]EU">$I&KY01,J!BV`I)RF2I'`.0`:^CZY:Z]X M=M=;TY))8+F#SHX_E#GC[AYVA@<@\XR.M86D_$"+6XHGT_P]K,IDD=-G^C`J M$8JS-^^PJ[@P&3DD'`-1>#O#^N^%(=6L%@T^33&GFN=-0W\KO&6P1&Y:+.TG M)1H*:!JMW=M`;F-H&M@DD8(#,"\RD8+`8(!],CFMC2-2_M;3(K MW[)<6@D+8BN-N\`$C.49E(.,@@D$$&N.\2>$M3UKQM!J\NB>']3T^WLVMH[? M4+ILLS,K;R/(<*1@@8SPZUVXTG4D2U1GGM2D8F15^\>7"D``G(8Y'3-9^J>&M0B\<1>+=':UFNOL!T^ M>TNY&B1TWAPRNJL58$?W2#QTJSKVG:YK7@;4],*:`-$U;P[X=.FZLMEYBW$LJ/:3O(&$DC.WTW4[S3K!VCNK^VB0Q1LOWP`7#OM[E%8>_!Q9UWQA8Z M)X?MM<6WN=0L+AHPDED8SQ(0$;YW7@D@<9Z^E85IX4\1:)H^J>'])ETR33;R M29X+JXDD6:V$I)93&$(DP2<'YF$!3:JEBS!)6=1QC)7&64=Q6A8:)#H^AW M,6DZ1IUC=7"^:]K;R%+?SB@7A@G`^4#(09QG&:Q/AYX'C\*Z1:"^TO2H=7MH MFMVO;!B3<(2"2Y*(60^ M=FW:Y8[@"1QQCG!XJL?&L$LUW_9VCZKJ=I:2F&XN[.*-HU"JSAY"O?8K> M@R>*BT/1=9LO'?B+6+R*P6QU-($A\FY=Y%\D,J[E,8'S!R3AOEQCYLYJ#1-! M\1>%XKK3-+_LNXTZ6YDN(+BYED26#S&+%6C5"),$\'>F:`-'7?%BZ%J^GZ:= M&U*]EU`LMLUL8`K.H+,O[R52"%&>1CGKGBM#1M6;5X)I&TZ\L6BE,12Z\LEB M`,E3&[J1DD=>"".U3):F!G\Y9=N2X=&RN[@?P]Z[H:;:#4O[0,.Z[V&-97 M8L44XR%R<*#@9QC.!GI2_P!G6O\`:/V\QEKD+L5W=FV`]=H)PN<#.`,XYH`X MBZ\5ZG'XFN&69OLEMK=OI'V,(I$BRQHQD)QNW`OG@XVJIV_B*_>. M8K:6&JV6FBSVKB83A"SDD;@P\P8`('R\@YXZR3PYI,NMIK#VI-ZA#!O-?9N" ME0_EYV%PI*[L;L<9Q3IO#^EW&KQZK+;;KM"I#>8P4LH(5BF=I8`D!B"1G@T` M:3`E2`Q4D=1U%>-:'XJ\5S^)[2P;6+J5'URYLS)?06PMI;>$G*`Q*'$^,$9P MIYQG%>RLH92IS@C'!P?SKED^'/A=+*2S%C<-#)=+>?/?W#,LZDD2JQ?\&/9@JTZX_B.ZTL13M:W;%Y_,NI7DD8X&3(S%\X4 M<[N,"@#!\&ZIJ.KV^L:=J-WK-KJ5NR96]@MUFMU=3M9&1/+D4E6P2O4$$'%< M[\-]8\5^*-'T;4K[4=9Q.TCS3M!9?8Y%20KL"HOF@D#&3MY!(R,`^B6V@6%G M97%K#]J"W`Q+*UY,\S>G[TL9!CMAN.V*R[#X?>'-+AMK>S@OHK:VD66&V_M2 MZ,*L&W@^69-I^;G!&":`,OXD>+]1\+VUI+I<,TS0NMU>K':M-FV5@'4L!B,D M%B&8@?NVYS4_Q'UR[TSX;WFOZ-J;VDL*1S0RQI&ZR!F"@$.K#!W`\8.0.>QW M9_#.F7,NHRS+=,VHQ"&Y_P!-F`9!G"J`^$ZG[N.I]35.?P)X>N?#,?AR>UN) M-(C8%;9KZ?''12=^XJ."%)P"`<<"@#*\!:OK.IZGK\&H7D\UM93QPQQ7R0K= MQ/LRV_R0(RAR"I&<\\U'X?N]?\8V5[J\.O2Z6$O);>VLXK:*2-1&Y7,N]2[$ MXY"NG!&,'FNDM/"^DV.KC5;>&=;[R%MWE-U*WF(HPN\%B'(S]Y@3[U#/X-T* MXO;BZ:TD1[EMUQ'%=2QQ3MZR1*P1SZE@RM$MRTP1"_!F'!XP?F'&<KZE8ZC>1W#75BVZV:.[EB$9[G:C`$D'!R.1P>. M*6W\-:7:>(+C788[@:CH;=\H//%=YJVDV>N:9/IM^DCVDZ[)4CF>(NO<%D(.# MT(S@C@UF:7X*T'1Y;62TM)B;1=MJ+B[FG6W&,?NUD=@G!Q\N.*`..^(?B/6] M"\2E++4]56S_`+)GO7@LH;1C$T94!OWJ9*%M(N]?37)X)WOTB,*N;J4)Y9&"OE[M MF#W&.3SUJO'X)T&/PS)X<6WNO[)?K;F^G/'`VAB^X+Q]T';UXY-`&-XPD\16 M/@2WU;2=:O1R"W9[F+@R'#1X#!MWFH:E;Z[>3 M:0Z+#9C9;E2VQ2TJ,$R<$X`8D9#<$8QT-M8P6NGQV,:NUNB>6%ED:0E>F"S$ MD_B34&GZ-8:5HL6D6$!M[&&+RHXXY&!5?9L[L\]>18&U$<3/@,JIYN6"!"<*,MD'H#ZI7,6WP_\`#UI'Y4$>HK#Y MAE,)U:Z,;.6W$LADVMD\G(.>]=/0`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`! M7%Z!XUM=?\:3V=GJ^GW%B;$2P002H[[A(P9F().2`IV]@1GDUVE5A86PU)M0 M$?\`I30B`R;C]P$L!CIU)YZT`<'X8\5ZMJ'B'3/M5P9+;5SJ.+4QJHM/LTP1 M-I`W'<"=VXGG&,#BM#1?&PU3Q!';W$5S;P75Q8S*NX[GV*3M3&-'L] M6;4[>SV73,[@^8Y16?[[*A.U6;N0`3WH`/%$.K3^&K]="NS:ZHL1>VD"*^7' M(4A@1@XQT[UYGI7BW6=1U^&,>);XV=[9IJ-K&(;7>NW*S6I_=$F3S-H'3C/. M1S['6'%X-\/07,-Q%I<*2PWLE^C*3Q.XPS]>!@8'`H`T]/AN(-/MXKNY M:YN4C42S,J@R-CDX4`#GT`IUZ;H6%R;(1F[\IO($GW2^#MS[9Q45WI5E?7UC M>W$.^XL7:2V?<1L9E*$X!P?E)'.:GNK:&]M)K6X3?#-&TLZU-?ZA:>(%U:&^CMTF%I>0P%%Y8,8985`=/8=8^SM&L\\>F?9XVMS'&[+L8E?,W$+]X.!DCCL?0]*T'3]&W_`&-;@LX" ME[BZEN'"CHH:1F(7V!Q5"3P/X=DN'E:P8+)*9I+=;B5;>1R6QSSDJ: M`,#Q;KNJOX<\*:KIFH76DMJ=[9PSPB*)B$GQD'S$;#+VQQR<@\8Z>&*\'B>Z MSJ]T]N+6-TM'CB\M&8LN[(0.?N9P6[GVQ;U;1M/US3VL-2MEGMF(;:25*D<@ MJ005([$$$4FFZ/9:2LGV59B\F-\L\\D\C@9P"\C,Q`R<#/&30!PLEIXAM_&5 MEX77QIJQ@ETB6X:=H+4OYBNB#DQ9Q\Q/)S_M5=\9:EK6CZ]X4M].O-0ECNYG MAN+6U2W+3A(R^0TPX)QS\PXSCGFNBD\*:1+XD3Q`\=T=31=BRB]F"A./EV;] MFW@$KC!/)&:DU/PUI>L:G8ZC>QW#75BVZV:.[EC$9[G:C`$D$@Y'(X/%`'-> M&]8UK4?B+K5G>RZC:65K:PS1:?=):DJ9"P)W1;B0-O'SYZY[5O>,[F[LO!6M M7UA=R6EW:64MS%+&J,0R(6`(=6!!Q@\=#Q@\U/;^&M+M/$%QKL,=P-1N4"2R M-=RLK*.@V%MN!SCCC)QUJMXPTW5M9T"?2]*:R1;U)+:Z>Z+@I"\;*63:#EP2 MIP>"`1D=:`.8N_%FKZ5\,O"^H"X:ZU367LX7NYX5*PM.`S.50*,*"0/^`YSS MF[)JNK>'/'>@:%YV>6)[JYEN)%3CY M5:1F*KP.`0.*`/.O&WBCQ%HOBG68+/5M16UM[.WGB"PVA@MY))&3]\63?Y7` MR5R1D\]*ZCQ[J&LZ7X)M[^SU1K2_2:VCEDMHXW23S)$1L"16X^8D=#TSGI6O M/X-T*ZU*^U"XM9I;B_@-O<[[N9DDB((V["VT#DXP."21@TR\\$:#?Z!!H=U! M=2Z;`P:.%K^?L<@%M^Y@.P)(&!C&*`*$%_J>B>.+#0;O4YM5M=2MIIHY+B*- M9;=XMN03&JJ48-QE<@CJ<\4M=\9W>E?$'2K("3^Q7?['=O\`9GV+/(`8SYNW M:,':NW=GYSD<"NGTSPWI>D7+W-K%.]RZ>69[FZEN)`O]T-(S$+QT!Q5*X\"Z M!=Z2VEW,-[-:-C'.,[L<#CKFMX?\`$4GB+Q6LEOJ5W#;QVC_:M(FBB#6] MPK*I5CLW]\_>P>"..*Z-M`L6N;"X9KUI;!=L!-].>,8^<;\2'U+Y)J:/2-/B MUB75H[6-+^:(0R3KP70'(![''KUH`H>,[F[L?!6MWMA=R6EW:64MQ%*B(Q#( MI<##J00<8/'0G&#S7,>`-6\2:G=V4M[=7E]IMQH\%S-/=V:P".Z<*Q2)E1!( MF"?7&/O&NWU72[36]+N--OTD>TN%V2I',\19>XW(0<'H1GD9!X--TS2+/1]) MATNQ66.TA3RXD>=Y"B]@&8EL#H.>!@#&*`..N?&UY;?%&STETE&AW(>R$AM6 M5!=@!P1*1M;/S)M!)!0Y%0_$/6]7T?Q+X>@T[4M32"_6Y\^TL(K5Y&$49?>1D9Y`P!D\]%<>!M`N]+M]-G@O)+6WN#=1*=1N-RRDYW[_,W$Y)(R>"21 M5B^\):/J.KZ=JMU%Z<,6LHO9E\OUX#@$GHQ()8<'(H`YNUUK7+CX*W&NR MZM'_`&HFG37D5Y:1H<[`SIN5E*Y(`##:,'.,<&J_PZUO4O$\%O/>^(;X7%M; MPRW%C);P(TWF1A_,.(P?+))"[2#A>23P.D@\'^'!H-[IEO#(-+OV9YXHKZ8( MVXDL%P_R*23D+@'H13-/\#>'+*[T_4+&&Z$MG`(;60:C<,%ASD)S(0R=.#D8 M`'0"@#@O$?B;Q+X=U'5DN_$-YLTV^ANC%';6P:?39<+E,QD[HW#`GN`?J/0O M"Z:BEK+)J.M2ZD%"Q^:\<2(SKDR.NQ%XW$KS_<]SF[J/AS2-6O4O+^QCN)TM MY;96?/\`JI``ZXS@Y`Q^?J:7_A']-'AY-!CAEATU(5@6.&XDC8(N,#>K!NW/ M//.$/&5YJWC#5]+OUE2&5%O-+\VV>','W64;E7?@[6W#(^?@X%17M M_P"(]!\J7-[IVM1/%I`6.!/LMP!N*N1'D@#)5CD8!!5C@UTXD15:0^N%`4?@*LT44`% M%%%`!1110!YUX>_L/_A='BC[+_9_VW[';_ZK9YF_+^;TYS]S=_P'/:O/-0AT MD>*/$5_;-IB:?::[;M=36,2B\MHBJAI(Y%;Y4\SAQM[MSGBO=]3\0:+HKQIJ MNKV%@T@)1;JY2(N!UQN(S5UIXD@,[2HL*KO,A8!0N,YSTQCO0!Y]\1M,TV]T MK3O&]I:V>H2Z/(EX9%19!<6@R74'H0`2Z\X!&1UK1L-&T:Q\):QJE]8:?:C5 MEDN[SS(4C78V2BR9XX4C.?XBQZDUUKWEK%8M>R7,*6BQ^:T[.!&$QG<6Z8QS MGI4.FZOIFLP-/I>HVE]"C;&DM9UE56QG!*D\X(X]Z`/+[1-"?]FI_,&GF%=( MN>%KN_LWTJ^8"2S*&07"2J8]H& M2VX'&/>@"S1638>*?#VJW0M=.U[2[RX()$5O>1R.0.IPI)JQ%K6E3ZI)I<6I MVOI2Z;K.EZS$\NE:E9WT<;;7>UG64*?0E2<&@"]14,-U;W$DT<-Q%) M)`^R94<,8VP#A@.AP0<'L14U`!1152ZU73K&Y@MKN_M;>>X.V&*694:4^B@G M)/TH`MT53OM6TW2VA74-0M+1IWV0BXF6,R-Z+DC)]A5B>>&VA::>5(HE^\\C M!0/J30!)15>?4+*U$)N+NWA$[K'"9)`OF,Q`55R>220`!US3+O4]/L)8(KR^ MMK:2X;9"DTRH9&]%!/)]A0!;HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**H7NN: M1IMW!:7VJ65KX1'D).!M4G)YXXJ:_U&QTJT:ZU&]M[.V4@&:XE6-` M3TY8@4`6:*JVVI6%Y8_;K6]MI[3!;SXI5:/`ZG<#C%45\6>&VL'OU\0:4;)) M!$UP+R/RU<':/SH`YSXE6]C=6&GQWFN:;I MC"=FB7585EM+@A3E9`^%X'(.=]HEPC2KCKE`Y1' M.:"5(]SS,T?E[\\F0@G!/S')QUJ? MXHV^@QZOX1M[F30[>9+DH6U.))52W$3XWJS*2F['5@-V.]>DZEJ^FZ-;K<:I MJ%I8PLVQ9+J98E+8)P"Q`S@'CVINGZUI6KV\D^FZG97L,1Q));7"R*AQG!*D M@<4`<_X`CT:'2[N+2KG1KF47#-=2Z-$([8DD[`JJ2H(CV`@$GCDGJ:7Q6ET^ MW\.64][N[<>,>]5VU_1DTD: MJVK6"Z:>EX;E!">A!'!%2T`%%%%`!1110!P&G>9X=\8>)IM8TV M_N1J&P#G.>M:/B)?M6A:?X>L;&6R3452(HVG MO+!;0@9,<@B(500!'C>/O'!P*ZZB@#S_`.&]]=Z3X5GT75K?4R^BO)#%A7VD:W%J*R21R1MI_/;. M#6%IFD7&L^./%L6@+891C(!]\"IO!-A=V&I M>*=9DMI[/2=0N4N+.R:`K(H5/WDGE@;@7/.W&[CIDUW%%`'AGANRU"PN]"U? M4].UNXT^WU&^+69TV4/9RR,S1SJJQ!W0KD')8`L.AX'<:_H5IXD\7S1JE]9: MI:6D;66JQV1U!QW=%`'(^#FU<3:W%2T=QLB`\R/C)!`'')!R.U4/`U^VE>#=3N+G3M41HM0NIA`=.G$KK),S)M3 M9N;(8=`<=\8-=[10!Y5X:&I^'/'OGW45[=VGB&U6>YDM])N42VN-WR^9NW8) M#$$_+@*N545Z/K-M>7NB7UKI]W]DO9H'2"XQGRG((#?@:O44`8'@O2M9T7PK M9V&OZG_:6HQ[O,N-S-G))`W-RV!QD\USWCKPM>:M>73Z=.QGU.Q73Y8I+5I$ M10Y82K)N`C*EBQ!W%MHP,\UZ!10!Q/C=;.:T;1[FRU&9;^W$-U=6^GSW.V%3 MG:OEJP$A).,XQU.<`'-\<)K4>H:;?Z9!J`CM],G-BD%K]H,=\=GEB1-K!05W MH7.-H9OF7.:](HH`X#QV)7T_PO/<:7#5V2']P] M@T^GWNTDJKL5*(1R"Q*D9!&2!6AXHM;JU\>:#K\UE<7VDVD$T+I;0-.]M,^- MLOEJ"QX!7*@D5W%%`'$^$;&Z;QAXDUN.SGL=*O\`R!!#/&T3RR*IWRF,@%HIJ']I3,O^B/Y)C>?>'$V/+QM;.-V>#QGBO2* MY\>*HV\92>&5TK4#!-;2WL9 M[B]O+1K:-;6U>:1R0=H.P$X&3R>!GWJ_#<0-X0>^CM+I6>TVNALI5G8JI7!C M*[R8?=/8@U2 MTKQL^L:E+9V_AS5X_L]W]DNIIC!L@<+N.=DK$\$<@$<]:`/.I-(U6/X3Z`C7 M'B2>6*:T6326TL8C\N16?A8!)M4`D$M@XZGI7ML4BS0I*H8*ZA@'4J<'U!P0 M?8\UE:CXET[2]=TO1[IY!=:F76`AZXS@\]!@Y(XR`9NF@_\+>U\XX_LJS_`/0Y:Y_3X)=# MTOQ5I.M:#?ZA>ZE>3RQR06;W$=ZDG$8,@!5-O`PY4+CTKHM+OM)T'Q-XS'GD[FE+@!W*[=O!)P,6NH6L=U97,-S; MR#*2PN'1AZ@C@UDZGXJLM+U5=.D@N)I1&DLQAV$0QNY168%@Q!8$?*&([XH` M\STDR/X9\=:7/X>UJ6ZU;5[VZT^.33)XUD$B@1OYC(%CY&PQ6]Y=FQEG@PJCS#(4P`'(V\LOWR>U=#K>O66@6L,]Z9")IXX$ M6-=S%G<(/H,L,G^I`JKKGBNPT"Y6&YBN92('NIVA52+>!2`TCY(X!/098\X! MP:`.<^'%Y=:9X4N-#U>VU)VT9I(8[B339E%U;*?D9%V?,<<;1D\=^MR?955O)MT(#2MN8?*-PX7)/8&I-=\66&A6ECG/)%=6SH#-'(@RR8!()Q@Y!(P:T@N+F"(L@EB4%9'4[2J9.3SQG[O!YX-8LOQ`L(-$MM3FT^]A%Q=O9 MK!/);PN)$+`_-)*J$?*<%6.>U`'6T5!+="&R:Z:*9@$W^7&F]S[`+G)^E:/;; MY'?5@6MV1/E5?+:0,Y/W00AQW)[<$ANA^*[#7Y_*MHYXM\`N;=I@H%Q"3@2) M@D[<\?-@\CCD4`;M%5H-0LKJZN+6WO+>6XMB!/%'*K/$2,@,`M*9/#H M,BWZ6JW1#*`I!/*@Y^\`5)&.C"L:'XB6\TNH6XT#6%OK&:*"2R;[.)F:3."J M^=\R^^<>F<'`!V5%-C8O&K,C1E@"4;&5]C@D?D:Y_4?&5C87*VT-K>7]R]PU MM%%:JF99%0NZJ791\BKDDD#/`R<@`'145STGC31UT72M5CDEFM]4EABMA''\ MQ,CJ@+`XP`6&2>G3DD`UX/'NFW.HFSCM+\AWGCMIO+79=/`<2K'\V"Y MVG;G%`'4T56AU"SGTU-1BNHFLGB\Y9PPV%,9W9],#;OB M"(JM*N"VX;F&T8'\>W]10!KT5S#^.+%9=%B6SNO,U>)98(Y)((753CJLDBL3 MST0,>/IG4\0:Y;>&]$N=5NX;F6"W1G=;>+>V`"3[#@'DD#WH`TZ*YW4/&-EI MTUJ)K.]:VGFB@>[1$,<$DN-BO\V[)W+RJD#<,D5H1:Y9S:]<:/&9#.1VH`TJ*S=&URSUV*ZELO-,=O<-;EG3;O90#E?53N&#WZCC!K2 MH`****`"BBB@`HHHH`****`"BBB@`HJI?ZKIVE)&^HW]K9I*XCC:XF6,.YZ* M-Q&3[51_X2[PUY'G_P#"0Z3Y.]H_,^VQ[=RC++G=U`Y(["@#9HK&7Q;X:<.4 M\0Z2PCB\Y\7L9VQ\?.?FX7D<].12)XP\,22>7'XCTAG\P1;5OHB=YSA<;NIP M>/:@#:HK.&O:.;"ZOEU6R:TM&9+B=9U*0LN,JQ!P",C@\\BL/_A/=.'B"WM# M-8#2+C3GOHM5^V@)A75"I!``Y;KN[$8H`ZVBJ=SJ^FV;6ZW6H6D!N2%@$LRK MYI]%R?F_"LZS\2(^H:]!J$4%C!I$J*UR]P"CHT8<.20-F`<$'/3K0!NT5S5_ MXQL[+4]'4264NDZBDS_VD+Q0D7EIOSTVE2.^X8K2D\1:'$MJTFLZ>@NT,EL6 MND'G*!DLG/S#'<4`:=%5$U33WU%].2_M6OD7>UL)E,JKZE\766F: M/K%UI\]CJ-]I4#3SV*WBJZJO+;L!BIQG&1R<#CK0!T5%9%MXFTB;3);Z34;. M);>)9+L&X4_9MR@X?^[U[XI)/%?AV'3[:_FUW3(K2Y&8)I;I$23_`'23ST/Y M4`;%%95OXFT"[FAAM];?[4/]+3_4_\].OW/]KI M4ECKNCZI,8=/U6QNY0@D*6]PDC!#T;`)X/K0!H453U#5]-TE8FU+4+2R65MD M9N9EC#MZ#<1D^U)+K&F0:A#I\VHVD=[.,Q6SSJ))!_LJ3D_A0!=HK,3Q'HE`%FBBB@`HHHH`****`"BBB@`HHHH`**Q-6\4Z?I!N5E$LKV_EB01;0`\C M!8X\L0`S$]R`!R2`1G.NOB#IEI:QS266H&39/+<0*B%[:.!MLSO\^TA20/D+ M$]@:`.LHK`/BZQ.NOI$5M>RSK9-?*Z1?))&I0'821N/SCH,<'G/%6[WQ#IEC MX;E\0/%YI6"1H,LQ["N4G^(^D0V,%XMK?RQ/:?;I@D2[K:WW%?,D M!8'&0>%RW!XXH`Z^BLJ;Q#80ZO:::6=I[F%YU95RBHH!)8]B<\#K4'A_Q39^ M(R_V:WN8E$27$32[")HG+!74HS8!*MPV&&.0*`-RN3U+0M8@\K)=W\">'-986%RMK<2`VV%=MNW`\[<8SQ0!T6EVDUEIPBGD2 M2=GDEGU:'3D34KUKU/LET\I0E5780T: M]ESGWZ5JP^)M.G\4W?AV-G.H6UNMPRD#:RDXPISR1\N?3*?`^L>)!>7_EV4.LQ7<$N MER_VE/Y4*1'*LZ"/:6R7_A/^L(##'-SQQX9UWQ;I?A^#[%H[-9ZC%?WL%Q=. M8I`@(\H?N3N5@QR2!C'0YX[I264$J5)&2IZCVXKG[WQ?8VV1;V]S?2?:&MHT MMS&/-D0$NJEW53MP0>>O`R00`#%L/!<^D?$F/6]*TC0[#218-9R1VKF*1RS* MYDV+$%)!7;C=R.F7BLUM=PM#*%;!VL,'![5B#QWI#7%NB M)=-!+';N]R8PL<'G\0J^XA@S'L`<9&<9%36WC+3KE=2:S>W,]C-`#J&EMI5V\[E62(L6$B`*0S#<_P`OR@Y'/&*V MYO$44'B*UT=K"_+708QW0C4PY5=Q!^;<,`CYMNW)`SGBIO$.O6?AK1+G5K_S M#!;H7*1+N=\`G"CN<`GT`!)P`30!D^)_!T&OV45LB+')]G>S:\$[I)'`XPZA M5XDR.S?*#@X.,5'XG\+S:M9V6FP:7HM[IT4+0E-1W[X"0%62,@,"0,\<$\89 M:L2>.-,BUS^S&@NP@NH[)KS8OD+<.H=8B=V[)!'.W;D@9SQ3;7QSIMU'JLHA ME2'39#%*_GV[[FW[,;4D9E)/]\+UH`W["U%CIUK9B1I!!$D6]^K;0!D^YQ5B ML_2-6CUBT>9+>>W>.0Q20S[=R,`#U1F4\$'*DCFM"@`HHHH`****`.&CT!)= M8\56&HVT=S_:5Q%?6BR2O$'"1HG$BCH+_`.&\TWA?4+*TUFYB MU"\2Z>0Y4Q32S*%PY='?:%54W`AL9YR37H%%`'%R^`X)[^RGG;B(P2WDXN'# M7CPX*%XU"Q@@JIWXSA=O`JWX1LIA-XAU!LK:ZIJ+7%L!P3&(TCW_`/`BA(]L M'O74T4`>::+X$U[P]/#+IW]C9L[#["OF-)C4%\Q3NG`4;"J`J"-_+$]/E+T\ M`WT6GO9G2?#EU9W-U-.@KFM*\->*=/\``^F>&IK' M1;FWMT,-TO\`:4J"XCX(&?(.`26#+CH`,\G'HE%`'"WO@C5-0U71=1EUAX3# M/YU[:Q>68H\V[1E828MY7)Q\Q^Z6(PV,2^$?!]]HNH6UQJ$MLRZ=IBZ59^0[ M,9(P^XR/E1M8[4^49Q@_,(?$&LZ1HEW#?F![(M.SS6SPKM4@F(;=V%)*G MC`'S5Z'10!YK>>"_$3:OH_B*RBT]==@O99[PS:K<-"\+#;Y2+Y>!E=HSM&-B MYW]IM5\,>*[_`%BW\1VUOHUIK]M,(XF6^D:)K3'S12?N`6)//MG((Q@^B44` M1P&9K>)KB...*>2 M:2$Q^;([I,K)AF!5\$`@'#*3P0/0J*`//K[X:RIHFE:=H^N7ENEB]HNQQ$4* MQ2AV<9B9@_4@9VDXR,5I)X4L-,\0?V](%M;2R,T\4$?"F?P_>R-:W-]!<#YAN-OYKNZJ1GG:&`(![8JI9> M$=;T]=3>/3O#\T.I/&+G2I)'^SL%0AI-WE??=B"V4(^7KGFO0J*`/-5^'5Z= M+TW1[J'1[RWM8%1-0D#K=6;>87/DC!&T?*J_,I`7DMTKH?$?A[5M0\,:YIUI MJDE[-J4+P1)J#1Q16X8$$J8H=QP#T;.<#DHRV<]A]ERXM_-W&1G)X MA`(^8G)R26;.:[:B@#G_``MH%YH7]J?;-2EOOM=XT\;2",$*549.Q$&XXY[< M#'>N@HHH`****`"BBB@`HHHH`****`"BBB@#)\2Z.==T&XLHY$BN?EEMIF7( MBF0AHW_!@/PK-T;PU=66JWLUX]O+9W+?:_)4D^7O444 M`<)8>"-0L;BQQ=6SVUNLMA)'\P\S3R2T:$8Y=>$]-I8CDX-C7?!EW?ZCJ%SI MUU#;"Z6*Y7<#E+V'_5R<#[I&T-SG"`=S79T4`@ZIHIELH[>^TZ2 M(RA6WBYDW;F(Z;/F&.]8]YX6\0W6K6MZ;?2"(M"FTUD:[D_UKXY'[K[HV@9Z MG)XXP>_HH`\O3X:WTMKI<6HBVNTCTB'2KJV74KF&("//SKY87S`V02C`=/O= MZM:MX(UO59M;W-8Q0SWMK=V82[F!?R%50DA50R;MN=RL2IQUQD^C44`<(G@R M_L9-&OM,ALXI[&XN+J:TGOIYEE>5`A'GNK/ZMNV]1C')-5$\`ZE:3^&A$FFW M5MI]Y=W5Y%/*R*?M&X%(U\M@0N\XSC..V()[NY87"?;)[ MRWNSJ%QYD32A@0(,^6"`V-^>0/N]ZC'@[6AX$N?#[P:-)=IIDFG6U^9'#R*^ M`6?Y"8^FXJ"^X@/J\5PNF6\%_X?CTI7AN'D9)%5OF*F-0 M5RY'7.%![X&5XJMY#?0V6IW6DVD\FE)9RI)J)M?/1F.^.-WAD\T'"_=5&7/4 M[N/6Z*`.%M=$O-4\5Z-XCCL;:/21HXMA#,5W-%`'F-AX5U; MPY;Z'=:G<:4+'0],NK.XF-PZYC;:5D`*8Z(`5)X]347P\TN[U;0_">LQ2:>( M=*TQX(&BE9WED=0I24``(JD=`6)//RXQ7J=%`'&S>']=FU6'5+F+2+Z6ZTU+ M'4;2=W$"')+M%E6+*=Q!1@-P`R1534/!&I7%QJEM#+8_8M5OK>\EN&++-;>4 M(QMC0*0V?+X)9=N[H<<][10!YIJO@OQ)>QZW'%;Z.1?:W!J,327D@/EQ[!M; M]R<$^6.F0-Y]/FZCP[H^HZ;KWB.\O$M%M]1NTN(!!,SL`(UC.X%%`/R`\$]2 M.V3T=%`!1110`4444`%%%%`!1110`4444`>=S:!>W$WBO2,6SS7^HQ:A''=@ MB*ZMML2M&6"G',;*2`2N5..1FF_PVU2'31#8S6<33V%YIDD$EQ(\=I;SNK#R MF*Y?9@@*0N<]5Q7J%%`'%G1]2TKQI;:TRV"Z)8:2VG[VN7\\KE'W[/+QG*;= MN[G.,MNZ5Z+10!@W7AR[O%99/$VK@> M>L\>([7$6W.%`,.",D'YLG**0>N>:'PX>?PQ8Z7=W"R7BP-:W%^)F5A`S9:, M*@02`@G&_A2=V#C%>AT4`<M1^!_!]WX:NKFXN([.W,\$<@44`>;R^#?$46M:/XALH MK`:S#-.]^)M6N&AEC?/[N,&(A0>#D*,%1][K4E_X8\5W.N6_B:V@T:VUZ&;R MCB^D:&2SQS$W[@$G/.<<'GI\H]$HH`;&7,:F1560@;E5MP![@'`S^0KS"V\( MW6I>#+7P_=65G>RZ;=W(N[2_F:$7&]I"DPD1&()#;P0.I(X(X]1HH`\X@^'6 MHP+':/J$5S!21H1"J,K1J!G;DG)QD]AFO0Z*`,&ZT!;SPM9:;>0QWEQ;1Q%6: M=X2)4`&]9$^93G/(YYKC]6^&%Q64?B?49;N2WEBC-TMLL;;P!M?9!D+QU4!N3STQVM% M`''S>!H;C6;2[=B%AEBNKB3SFW7L\:X1GC`6-2"%8LHR=H'`XK'/@#4+B*_N MGL]"L=1N+1[:1+'=Y%]OE5W:;QR>!7I%%`'.>#/#LGAK2KBT9 D(8(9;EIH;."9I8K56`RB,RJ2-VYN@Y8X%='110`4444`?__9 ` end GRAPHIC 4 cover1.jpg GRAPHIC begin 644 cover1.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#UZ*+4-3U; M6`-;O;2*VNEABB@C@*A?(B<\O&Q)R[=ZL_V-?_\`0S:K_P!^[7_XS1HW_(5\ M0_\`803_`-)8*V*UE)IV7ET781C_`-C7_P#T,VJ_]^[7_P",T?V-?_\`0S:K M_P!^[7_XS6Q14\[\ON0[&/\`V-?_`/0S:K_W[M?_`(S1_8U__P!#-JO_`'[M M?_C-;%%'._+[D%C'_L:__P"AFU7_`+]VO_QFC^QK_P#Z&;5?^_=K_P#&:V** M.=^7W(+&/_8U_P#]#-JO_?NU_P#C-']C7_\`T,VJ_P#?NU_^,UL44<[\ON06 M,?\`L:__`.AFU7_OW:__`!FC^QK_`/Z&;5?^_=K_`/&:V**.=^7W(+&/_8U_ M_P!#-JO_`'[M?_C-']C7_P#T,VJ_]^[7_P",UL44<[\ON06,?^QK_P#Z&;5? M^_=K_P#&:/[&O_\`H9M5_P"_=K_\9K8HHYWY?<@L8_\`8U__`-#-JO\`W[M? M_C-']C7_`/T,VJ_]^[7_`.,UL44<[\ON06,?^QK_`/Z&;5?^_=K_`/&:/[&O M_P#H9M5_[]VO_P`9K8HHYWY?<@L8_P#8U_\`]#-JO_?NU_\`C-']C7__`$,V MJ_\`?NU_^,UL44<[\ON06,?^QK__`*&;5?\`OW:__&:/[&O_`/H9M5_[]VO_ M`,9K8HHYWY?<@L8_]C7_`/T,VJ_]^[7_`.,T?V-?_P#0S:K_`-^[7_XS6Q11 MSOR^Y!8Q_P"QK_\`Z&;5?^_=K_\`&:/[&O\`_H9M5_[]VO\`\9K8HHYWY?<@ ML8_]C7__`$,VJ_\`?NU_^,T?V-?_`/0S:K_W[M?_`(S6Q11SOR^Y!8Q_[&O_ M`/H9M5_[]VO_`,9H_L:__P"AFU7_`+]VO_QFMBBCG?E]R"QC_P!C7_\`T,VJ M_P#?NU_^,T?V-?\`_0S:K_W[M?\`XS6Q11SOR^Y!8Q_[&O\`_H9M5_[]VO\` M\9H_L:__`.AFU7_OW:__`!FMBBCG?E]R"QC_`-C7_P#T,VJ_]^[7_P",T?V- M?_\`0S:K_P!^[7_XS6Q11SOR^Y!8Q_[&O_\`H9M5_P"_=K_\9H_L:_\`^AFU M7_OW:_\`QFMBBCG?E]R"QC_V-?\`_0S:K_W[M?\`XS1_8U__`-#-JO\`W[M? M_C-;%%'._+[D%C'_`+&O_P#H9M5_[]VO_P`9H_L:_P#^AFU7_OW:_P#QFMBB MCG?E]R"QC_V-?_\`0S:K_P!^[7_XS1_8U_\`]#-JO_?NU_\`C-;%%'._+[D% MC'_L:_\`^AFU7_OW:_\`QFC^QK__`*&;5?\`OW:__&:V**.=^7W(+&/_`&-? M_P#0S:K_`-^[7_XS1_8U_P#]#-JO_?NU_P#C-;%%'._+[D%C'_L:_P#^AFU7 M_OW:_P#QFC^QK_\`Z&;5?^_=K_\`&:V**.=^7W(+&/\`V-?_`/0S:K_W[M?_ M`(S1_8U__P!#-JO_`'[M?_C-;%%'._+[D%C'_L:__P"AFU7_`+]VO_QFC^QK M_P#Z&;5?^_=K_P#&:V**.=^7W(+&/_8U_P#]#-JO_?NU_P#C-']C7_\`T,VJ M_P#?NU_^,UL44<[\ON06,?\`L:__`.AFU7_OW:__`!FC^QK_`/Z&;5?^_=K_ M`/&:V**.=^7W(+&/_8U__P!#-JO_`'[M?_C-']C7_P#T,VJ_]^[7_P",UL44 M<[\ON06,?^QK_P#Z&;5?^_=K_P#&:/[&O_\`H9M5_P"_=K_\9K8HHYWY?<@L M8_\`8U__`-#-JO\`W[M?_C-']C7_`/T,VJ_]^[7_`.,UL44<[\ON06,?^QK_ M`/Z&;5?^_=K_`/&:/[&O_P#H9M5_[]VO_P`9K8HHYWY?<@L8_P#8U_\`]#-J MO_?NU_\`C-']C7__`$,VJ_\`?NU_^,UL44<[\ON06,?^QK__`*&;5?\`OW:_ M_&:/[&O_`/H9M5_[]VO_`,9K8HHYWY?<@L8_]C7_`/T,VJ_]^[7_`.,T?V-? M_P#0S:K_`-^[7_XS6Q11SOR^Y!8Q_P"QK_\`Z&;5?^_=K_\`&:/[&O\`_H9M M5_[]VO\`\9K8HHYWY?<@L8_]C7__`$,VJ_\`?NU_^,T?V-?_`/0S:K_W[M?_ M`(S6Q11SOR^Y!8Q_[&O_`/H9M5_[]VO_`,9H_L:__P"AFU7_`+]VO_QFMBBC MG?E]R"QC_P!C7_\`T,VJ_P#?NU_^,T?V-?\`_0S:K_W[M?\`XS6Q11SOR^Y! M8Q_[&O\`_H9M5_[]VO\`\9H_L:__`.AFU7_OW:__`!FMBBCG?E]R"QC_`-C7 M_P#T,VJ_]^[7_P",T?V-?_\`0S:K_P!^[7_XS6Q11SOR^Y!8Q_[&O_\`H9M5 M_P"_=K_\9H_L:_\`^AFU7_OW:_\`QFMBBCG?E]R"QC_V-?\`_0S:K_W[M?\` MXS1_8U__`-#-JO\`W[M?_C-;%%'._+[D%C'_`+&O_P#H9M5_[]VO_P`9H_L: M_P#^AFU7_OW:_P#QFMBBCG?E]R"QC_V-?_\`0S:K_P!^[7_XS1_8U_\`]#-J MO_?NU_\`C-;%%'._+[D%C'_L:_\`^AFU7_OW:_\`QFC^QK__`*&;5?\`OW:_ M_&:V**.=^7W(+&/_`&-?_P#0S:K_`-^[7_XS1_8U_P#]#-JO_?NU_P#C-;%% M'._+[D%C'_L:_P#^AFU7_OW:_P#QFC^QK_\`Z&;5?^_=K_\`&:V**.=^7W(+ M&/\`V-?_`/0S:K_W[M?_`(S1_8U__P!#-JO_`'[M?_C-;%%'._+[D%C'_L:_ M_P"AFU7_`+]VO_QFC^QK_P#Z&;5?^_=K_P#&:V**.=^7W(+&/_8U_P#]#-JO M_?NU_P#C-8]W<:II/C7PYI_]LW=W:ZA]I\^.XBA_Y9Q[EP4C4CD_I785Q_B+ M_DH_@O\`[?O_`$2*TI2YI--+9]%V8F;&C?\`(5\0_P#803_TE@K8K'T;_D*^ M(?\`L()_Z2P5L5G/?Y+\AH****@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"N/\1? M\E'\%_\`;]_Z)%=A7'^(O^2C^"_^W[_T2*VH?$_1_DQ,V-&_Y"OB'_L()_Z2 MP5L5CZ-_R%?$/_803_TE@K8J)[_)?D-!1114`%%%%`!1110`4444`%%%%`!1 M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%% M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 M110`5Q_B+_DH_@O_`+?O_1(KL*X_Q%_R4?P7_P!OW_HD5M0^)^C_`"8F;&C? M\A7Q#_V$$_\`26"MBL?1O^0KXA_[""?^DL%;%1/?Y+\AH****@`HHHH`**** M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`****`"N/\1?\E'\%_P#;]_Z)%=A7'^(O^2C^"_\`M^_]$BMJ M'Q/T?Y,3-C1O^0KXA_[""?\`I+!6Q6/HW_(5\0_]A!/_`$E@K8J)[_)?D-!1 M114`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11 M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444` M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4 M444`%%%%`!1110`4444`%%%%`!1110`5Q_B+_DH_@O\`[?O_`$2*["N/\1?\ ME'\%_P#;]_Z)%;4/B?H_R8F;&C?\A7Q#_P!A!/\`TE@K8K'T;_D*^(?^P@G_ M`*2P5L5$]_DOR&@HHHJ`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"JNIZ?!JNE7>G7*AH+J%X9`>X8$'^=6J*`/# M(]5O+WX1VO@KS"NL/J8\/2;$Y5$?+-@]O*`YK?\`'/CO4?`TRZ=I2^'[>RL+ M1'6/4+DF>X`X"111G]7#\0=4_X0GP7K0@LC<:YJEM9W*[ M&V(DA<,4&[(8;1C)/?BM72/`/]F:GHUY)J7GC3=%_LDQB#9YHR/GSN..!TY^ MM8-K\(;VVAT:S;QA=3Z9H^I1WMG9RV:8558L5+`AB23PV<`$_+Z`%/QM\5]6 M\*ZY=HD>@&QM)DB-G)=E[VX!`RZJA*QCD\/S@>XJ:&\\32_%/Q.LCZ=)I$6G M(\D,C2[UB,VGV566;:C*C!BI+[XE:U8>%]9 M,VFV/_"2:->6]KWNHRP#,KQLI`"`@*N M%P!GC/>@"3P_XJ\1/X]N?"_B.PTZ&4V']HVSV$CN!'OV;7+8RV<\@`<58\5^ M)=:MM?L/#GAFVT^75KN![EI=0=Q#%$A`Y"?,22<#'I6@?"^?B(OBS[9TTO\` ML[[+Y7_37S-^_/X8Q^-5_%7A"XUR_LM5TK69=&UBS5XXKM(5F4QMCBZ4^B6D'BO5IIH88)9]]LHC&6E++D[<8.WAN3Z50O/B)K M^D^'O%$6IZ=81>(="BAFS"7>UN$D(PR@D,.X()]/>M6[^'4MUI.G@^)=1.O: M?<27-OJ\H65UD<89=C<"/I\@P.![YAD^&37/AK7[*^UV:[UC7%C6ZU.6W48" M8VA8U(`4`=,]Z`&V'B_Q7;>)QIVO:1IPBN].DOK..PE=Y`8P,QN6`!8Y'0`# MWK.\"?$G6O$NO06M]'H36]RLA\FSN&2ZLBO\,T^@\1:=J>L>*KK5HM,8M M912VL:2`E=O[R4?-)QCKCI0!3U#XB:M:_#+Q#XECM[%KW3=1DM(HRC&,JLZQ M@L-V<[6SP1SVK#\37&I0:]\3+C2Y8XKI-'M',CLR[4V-O*E>0VW.WWQFM;5_ M@_=ZA9:WIEMXONK;2=3NS>_8C:)(J2EPS9;(8KQPH*X."<]^CN?`D5YJ?B:Z MGOW\K7;".R>-(L-"%1EW!B3DG=G&!T[T`FSWTUM=F.Y@ M:;,,8@4KC+`%BN`VX,,],4K?$?QC'I)U^32M'_L6WU-[*?$DGGRKYWEJR+]U M<9P+M7TWP[I=A/8Z'& MAOGO)'1YG=-P6$CC('7=U]1P:WO"6MW_`(D\":?K#I;)?W=L9`JAA$'Y`XR3 MC('?-><>,K/7-)^(FIWFF:;XACL-6MD2X?1[=+H7K*FT!BP'V?&<%AN)&2,' M->B^`-*N]$\`Z+IU_'Y5U!;*LL>0=K=<<>F:`/*_!&H:CX5T37O%=_96-[J6 MI:E]@@,,\OF33^:R[7WDJJ`XVD#.!SVKK)?&_BO0!JEAXFL-)&I)I-QJ5A/8 M-(8)#$A)C=6.[(.#D'!!_&M>+X=6I\'77A^ZOY7$M])?1W4*>6\,AD\Q2O)Y M4\>_M52'X;WUS#JL^O\`B>?5M4O--ETV"Z:U6%+:*12"1$IPS9Y)R,@8]Z`- M/P#K'B;7]'CU;7K?2H+6\MX9K..R,ADY4[S)NX&?E(`S@'!)QFO*O$5EX?O/ MB_XQ&N^$M<\0;19^1_944C^03`N=^QUQGC&<_=->X>'M)_L'PYIND>?Y_P!B MMHX/-V;=^U0,XR<9QTR:H:3X7_LOQEXB\0?;/-_M@6P\CRMOD^5'L^]D[L]> M@Q[T`<)IVJ^,/"/AGPMI$5G#+J&IWMQ"D.IS,S01?,T89U)^Z,9X/`P,5#XL M^+FI>&=5CT6630HM3M+>*74&G6Y:.21EW&.'8K$<$$,_'S"O1=;\.?VSK>@Z ME]K\G^R;AY_+\O=YNY"N,Y&WKG.#61KW@6]O_$,^M:'XDNM$N;R%+>^$,"2B M=%S@C=RCX.`PZ8Z4`8A^(?B#7-3T2T\+Z?IKC5=(:^!OW=1`X?:]=I;>#Q:^ M*].UL:E/,++3#I_EW&9))GXUFK\.MOA.UT+^U?]1JHU'SOL_W MOWQDV;=W'7&<^^.U`&'-XSMO",?CK5?[.@$D&JQ0KM:3]\[1H`TF2V,#KM`X M'3-9^B?&6[U'1_$*,VD76IZ;IS7\$UDDXMY0#@JRRA7!!*]^<\=*["Z^'5M? M0^(8KG4)1_:U['>QO"FQ[61`H4@Y.X@KGH.M,7P)JUUX?UJPUGQ=>:G=ZG:_ M9A,\"QPP+SRL*G&[GDYR<#I0!L>$+[Q#J>D+?:_;:?;-(-?G6\01S:7#(Z1+Y2?*Q1U`.>>AKWBPM M?L.G6MIOW^1"D6_&-VT`9QVZ5P]UX$\3Q^(=6U/0O&_]E0ZE,LTEO_9,<^&" M!?O.WH/04`>`6O%BU-W\2PQ+]JDE+VO[R3:"0RDR(,##97V(Q737 MOCGQ3?7>N77AG2M,N-(T&>2WN_MF:G\-+FXU#5&TGQ/=Z5INL2-)J5C%; MQOYK,`&*.>8RW.3SG-`&;)\0_$FLZXECX6T[37AGT2/54DU`R+Y6YL%6V9W' ML`,%]7N=*TZ'0M1:>(YUQIG]DP71MGMF$_VQE#[6E# M!#%C&3MSGCK71:]XJ\3ZKJ7B33?#^EZ=-IFD0-%>/=3,DL[M$6Q%@$`C/\0P M?45H0?#N]LM6?[!XLU&ST)[LWCZ7`BJ3(6W,!,/F$9/5?<\T:S\.KJ]US4[[ M2?$]YI%OJ\>S4;:&%)/.(3:&5FYC..N.3ZB@#F?!%[!:S^!!+:0L1X=GD^TD MOYB*I7(`#;<'W4GC@BM_POXJ\;>()K#6/["TW_A&M0=A&D4Y%W;QY($DFXA& M''W5YY'IS>T7X?+I-UH$KZC]H72=-DT\H8-OG!R/F^\=O3ISUZU5T7X,-2/AZRF,UKI2((RISD(\RGL]+F>X\-177F7SR*(V4*N25SE>@VX!R>HKTK7]*_MSP[J6D^=Y'VVUDM_ M-V[MF]2N<9&<9Z9%86B>!_['UC1;_P#M'SO[,T5=)V>1M\S!4^9G<EVA\1W^HOI:0F0BW29&8-(?XM@VYP#GWKK?"]UXFG@N M8?%&G6=O=0R8CN+&7=!<*1G*ACO7'0[NO45AR_#5)/#G]GIJ\T%]#J_R7Y#04445`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4451UJ2^AT2^DTNW^T7ZP.;:+>%WR8.T9)`'.*`/,U\=ZX/'HOGNQ_PB,FL' M1%A-N!B4(,2;\;B#)D=<5TVO_$W1O#^L7&FRV6JWCV:H]]-8VAEBLE89#2MD M8&.>,\`UQ1^"UY_PK\0#Q!K_`/:XM_M'V#^T%^R_:\;\;=N/O_Q9Z\YI_B+P MSXNU2]CU(>$X?[6NK../^T+#5S9SVPP7,-S:QW4, MJO!*@D20'AE(R#],5QEI\5O#UYJD5M'#J0LIIOL\.JO:$6 M]=)IEA>KX7M;#5;K[1>_9%AN9U_C?;AF'XYKS&+PCXRN_#5CX!OM*LH](M9H MR^M178'F1))O`6(#>KD<9SCK0!>T3QAXAU_XSZGI*R7]GHNF?(UJVFH5D.QO MFDE)W1[F^9,9#*!P.<^FWLC0V%Q(APZ1,RGT(!KD_#>A:E8?$GQGJUU;>78Z MC]C^RR[U/F>7$5?@'(P?4#VIGBI_'%KK3/H5C;ZOI-U:&W:TDG2!K:8D_O=Q M&67'5<_3%`%?P9XW>Y\,^$!K+S7.IZZ)E69(T5=T>YB6`QC@8X!K1U;XAZ3H MVG:_?7%O>M%H=Q';W(C1"SL^S!3+#(^<9SCO7+W'@WQ#X?\`#G@A])LX=5U# MP\SF>U%P(1+YBD-M=AC@D]>W;M6?K'@_Q?J_@OQQ!<:3"NIZO?V\]M!#=(R, MBF/.&8KT"G.<9(..U`';:/\`$?1=7UJ[TKR-1L9K>U^V!]0M3`LT`.#(F[G: M/<#VS@X-"^(VCZ_JL5C%::I:?:5+V5Q>VC0Q7H`R3$Q^]QSR!Q5'Q5X1OO$' MBXND?EZ?/H-UI[W(9?W>$=.TXZ;&?.U M,:E+.]Y)MVAHXPX6/N2&4CG@"@#TCQ8?$LEG:VOAGRH;BXG$<][*%<6D6#EP MC$;SG``Y^E MM:7Q*'BR?PT++PC9R375R^R>6*XCA>*+^+:SD88]`1G')ZXI_P`.[:^T[0?[ M,N?"8\.P6N%@C%]'=&;.=SLR`3WKJ+Z6X@T^YEM+?[3>GI777-U=#1);NSLS/=_9S)% M;;PN]]N0NXX`YXR<4`>=Z9KGC/1?&&@6'B/4K6].M02RW&GPVJHVG;$W9#J3 MO7/RDL>W&:H:)XW\3NWA[Q-J.H0'0_$.IFPCTS[(%:U!+K&PD!RQ)0$YXYX] MI/`>F^,;3Q'<7WB7P>SW^I,R7>LOJD+>1%@E8XXER53@#`/)Y/0`,T7P/XGC M/ASPSJ-C;C1/#VI&_CU+[6&:Y`9VC01XRI!<9SQ@<>X!O:KXI\0Q_$KP_I4= MD;+1+BXGA>67:7NRD1;*CDJ@.,'@GZ=)-:TF^M8=+\-7"PR:= M);AC>_*K2%I.J8#<;?3FNL\2Z-?ZAXS\(:A:V_F6NGW%P]T^]1Y8:(JIP3DY M/'&:Y3Q%X3\6-<^)-%TFQM9M+\2W"S2:A)-OKS0!ZG!,M MQ;Q3I]V1`X^A&:DJ."%;>WB@3[L:!!]`,5)0`4444`%%%%`!1110`4444`%% M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444 M4`%%%%`!1110`4444`%%%%`!7'^(O^2C^"_^W[_T2*["N/\`$7_)1_!?_;]_ MZ)%;4/B?H_R8F;&C?\A7Q#_V$$_])8*V*Q]&_P"0KXA_[""?^DL%;%1/?Y+\ MAH****@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`&2Q1S1F.6-9$.,JXR#WZ4^BB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"N/\1? M\E'\%_\`;]_Z)%=A7'^(O^2C^"_^W[_T2*VH?$_1_DQ,V-&_Y"OB'_L()_Z2 MP5L5CZ-_R%?$/_803_TE@K8J)[_)?D-!1114`%%%%`!1110`4444`%%%%`!1 M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%% M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 M110`5Q_B+_DH_@O_`+?O_1(KL*X_Q%_R4?P7_P!OW_HD5M0^)^C_`"8F;&C? M\A7Q#_V$$_\`26"MBL?1O^0KXA_[""?^DL%;%1/?Y+\AH****@`HHHH`**** M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`****`"N/\1?\E'\%_P#;]_Z)%=A7'^(O^2C^"_\`M^_]$BMJ M'Q/T?Y,3-C1O^0KXA_[""?\`I+!6Q6/HW_(5\0_]A!/_`$E@K8J)[_)?D-!1 M114`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11 M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444` M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4 M444`%%%%`!1110`4444`%%%%`!1110`5Q_B+_DH_@O\`[?O_`$2*["N/\1?\ ME'\%_P#;]_Z)%;4/B?H_R8F;&C?\A7Q#_P!A!/\`TE@K8K'T;_D*^(?^P@G_ M`*2P5L5$]_DOR&@HHHJ`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**PDDUS_A M("K!?[/SQP,8QZXSFMV@2=PHHI#0,6BO+/&/B_7=*\3W5G97WE6Z!-J>2C8R MH)Y*D]36%_PL#Q1_T$__`"7B_P#B:[(8*I**DFM3-U4G8]PHKP__`(6!XH_Z M"?\`Y+Q?_$T?\+`\4?\`03_\EXO_`(FJ_L^KW7]?(/:H]PHKP_\`X6!XH_Z" M?_DO%_\`$T?\+`\4?]!/_P`EXO\`XFC^SZO=?U\@]JCW"BO#_P#A8'BC_H)_ M^2\7_P`31_PL#Q1_T$__`"7B_P#B:/[/J]U_7R#VJ/<**\/_`.%@>*/^@G_Y M+Q?_`!-'_"P/%'_03_\`)>+_`.)H_L^KW7]?(/:H]PHKP_\`X6!XH_Z"?_DO M%_\`$T?\+`\4?]!/_P`EXO\`XFC^SZO=?U\@]JCW"BO#_P#A8'BC_H)_^2\7 M_P`31_PL#Q1_T$__`"7B_P#B:/[/J]U_7R#VJ/<**\/_`.%@>*/^@G_Y+Q?_ M`!-'_"P/%'_03_\`)>+_`.)H_L^KW7]?(/:H]PHKP_\`X6!XH_Z"?_DO%_\` M$T?\+`\4?]!/_P`EXO\`XFC^SZO=?U\@]JCW"BO#_P#A8'BC_H)_^2\7_P`3 M1_PL#Q1_T$__`"7B_P#B:/[/J]U_7R#VJ/<**\/_`.%@>*/^@G_Y+Q?_`!-' M_"P/%'_03_\`)>+_`.)H_L^KW7]?(/:H]PHKP_\`X6!XH_Z"?_DO%_\`$T?\ M+`\4?]!/_P`EXO\`XFC^SZO=?U\@]JCW"BO#_P#A8'BC_H)_^2\7_P`31_PL M#Q1_T$__`"7B_P#B:/[/J]U_7R#VJ/<**\/_`.%@>*/^@G_Y+Q?_`!-'_"P/ M%'_03_\`)>+_`.)H_L^KW7]?(/:H]PHKP_\`X6!XH_Z"?_DO%_\`$T?\+`\4 M?]!/_P`EXO\`XFC^SZO=?U\@]JCW"BO#_P#A8'BC_H)_^2\7_P`31_PL#Q1_ MT$__`"7B_P#B:/[/J]U_7R#VJ/<**\/_`.%@>*/^@G_Y+Q?_`!-7M%\<>([O M7=.MI]1WPS7,<;KY$8RI8`C(7TI/`5$KW7]?(/:H]BHHHKB-`HHHH`****`" MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*X M_P`1?\E'\%_]OW_HD5V%_P`E^0T%%%%0`4444`%%%%`! M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%% M%%`!112$@=:`%HJJ=1LU;:;F//\`O5*TRFW:6,AP%)&.]%@N2TAKC9-9OI)" MPF*@G@`=*Z#1KV6\LV,O+HVW=ZU3@TKDJ29B:AIVORZP\EO=;8211IPU(2R?;=NS^'&.M*Q=SR3XA?\CI>_[L?_H`KEZZ M?X@_\CI>_P"['_Z`*YBO?H?PH^B.67Q,**53M8'`.#GFNHU0QVT.BFVTRW=[ MBS260;"=[%B/7VJI3Y6E;<$KG+45U.O^'UD\0FTT>WY^SK++"&SY38)89_`5 MCRZ'J$-S%;O!^]DB\X`,#A.1D^F,'K2C5C))W"S,ZBK]QH][;&#=&K+.<1/& MX96/<9'&:M-X5UA/.!MAOA7<\8<;\8SD#.3UJO:074+,QJ*T;C0M0MM/^W2P MCR`0K$,"4)Z;AU'XT^[M9H]#L';3UB#R.%N`V6FZ<8]J.>+M8+&716D=!U!8 M))/*4F)=\D0<&1%]2O4"GVGAO5+V*"6"VS'.2$8L`#CZT>TAO<+,RJ*EB)AN MUW*K%6P5;D&NWEL+=?&\]@VE0#2T;#N5(V)MR6W9J9U.0:5S@Z*V;:U#1ZNU MK9"ZMD1MLSM@Q*#PWN<53M-*NKR+S4")$6VAY7"*Q]`3U-/G745BE16BFA:E M)JG]G+;-]J_N'C\?I4K^&M56V^T"VW)N",$8,4)_O`N*.>-KW"S,RBKE MEIMS>_-$JJ@.-\C!%SZ9/&:W_$M@;>\T.!;2,3M:1M)&F`';<,[A'QGK23Z'?0K"VQ)1,Q1/)D#Y838N-S M9ZTO:*Z2ZA8YNBBNAO(H?^$.TRX2VB6XGGEC>0#E@N,?SIRERV\P.>HK9C\* MZN\J1_9U5Y$#H'D5=P/3&3R:SEL;EKM[40OYT9(=2/NXZY]*%.+V8697HJ[> MZ7M_&6IQ2AIO+E3NNW'ZUZ##()H(Y0"`ZAAGWK`M?!NEPRB5 MFEF'4*[#'Z#FNB`"@`#`'`H=A4HS7Q,6D-+2&D:GB7Q"_P"1TO?]V/\`]`%< MO74?$+_D=+W_`'8__0!7+U]!0_A1]$"2 M:#_B7HCE"5YW,<'WYKE:,54H\S3[`G8Z;P3YK>())@6)%M-E_I(DST_.K]J4M-!\+S7:$0PWTCR[ MA]U2PP3[5Q.!2XINE=[_`-6L',=SJ`U'2=%EE\QA=[F9&C;.23G'0 M]*S;M;F/P%I6WS`%NI9#C(P.,'^?-*;@>E*-%JU^@7)(%:2 MYB0`EF<`>YS7=:E+JJ>/YI(YIDL1.I=I&(A\L`;LYXQUK@:3`JYT^9W]1)V. MVM&M[N?Q9/IT)6TEM6$("X!^8=!^9Q5/5H#J?AG1)=/B:5;6-H+B.,9*2$@Y M(]_6N6Q2H[(3L9E)]#BI5%IW3_JUAN5ST"RF$WBWPS"?FGLK58[I^NUMK<$^ MH_K69H4-T-.\4+MD5FM\8(.6.[)'N<9_.N0P*,"E[#2U_P"KW#FUN==8NB>$ M-.EF&Z*#6`\@ZX3:,_A6GJQOM/\`%$VJ66E0SJY,D=YN9D*E<')S@<&O/\"G M;WV;-S;>NW/%#H:WOW_$.;2QU6H6,NJ^%-&FTR(S+;AX[B.,99)"?X;51YFVTBC+1G<-P8Y&17(J[)D*Q7/!P<9IO%-4FGOW_$+GHYB2X\4 M^*K+>L=S>0%;9F.-_3(!]^/RKG-#\/7N_P"%@O<;=6[6EW+;.R,\3%&*'(R/0UT%];S'P+I*B)\B MYF)&WD`XQ^=E:2BW;R$=7XD65-2T+.Y=ME;J#Z,.H^M;%Q;"\UOQ M;81[5N[I$:W!./,`(+`'WXKSW`H&5.5.#ZBLW1T2O_5[CYM;FI'H6JR7<5@] MM)%)(6*),=@)`Y//L!68058J>H.#0S,YR[%CZDYI*V5^H@K3\.?\C/I/_7[# M_P"ABLRM/PY_R,^D_P#7[#_Z&*4_A8+<^@Z***^<.L****`"BBB@`HHHH`** M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"N/\`$7_) M1_!?_;]_Z)%=A7'^(O\`DH_@O_M^_P#1(K:A\3]'^3$S8T;_`)"OB'_L()_Z M2P5L5CZ-_P`A7Q#_`-A!/_26"MBHGO\`)?D-!1114`%%%%`!1110`4444`%% M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!16'?Q:XV MK1M9RQK9Y&5/ZYJ'Q(^LHT/]F!O+P=^S&<_X4$.=KZ&[!.(R?WOFYV[>_7O M51;1$IJZ5CJ!-:^'=-474W))/`Y8^@%,L?%.FWTPA5WCD8X42#&XU4\5:)BBD="5E8*0TM(:!GB7Q"_Y'2]_W8__`$`5R]=1 M\0O^1TO?]V/_`-`%VX[>!]# M^%95%')YA.E8-%+V?FPN:\T&C>7,8KALJI"`DDL<`CL.^1^%.2:QN;2V2X:!&"MN"1; M3D$;=S!.S MD>:45Z7_`,*D_P"HW_Y*?_9T?\*D_P"HW_Y*?_9T?7*/\WX,/9R/-**]+_X5 M)_U&_P#R4_\`LZ/^%2?]1O\`\E/_`+.CZY1_F_!A[.1YI17I?_"I/^HW_P"2 MG_V='_"I/^HW_P"2G_V='URC_-^##VSD>:45Z7_`,*D M_P"HW_Y*?_9T?\*D_P"HW_Y*?_9T?7*/\WX,/9R/-**]+_X5)_U&_P#R4_\` MLZ/^%2?]1O\`\E/_`+.CZY1_F_!A[.1YI17I?_"I/^HW_P"2G_V='_"I/^HW M_P"2G_V='URC_-^##VA4445XIT!1110`4444`%%%%`!1110`4444` M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5Q_B+_DH_@O\`[?O_ M`$2*["N/\1?\E'\%_P#;]_Z)%;4/B?H_R8F;&C?\A7Q#_P!A!/\`TE@K8K'T M;_D*^(?^P@G_`*2P5L5$]_DOR&@HHHJ`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* MX_Q%_P`E'\%_]OW_`*)%=A7'^(O^2C^"_P#M^_\`1(K:A\3]'^3$S8T;_D*^ M(?\`L()_Z2P5L5CZ-_R%?$/_`&$$_P#26"MBHGO\E^0T%%%%0`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!7'^(O\`DH_@O_M^_P#1(KL*X_Q%_P`E'\%_]OW_`*)% M;4/B?H_R8F;&C?\`(5\0_P#803_TE@K8K'T;_D*^(?\`L()_Z2P5L5$]_DOR M&@HHHJ`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@ M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`" MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`** M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH MH`****`"BBB@`HHHH`****`"BBB@`HHHH`*X_P`1?\E'\%_]OW_HD5V%_P`E^0T%%%%0`4444`%%%%`!1110`4444`%%%%`!1110`444 M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`! M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%% M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!7'^(O^2C M^"_^W[_T2*["N/\`$7_)1_!?_;]_Z)%;4/B?H_R8F;&C?\A7Q#_V$$_])8*V M*Q]&_P"0KXA_[""?^DL%;%1/?Y+\AH****@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"N/\1?\E'\%_\`;]_Z)%=A7'^(O^2C^"_^W[_T2*VH?$_1_DQ,V-&_Y"OB M'_L()_Z2P5L5CZ-_R%?$/_803_TE@K8J)[_)?D-!1114`%%%%`!1110`4444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%% M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!1110`5Q_B+_DH_@O_`+?O_1(KL*X_Q%_R4?P7_P!OW_HD5M0^)^C_ M`"8F;&C?\A7Q#_V$$_\`26"MBL?1O^0KXA_[""?^DL%;%1/?Y+\AH****@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB MB@`HHHH`****`"BBB@`HHHH`****`"H+V6:"PN)K:`3SQQ,T<1?8)&`R%W8. M,GC.#]*GHH`XJ'XC64WPM;QO]G"QK`SFU,N/WH;9Y>[;W;C..^<5NCQ%8V>F M6%SKMU9:1/=1JWD7-VJ[7(!*!FQN(Z<"O(/[/NO^%@R_#GRIO[,DUD:V6^4K M]FV^88_]WS<#_/*_%.:WNO&NI6$]C:PW3:6$LYY=+DOI[S"LQ2`9V1E22"V` M1DDGB@#UBY\2K!XQT[0!;!UO;26Z%R)>%"%1C;CG.[KFKZ:YI,MA#?QZI9/9 M3N(X;A;A#'(Y;:%5LX)R",#OQ7E7@T^9K7P]VMN_XIJ9$9(;I=9T_78!>0FW<"W!N6=2[$;><@`9S0![_`'>N:387L-G>:I96 M]U-_JH)KA$>3_=4G)_"LG_A-])/B^Z\-+<0?;K>W$V'N$7S&.3Y:C.=P`R?0 M$&O#OB7-;WVJ^,(6L;6TU&.19!'_`&7)<)V)6&/']W'`QU-=Q&=# MLOBM*UY;0"\U'1(FL)S:[C+*$?S&5PIPVS&3D<8%`'H>D>(X+SPK;:YJ;6>G M1R(7D_TZ.:*/DC_7*=K#CJ*N/K>DQZ5_:KZI9+IV`?M;7""'!.!\^<] M>&64=O#X,^&VI:[:O=>%[1;DWZ>298XW.X1O(@!RH.?\\&KKL44GP[^(>I:- M;M:^%KRZL6TV+R#"K,&C$LB*0,*3C'T]J`/H"UU;3;Z[N+6TU"TN+FV($\,, MRN\6>FX`Y7\:P_&'C'_A%VTVSM=-EU/5=3E:*SLXY%CWE0"Q+MPH&1S[USMK MH&D^'_C1IL>D:?;V,67N& M5(=>&4@'GVK5C\0:9=V5[<:=?VE_]D5C(MO<*^UE&=IVDX/UKQ2&Y\0Z[X'\ M:Z=X?U75=1Z`5TWAN_\``M_+='PKHD\5 M[%I,L5U54/?'!(]\5J-K&F+J8TQM1M!J!7>+4SKYI7UV9SC\*\7TK1=,L?#'PNU.U ML8(M0N-2@6:Z1`)9%*/D,W4C@<'CBN7DT2>X\2W6GWVM75KXCDU``!X(H`^B=6U_3M(1TGO+5;PPO+#:R3JDDVU22%!Y/3 ML#5;PUXGM?$.BZ7>L8;6ZU"V^TI9F<,X7N1T+`9'..]>4>(?^$?L?&'C6'Q= MI$MY?ZA"K:0QM&F,L:PD$0D`["IZGC'KQ1H.M6GAC_A7>KZIYT6GR:++:>>D M#R`2LRE5PH)R<<"@#T[Q#XSM-&L+2[M!#J*S:G%IL@AN!B)V;:V2`>5[KP?I M6S-K&F6^HPZ=/J-I%?3?ZJV>=5DD_P!U2:JS6-K!H"75Q(YPIP1RV>>*]CTZ75I_`UI+9V<- MGJS6*&*WO7=DBDV#"N?OD#OW_&@#>KG?&GB:;PIHD=];:;_:,\MU%;1V_GB' M,U'\7;?[7X5T M^V\Z6'SM7M(_-A;:Z9DQN4]B.H/K0!/;>+/%J6FHW6L>"(]+@M;1YXY)=;@9 M99%(Q&6P`@().X\#'O701^)=*CM87O\`4=/L[AK1+N2&2\C/EQG`W9SRF3C? MT-<9XB\)_P#"-?#KQ8__``D&O:KY^G2#;JM[YXCPIY7@8SGGZ"L/2=%TS7/B MGHMOJMA;7L$?@N"18KB,2*&\T+G!XSAC^=`'K3ZMIL>F#4WU"T73R@<733*( MBIZ'?G&/?-8GB3QI9Z+X4_M^P\C5;' MK:ZLK5M-BUF[!NKZ"6Y@L]LD@4M$A^?.X@;LCD\9JK:1?9_AIXNM\D;?$5NR MJ;3[+\I>(JPA_P"68(Y`],4`?2-%%%`!1110`4444`%%%%`!1110`4444`%% M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444 M4`%%%%`!7'^(O^2C^"_^W[_T2*["N/\`$7_)1_!?_;]_Z)%;4/B?H_R8F;&C M?\A7Q#_V$$_])8*V*Q]&_P"0KXA_[""?^DL%;%1/?Y+\AH****@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"N/\1?\E'\%_\`;]_Z)%=A7'^(O^2C^"_^W[_T2*VH M?$_1_DQ,V-&_Y"OB'_L()_Z2P5L5CZ-_R%?$/_803_TE@K8J)[_)?D-!1114 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`445%<_\`'K-_ MN-_*@"6BOESP]H=GJ'@W3?\`A'?!OB2/Q:Y4PZV@DCM0P?EO,+E=NW(^Z,]* MZ?QLGAM/B7K4_BSPYJNMP6^GVK>9IZ/MM^&W,Y5TV@\8SZ&@#WRBO`M1L9K; MX&:T[P7"Z+%#!CUYP-QKH?`NC>#$\5VT^E?#SQ/HU[" MKO%>:C!,D2?*5():5AD@D#(H`]8%&T<'Y>H_&O2/B1)='LO!GA?7-!\0PS0W%S-?RM"#:Y_>'8\K%U..RT`?0U%>`:U8^&[OX MG^+CKW@W7_$#K/;^4^EPR.(1Y*Y#;'7!/&,YZ5KZ[X;\/Z@?ASHB:)=V6BW% MS=$Z=>-)'*@*%R&^8L#NY^]0![117F^BZ+:^!_B59Z+H;30Z1J6G2S/9/,\B M12QLN'3<21D.>$XM3TN\U6R:]E\VRLE9II1Y1P%"D'K@\$<`T` M>J45XIX$TW1I_&FKZ/8Z1J>AZ%=Z3MET75DD62XD+X:90[-P%PN0<\TVUTW6 M]1O[?X57WF-I6F2BYN;TL,W-@I!ABQCJ6^4],!/K0![;13418XUC10J*`%4# M``':G4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M1]:X*'XD3- M\'Y/%TEM&FIHC0FU,;;?M0?RPNW.[!;!QG.#0!Z)17$>*_%&OZ'H.B6]E;6% MQXFU.1(A"ZOY(8(7E8`-NVC&.IZBL[5?B/>)\';;QEI,%K+>RK"IA=6=!(7" M.N`0>#G'/IUH`](HKA1\0&OM/\(WVFQ1>5K-\+6Y2927A.QBZC!&&#+CG/TK M#UKQ1\2]+\8Z9H"1>$F;5GG-F[+:`/5J*XSQ3XCUWP[X M4TW;%ITWB:_N(;.*)5D:W:9C\Q`R&V!0QR3QQ]*70O'<5U\.'\4:M$+>6S20 M7T$8QLEC)5E`)/4@8!/<4`=E394\R)TSC:`.E\(^'_\`A%?"FGZ']J^U?9$*>=Y>S?EB<[[G=GG.[I@?C4WAO_`(27[!)_PE']D_;?-/E_V7YGE^7@ M8SYG.[.[VQBN.NO$?C[4?%OB'3?#L?AI;/2)(D+:B)Q(V^,/U0X]?3M0`]_A M;*GA'5O#-GKQ@TZZNTNK%6M-[66)`Y0?.`ZD@8X&.>N:U-'\.>-;+5K>XU/Q M]_:-DA)EM/['AA\P8(`WJ/4#WJU8^*/%6C:_IFE^,K'2?*U21H;:]TJ238DH7(1UDYR<'!' MMQWH`Z'PGX=_X1?0_P"S?M7VG_2)IO,\O9_K'+XQD],XZUG7/@+3]4\:7?B# M6TM=4B>U2UM;.YM0Z6Z@Y8_,2&8GOM&!QZURFJ_$_6[#P1>ZW#8V4UU!KTFF M)"$?#QJQ`Z-G><=>GM71R>.?ME]X-;21!+8:^9O,:0$N@2(N`,$`$,,'(/2@ M"G>_"RU8^)(=*O(=,L-<4`>`_$J^) M]7UC0O&W]DIJ;QO+!_94<_*($'S.WL>@'6G:MX#\1:M::'+)XSVZSI,TTJZC M_9<9W[Q@#R]P48''?-4_#GQ(O]6\9,T#`-N.2I!& MXC&.E)<^)_'FI^._$.A>&H?#@MM(\C+:BLX=_-CW=4.#R&[#M0!O^'/!UUIF ML2:WKFNSZYK#0?9TN)($@2*/.2$C7@$G&3GG%.\9>$[_`,23:3=:9KG]D7NF MS/-%/]D6XR67:?E8@=">N:YV[^)>HV_AF+5WL+:VDT_6%T[7()MS>0NX!GC8 M$9'S*02".:Z+6_$U[:^--"\/Z;#;RF[CENKUY,GRH$'!7!'+-QGF@"'P_P"# M=3L=>&M^(?$LNN7\4#6]NWV1+9(D8@M\J9R3@8ZAGR2VW" MC//KTKI-`\4:["FL1^,--@M?[-@%S_:%B'-I<1;2QV,_.5`Y&?RH`[2BO,X? M%WC^]TA?%%IH.C_V"T1N$LI+B3[;)#@D,&`\L$C!QSZ58U7QGX@U/4/#MOX, M32&75[&2]WZJLN%5=O'R'@_-Z'I0!Z)17`Z-XSURVO-?TWQ18V#7ND6(OR^D ML[1RH0QV[7^8-\OXY_/,\.>/?%^J'1]5N=%TZZT'5IA$O]EM+-/99R-TW!7` M(Y/&.^.E`'J-%%<-K7C/4=-U;Q7:0PVK1Z1HHU"W+JQ+283CXM7=S\'KSQ3:VUJNM6+11W%K*C^6&=T`8#<&VLK;AS^)Q72:]XFU^7 MQ,_AKPG8Z?+?P6RW-U=:C(P@A#'"IM3YF8@$]@..M`':45@>%-2U[4+&=?$6 MD)I]];RF(M"^Z&X`_P"6D>>0I]#S6_0`4444`%%%%`!1110`4444`%%%%`!1 M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%% M%`!7'^(O^2C^"_\`M^_]$BNPKC_$7_)1_!?_`&_?^B16U#XGZ/\`)B9L:-_R M%?$/_803_P!)8*V*Q]&_Y"OB'_L()_Z2P5L5$]_DOR&@HHHJ`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"BBB@`KQC_A%-8'Q0DT`:?/_P`(L^JC7C<@.(MX0YBSC'^LP=N> M@SCT]GHH`\OU[1/$WBGXH/<:7J,^A6^B6:QV][+IHF6:27)D\O?A3@!02,XQ M[URMYX=\3:3X:\2^%9[6^U15U*TO[2]ALR$G$DBM*%5$M5TKXJ:+/I5K++H%]J8U&Y6*(LMKW'Q M:\"WL%G<2VMLM[Y\Z1,R1;HL+N8#"Y/`SUKOJ*`/,_%VB>(_%7Q)TZ+2[V?1 MK71;1KB/47L_.C>>0[=JJV%8A.^3C)K%L_!6O1?\)GX-OKF2\BUFW&H0:H+' MR(# M/<]1Q7M]%`'(_#L:5%X>DMM&\.:OH-G#.V+;5(6C=F(!++N9B1^/4&N7B^&^ MB^*/B#XOO?$NAS31^?;_`&.9WEB5U\D!MI5@&Y&.^*]6HH`X#QAX9N+&7POK M'AO2DF/AZ=\:?`1'O@D7:X3/&X8!P>O/>L^XN-3^(WB+P]M\-:MI.DZ3?"_N M)M5B$#O(@_=HB9)(R7PT]U<7ZND;,MI+)$RR*6Z*I."`<X$9,:L7&%+=`3Z5K^-K^^TWP9JMQI=K< M75_Y#);Q6\+2N7;Y00J@DXSD_2M^B@#PW4/A[XS\-^%-(O;37FU4Z#+%=6VD M0:8D;YR-ZB126;AFSD'/IFM.VUZ]\+_$SQ=J4WA/Q-?6NJ+9-;R6.G-(/DA^ M8$DCG+8XSR#Z5Z_10!YSI'A"^U;P=XKBUJW%K<^(KF:X6V.&-L"H6(,RZAXB\3:?/:ZB+6'2[=+B(H_E1("S<@'#N<^F1[5ZG10!XEH MFF:WI_P6\/V5WX2_M2VCN)CJ>F7-NPNEB,KD/$I((<`Y`P2UCM-6W!Q_.>_;VNB@#RC3_`!'XFTCP MG;>$3X*UB36K>T%C%;X:6UWJ?@W0-:L);_3 MK#29XYYH_,2-9LH1\ZD8YW8!/..E>OT4`>5^#-%U7P;)XC\+V.CP-((SO)VNB7<^MZ1+H'@?6/#GB5+F(ZE=1*T.GF($ M>8%^8JRG@[1CIWQS]`44`9^GZO'J-[J-JMM=0O8S"%S/'M$F5#!DYY7GKQR# M7G_B72M1GU_Q[)#874D=UX;$%NR0L1+)MD^12!\SA!J*[O;33X//O;J&VAW M!/,FD"+N)P!D]R>!0!/1110`4452U#5],TE8VU+4;2S$K;(SVD]W/:0W4,ES;[3/"D@+Q; M@2NY1R,@'&>N*`)Z*@^VVGV_[!]JA^V&+SOL_F#S/+SC?MZ[VVIFRACO(Q,(; M=%&S:K9"AN6X'K7J-HVQT]I8[I;)8IA@9DB*`;=K*"`V=P)Z=*Z^'P#X$/">GZY`E]J-BUU)JLMFA,,**I6-(L[68!@,GL M,UD>*==UJ]\&:]H6IS6]UJVBZK8Q+>B+RHKC>ZLC,!P#_>`Z5W4GPQTB70=. MTR34M9:;368V>I?:\7<`;@JL@``7&!C&,`4^7X9:#-X3G\.R/?/;W,Z7%UOK7Q#J-OK5L^E7&IPM#:BW:%HNL0 M`)RO(P22:R/`?CGQIJOB'36U&RU:ZTS4TW2-)HOV>WM,KN5HIE9C(A.!E\<$ M&NYT;X=Z-H]_>WKS:AJ5Q=P-:E]2N3.8X">8E)Y"?7)]ZCT#X::)X>U>'48; MC4KIK5&2QAO;HRQ62L,,(5/W!C')&>P\*>&;+P?X=M]$T^6XEMH"Y5KA@SGQPB&,Z?=K"$7G('R$C.3GGF@#C=>N!H?@?1?AWJ&M6UC=RZ M:9-0N))T0)`H/[I"W5F;Y!_LJQKM/A1>6MW\,]#6VN89F@MEBF$<@8QN!DJV M.AP1P>>:O?\`"":#/ID-IJEHFKSQ0F`7^IQQW%T5R3S(RYX+'%5;#P9#X>M] M`T_03/;VEE<&6Y=)%C^T#RRN9@JCS&)V]ATSV`(!=\::-I&LZ#C7KN2VTNTF M2[N,,JI(L?.R3(.4)QD#!.!S7CNJ6[1_#WQOXDTRT.B:#K,MI#96Z1;`8`ZH M\VP<*'#'@`9'U!/L?C+P?9>-]%&DZA=WMO:^:LK?9'52Y&>OYT?#;3%T?XC_$"Q%S<71C:P+3W+[I)& M:)V9F/N2?I77>&/!>G>%I;FX@NM0OKNY54DNM0N3-)L7.U`>,*,GM5K3?#5G MI?B/6M<@EG:YU9XI]2NM1N9O# M9FGN;DC<[FX4<*``J@*`%'2O5ZQAX:LQXS/BCS9_MQL/[/\`+W#R_+\SS,XQ MG=GWQCM6S0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4 M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11 M10`5Q_B+_DH_@O\`[?O_`$2*["N/\1?\E'\%_P#;]_Z)%;4/B?H_R8F;&C?\ MA7Q#_P!A!/\`TE@K8K'T;_D*^(?^P@G_`*2P5L5$]_DOR&@HHHJ`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`*X_Q%_P`E'\%_]OW_`*)%=A7'^(O^2C^"_P#M^_\` M1(K:A\3]'^3$S8T;_D*^(?\`L()_Z2P5L5CZ-_R%?$/_`&$$_P#26"MBHGO\ ME^0T%%%%0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!7/7W@G0-1P;BR)8*0K"9P5S^.*Z&B@#B+G1_%GAY&D\/7\. MK6RG/]GZC&D;8[^7*@49_P!X$>]6O"OQ`TOQ-<2:>TCWOQ.%UXJT*W.FRZ8=NFS[= ML]ZR'+%CGY0",+WSD''04M=R7IL>V45Q/PQ\:GQEX;#W0"ZG9D0W:8QENSX[ M9QT[$$5VU)JPT[A1112&%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11 M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%% M`!1110`4444`%%%%`!1110`5Q_B+_DH_@O\`[?O_`$2*["N/\1?\E'\%_P#; M]_Z)%;4/B?H_R8F;&C?\A7Q#_P!A!/\`TE@K8K'T;_D*^(?^P@G_`*2P5L5$ M]_DOR&@HHHJ`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`*\OU3XKWOAWQ+=VVN^&KVUT5)6B@U`(V)"H.",C:V['&# MQ^=>H$XZU\]7$ECX^/B+6=6%U=+-RG=[9I]A;Z7IMO86J M;(((Q'&OH`,?G7C7PBF?P=XNU;P5K,<$5\^)()U_Y:X&=H;NNT[@.,?/W->W MT2WL$>YY':61\(?'MHX6VV/B.WDD"YP!*,LWXY4_]]UZX*X/XBV!.I^$-6B! M\ZTUN"$MV$#I2;O8%H%%%%(H****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`KC_$7_)1_!?_`&_?^B1785Q_ MB+_DH_@O_M^_]$BMJ'Q/T?Y,3-C1O^0KXA_[""?^DL%;%8^C?\A7Q#_V$$_] M)8*V*B>_R7Y#04445`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`97B4W(\,ZF+*%YKLVLBP1IU9RI"C\R*Y#X:_#Q_ M"UG%>:M*MQJ@C\N-%Y2T0DDJGNQ.6/<_B3Z)6;KVN6/AS1KG5-1E\NW@3I)X%._032W/G_P",^J7&E_%BSO[,"&YL[:!XWQ]Y@S-D^HYQ]!7O/A;Q M!;>*/#EGJ]JPV7$8++G_`%;CAE/T.17CFC^$-2^,-_>^*?$,DEC9/$8-/BBY MQC.#SU4$DGIN)/0<4WX6ZM>^!/&UYX*UXF)+F0>22*=0\7>()O"OA24QP0G&I:N@R M(5Y!2/MO/3/;G'3([K2M*M-%TV#3[&+RK>%=JC.2?4D]R3R2>II[$[EF&&*W MA2&&-(XXU"HB+@*!P``.@K@?BC\/QXMTV._T[;%K=BI:!QP95'.PGZ\@]C]3 M7H5%"=AM7.6\`^*?^$J\,074PV:A`3;WT17:8YEX/';/7\<=JZFN"UE8?!7C M&V\019BTW5Y5L]34#Y5E/^JF]NM=X#FA@A:***0PHHHH`****`"BB MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"N/\1?\E'\% M_P#;]_Z)%=A7'^(O^2C^"_\`M^_]$BMJ'Q/T?Y,3-C1O^0KXA_[""?\`I+!6 MQ6/HW_(5\0_]A!/_`$E@K8J)[_)?D-!1114`%%%%`!1110`4444`%%%%`!11 M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`!7`?$#7=1N9X/!WAQC_`&QJ2$S3 M*2!9P=Y"1TSR!W_'%=_7(^`=-']B0^(+I_M&K:U#%=W5P5P<,H*QJ.RJ"`!^ M/>FNXGV-/PIX8L?"6@0:58#*1C=)*1AI7/5F]S^@`':MNBBD,****`,KQ)HE MMXC\/7NDW2@QW,10,1G8W56'N#@_A7/?#CQ!<7^E3:)JQ*ZYHS"UNU8DEP,A M)`>X8#KZ\]Q7;5Q'B^P_L+4X/&UB`LEFI34XUX^TVO<^[)PP]<8]*:["?<[> MBHX9DG@CFC;*2*&4XQD'I4E(84444`%%%%`!1110`4444`%%%%`!1110`444 M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%%%%`!1110`4444`%%%%`!7'^(O^2C^"_^W[_T2*["N/\`$7_)1_!? M_;]_Z)%;4/B?H_R8F;&C?\A7Q#_V$$_])8*V*Q]&_P"0KXA_[""?^DL%;%1/ M?Y+\AH****@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`*I:1ID6C:1::9!)+)#:1+#&TI!;:HP`<`#@`#I5VH;N.>:TECMK MC[/,RX278'V'UP>#0WH!-17':%?:R/[2O+_49[^&RNI+3[+!9IOE92`&&WIU MZ=!ZT:AXRC@O["7=+;VB2W,-Y#(BEM\:`A<@D9R1C!YS7,L5#EYI:>OK8GG5 MKG8T5S\WBZQMKR.UGMKR-SL\UO*!6W+_`'1(0>">/7K5[5=8328_,DL[N=`C M2.T$8*QJO4DD@?AU]JU]K"S=]A\R-*H;NUCO;.>UE)$2!((8K=,-/U>]AM88;N)YE8HTT6U6* M_>4'/)%2L13;Y;ZBYD4_#_@8>&HA!8^)=>>W`VK!5^@(%=911 M6Q04444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444` M%%%%`!7'^(O^2C^"_P#M^_\`1(KL*X_Q%_R4?P7_`-OW_HD5M0^)^C_)B9L: M-_R%?$/_`&$$_P#26"MBL?1O^0KXA_[""?\`I+!6Q43W^2_(:"BBBH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#GC MX8?^S=2M$U!D:\OFO-ZH1MR0=A`;D<>HK.'P_@<+':S61G*#&5+$["0`#P?6K7 MB#PV^NRJWVWRHQ"T1B>/S%R?XP-PPP]3FM^BG["GRN-M&'*MCF(/"!BOX;HW M^XQRP2;?)QGRXO+Q][OU]J6'PG+;?8F@U+9+:?:BC^0#\TPX."?X3S[^U=-1 M1]7I]OZW_0.5#(5=((TED\R15`9]N-QQR<=LT^BBMB@HHHH`****`"BBB@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"N/\1?\E'\%_P#; M]_Z)%=A7'^(O^2C^"_\`M^_]$BMJ'Q/T?Y,3-C1O^0KXA_[""?\`I+!6Q6/H MW_(5\0_]A!/_`$E@K8J)[_)?D-!1114`%%%%`!1110`4444`%%%%`!1110`4 M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11 M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444` M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5 MQ_B+_DH_@O\`[?O_`$2*["N/\1?\E'\%_P#;]_Z)%;4/B?H_R8F;&C?\A7Q# M_P!A!/\`TE@K8K'T;_D*^(?^P@G_`*2P5L5$]_DOR&@HHHJ`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`*X_Q%_P`E'\%_]OW_`*)%=A7'^(O^2C^"_P#M^_\`1(K: MA\3]'^3$S8T;_D*^(?\`L()_Z2P5L5CZ-_R%?$/_`&$$_P#26"MBHGO\E^0T M%%%%0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!7'^(O\`DH_@O_M^_P#1(KL*X_Q% M_P`E'\%_]OW_`*)%;4/B?H_R8F7-5\`^&=:U*74-0TSSKJ;&^3SY%S@!1P&` MZ`53_P"%6^#/^@-_Y-3?_%T44E7JI64G]X60?\*M\&?]`;_R:F_^+H_X5;X, M_P"@-_Y-3?\`Q=%%/ZQ6_G?WL+(/^%6^#/\`H#?^34W_`,71_P`*M\&?]`;_ M`,FIO_BZ**/K%;^=_>PL@_X5;X,_Z`W_`)-3?_%T?\*M\&?]`;_R:F_^+HHH M^L5OYW]["R#_`(5;X,_Z`W_DU-_\71_PJWP9_P!`;_R:F_\`BZ**/K%;^=_> MPL@_X5;X,_Z`W_DU-_\`%T?\*M\&?]`;_P`FIO\`XNBBCZQ6_G?WL+(/^%6^ M#/\`H#?^34W_`,71_P`*M\&?]`;_`,FIO_BZ**/K%;^=_>PL@_X5;X,_Z`W_ M`)-3?_%T?\*M\&?]`;_R:F_^+HHH^L5OYW]["R#_`(5;X,_Z`W_DU-_\71_P MJWP9_P!`;_R:F_\`BZ**/K%;^=_>PL@_X5;X,_Z`W_DU-_\`%T?\*M\&?]`; M_P`FIO\`XNBBCZQ6_G?WL+(/^%6^#/\`H#?^34W_`,71_P`*M\&?]`;_`,FI MO_BZ**/K%;^=_>PL@_X5;X,_Z`W_`)-3?_%T?\*M\&?]`;_R:F_^+HHH^L5O MYW]["R#_`(5;X,_Z`W_DU-_\71_PJWP9_P!`;_R:F_\`BZ**/K%;^=_>PL@_ MX5;X,_Z`W_DU-_\`%T?\*M\&?]`;_P`FIO\`XNBBCZQ6_G?WL+(/^%6^#/\` MH#?^34W_`,71_P`*M\&?]`;_`,FIO_BZ**/K%;^=_>PL@_X5;X,_Z`W_`)-3 M?_%T?\*M\&?]`;_R:F_^+HHH^L5OYW]["R#_`(5;X,_Z`W_DU-_\71_PJWP9 M_P!`;_R:F_\`BZ**/K%;^=_>PL@_X5;X,_Z`W_DU-_\`%T?\*M\&?]`;_P`F MIO\`XNBBCZQ6_G?WL+(/^%6^#/\`H#?^34W_`,71_P`*M\&?]`;_`,FIO_BZ M**/K%;^=_>PL@_X5;X,_Z`W_`)-3?_%T?\*M\&?]`;_R:F_^+HHH^L5OYW][ M"R#_`(5;X,_Z`W_DU-_\71_PJWP9_P!`;_R:F_\`BZ**/K%;^=_>PL@_X5;X M,_Z`W_DU-_\`%T?\*M\&?]`;_P`FIO\`XNBBCZQ6_G?WL+(/^%6^#/\`H#?^ M34W_`,71_P`*M\&?]`;_`,FIO_BZ**/K%;^=_>PL@_X5;X,_Z`W_`)-3?_%T M?\*M\&?]`;_R:F_^+HHH^L5OYW]["R#_`(5;X,_Z`W_DU-_\71_PJWP9_P!` M;_R:F_\`BZ**/K%;^=_>PL@_X5;X,_Z`W_DU-_\`%T?\*M\&?]`;_P`FIO\` MXNBBCZQ6_G?WL+(/^%6^#/\`H#?^34W_`,71_P`*M\&?]`;_`,FIO_BZ**/K M%;^=_>PL@_X5;X,_Z`W_`)-3?_%T?\*M\&?]`;_R:F_^+HHH^L5OYW]["R#_ M`(5;X,_Z`W_DU-_\71_PJWP9_P!`;_R:F_\`BZ**/K%;^=_>PL@_X5;X,_Z` MW_DU-_\`%T?\*M\&?]`;_P`FIO\`XNBBCZQ6_G?WL+(/^%6^#/\`H#?^34W_ M`,71_P`*M\&?]`;_`,FIO_BZ**/K%;^=_>PL@_X5;X,_Z`W_`)-3?_%T?\*M M\&?]`;_R:F_^+HHH^L5OYW]["R#_`(5;X,_Z`W_DU-_\71_PJWP9_P!`;_R: MF_\`BZ**/K%;^=_>PL@_X5;X,_Z`W_DU-_\`%T?\*M\&?]`;_P`FIO\`XNBB MCZQ6_G?WL+(/^%6^#/\`H#?^34W_`,71_P`*M\&?]`;_`,FIO_BZ**/K%;^= M_>PL@_X5;X,_Z`W_`)-3?_%T?\*M\&?]`;_R:F_^+HHH^L5OYW]["R#_`(5; MX,_Z`W_DU-_\71_PJWP9_P!`;_R:F_\`BZ**/K%;^=_>PL@_X5;X,_Z`W_DU M-_\`%T?\*M\&?]`;_P`FIO\`XNBBCZQ6_G?WL+(/^%6^#/\`H#?^34W_`,71 M_P`*M\&?]`;_`,FIO_BZ**/K%;^=_>PL@_X5;X,_Z`W_`)-3?_%T?\*M\&?] M`;_R:F_^+HHH^L5OYW]["R#_`(5;X,_Z`W_DU-_\71_PJWP9_P!`;_R:F_\` MBZ**/K%;^=_>PL@_X5;X,_Z`W_DU-_\`%T?\*M\&?]`;_P`FIO\`XNBBCZQ6 M_G?WL+(/^%6^#/\`H#?^34W_`,71_P`*M\&?]`;_`,FIO_BZ**/K%;^=_>PL M@_X5;X,_Z`W_`)-3?_%T?\*M\&?]`;_R:F_^+HHH^L5OYW]["R#_`(5;X,_Z M`W_DU-_\71_PJWP9_P!`;_R:F_\`BZ**/K%;^=_>PL@_X5;X,_Z`W_DU-_\` M%T?\*M\&?]`;_P`FIO\`XNBBCZQ6_G?WL+(/^%6^#/\`H#?^34W_`,71_P`* MM\&?]`;_`,FIO_BZ**/K%;^=_>PL@_X5;X,_Z`W_`)-3?_%T?\*M\&?]`;_R M:F_^+HHH^L5OYW]["R#_`(5;X,_Z`W_DU-_\71_PJWP9_P!`;_R:F_\`BZ** M/K%;^=_>PL@_X5;X,_Z`W_DU-_\`%T?\*M\&?]`;_P`FIO\`XNBBCZQ6_G?W ML+(/^%6^#/\`H#?^34W_`,71_P`*M\&?]`;_`,FIO_BZ**/K%;^=_>PL@_X5 M;X,_Z`W_`)-3?_%T?\*M\&?]`;_R:F_^+HHH^L5OYW]["R#_`(5;X,_Z`W_D LU-_\75S2O`/AG1=2BU#3],\FZASLD\^1L9!4\%B.A-%%)UZK5G)_>%D?_]D_ ` end GRAPHIC 5 cover2.jpg GRAPHIC begin 644 cover2.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#UNVTV+5-8 MUQ[JYU#]S>)%&L-_/$JK]GA;`5'`ZLQZ=ZN?\(S8?\_&J_\`@VNO_CE&C?\` M(5\0_P#803_TE@K8K64Y)V3Z+\A&/_PC-A_S\:K_`.#:Z_\`CE'_``C-A_S\ M:K_X-KK_`..5L45/M)]V.QC_`/",V'_/QJO_`(-KK_XY1_PC-A_S\:K_`.#: MZ_\`CE;%%'M)]V%C'_X1FP_Y^-5_\&UU_P#'*/\`A&;#_GXU7_P;77_QRMBB MCVD^["QC_P#",V'_`#\:K_X-KK_XY1_PC-A_S\:K_P"#:Z_^.5L44>TGW86, M?_A&;#_GXU7_`,&UU_\`'*/^$9L/^?C5?_!M=?\`QRMBBCVD^["QC_\`",V' M_/QJO_@VNO\`XY1_PC-A_P`_&J_^#:Z_^.5L44>TGW86,?\`X1FP_P"?C5?_ M``;77_QRC_A&;#_GXU7_`,&UU_\`'*V**/:3[L+&/_PC-A_S\:K_`.#:Z_\` MCE'_``C-A_S\:K_X-KK_`..5L44>TGW86,?_`(1FP_Y^-5_\&UU_\TG MW86,?_A&;#_GXU7_`,&UU_\`'*/^$9L/^?C5?_!M=?\`QRMBBCVD^["QC_\` M",V'_/QJO_@VNO\`XY1_PC-A_P`_&J_^#:Z_^.5L44>TGW86,?\`X1FP_P"? MC5?_``;77_QRC_A&;#_GXU7_`,&UU_\`'*V**/:3[L+&/_PC-A_S\:K_`.#: MZ_\`CE'_``C-A_S\:K_X-KK_`..5L44>TGW86,?_`(1FP_Y^-5_\&UU_\TGW86,?_A&;#_GXU7_`,&UU_\`'*/^$9L/^?C5?_!M=?\`QRMBBCVD^["Q MC_\`",V'_/QJO_@VNO\`XY1_PC-A_P`_&J_^#:Z_^.5L44>TGW86,?\`X1FP M_P"?C5?_``;77_QRC_A&;#_GXU7_`,&UU_\`'*V**/:3[L+&/_PC-A_S\:K_ M`.#:Z_\`CE'_``C-A_S\:K_X-KK_`..5L44>TGW86,?_`(1FP_Y^-5_\&UU_ M\TGW86,?_A&;#_GXU7_`,&UU_\`'*/^$9L/^?C5?_!M=?\`QRMBBCVD M^["QC_\`",V'_/QJO_@VNO\`XY1_PC-A_P`_&J_^#:Z_^.5L44>TGW86,?\` MX1FP_P"?C5?_``;77_QRC_A&;#_GXU7_`,&UU_\`'*V**/:3[L+&/_PC-A_S M\:K_`.#:Z_\`CE'_``C-A_S\:K_X-KK_`..5L44>TGW86,?_`(1FP_Y^-5_\ M&UU_\TGW86,?_A&;#_GXU7_`,&UU_\`'*/^$9L/^?C5?_!M=?\`QRMB MBCVD^["QC_\`",V'_/QJO_@VNO\`XY1_PC-A_P`_&J_^#:Z_^.5L44>TGW86 M,?\`X1FP_P"?C5?_``;77_QRC_A&;#_GXU7_`,&UU_\`'*V**/:3[L+&/_PC M-A_S\:K_`.#:Z_\`CE'_``C-A_S\:K_X-KK_`..5L44>TGW86,?_`(1FP_Y^ M-5_\&UU_\TGW86,?_A&;#_GXU7_`,&UU_\`'*/^$9L/^?C5?_!M=?\` MQRMBBCVD^["QC_\`",V'_/QJO_@VNO\`XY1_PC-A_P`_&J_^#:Z_^.5L44>T MGW86,?\`X1FP_P"?C5?_``;77_QRC_A&;#_GXU7_`,&UU_\`'*V**/:3[L+& M/_PC-A_S\:K_`.#:Z_\`CE'_``C-A_S\:K_X-KK_`..5L44>TGW86,?_`(1F MP_Y^-5_\&UU_\:@(+O[7Y\4U]-,LFV(%_R7Y#04445`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%_R7Y#04445`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!4-W>6UA:R75Y%-)UGP7\)]+L]&TE+[5Y%666*:98TC>0 M[F9SGD*"!@9)P/K0!Z)17F_A;QWKMQX^E\(^(8]$FNA:FZ6YTB5VC7I\C!\G M=@Y[<8XYS6)8_$CQSJWAO7]7L-+T+RM%NIQ,\[2KOAC7<51`3E\9))8#H,4` M>Q.ZQH7=@J@9))P!2UXG\1/$FM>(_AKX9UK3$M+:TO[J$W$4KN7$V["*",`Q MY#9SSPN*[O5]0\=6FDZ;#9:=HLFIRJ3>WLT[)96Q'3"D^8V[H,#@]:`.QHKS M?PC\3)M0T_Q1_;\-DMSX?4[CR;6V0KG+'.3D@@`'M6A\/\`QX_BNXU33+T6!U'3&023:=/YUM.K M#AXV],@C&3B@#J]2UC2]&A2;5-2L[&)VVJ]U.L2L>N`6(R:ATWQ'H6L3-#I> MM:=?2J,LEK=)*0/4A2:\S^/\EG%HOAR348GFL5U9&N(T.&>,*=P'(Y(R.H^M M<'I)\+:]XU\.GX;>'=7T^[MKY)+RXF=F18?XLYD?&0#Z9Z`/>N%U?QCX@U#Q?>>%_!MEITMWI\2RWMWJ;N(8 MRPRJ`)\Q)!Z].OI56+Q[+JW@KQ?Q#XK?49--DM?[5G6\9&E,O MV@8&(]W'E`#`SSP*],\2:U%X=\-:CK$W*6ENTNW^\0.!^)P/QH`FL]:TK4+R MXL[+4[.YNK8E9X89U=XB#@AE!RO((YJ]7SOX5TNX\!ZQX+\6WDKG_A(Q);ZD MSYX:9M\1QVS\I/;Y3QWKU/QQXRU'1-5T;0-!L;>ZUK5V<0FZ8K#$JC)9LT^*5VGPOUK7M3@M8M;TJXDLI;9$;RO M/#;4&-Q)'S#//9NE`'H\^I6-K>6]G<7MM%=7.?(@DE57EQR=JDY;'?%6J\VO MM?U"+Q9\/K75M)TA]0U**9[B8VY:2U<1JQ$+%B5ZX/7.*R;GXH^(=0\4:KIN MA1>'8%TVX:W%GJUTT5U>E3@^5R%&<<9]0:`/7Z*XKQ3XYN_#F@Z/(VC[M M>.U@T]YUPDK8SN=<@J"0,CKD=.U+3/&7B32O%VG^'/&EAIJ2ZHK-97FENYB+ M*.8V5_F!]^G(]S0!Z%17E^@>-O&?B;Q7KNE:=8Z,EIH^JFWFN+CS5)MQ(RX4 M`D-)A2<\`<<<\9S?%+Q'JOB'4[30HO#44>GW36XL-3NVBO+LH3N,?(09P<9Z M8YS0![#03@9/2H+&:>XL8)KFU:UG>,-)`SJQC8CE.O%&D>-="T[7M+TN+3=>9DM!:S.\\!`7_`%A("DY9>`._ M4XY`/2Z*\\U/QEXFU7Q;J?A[P98Z4\FE(C7=SJ;R;"S`D(BI@Y]R<<'ZUU7A M;5-4UC0(+S6-(DTF]?(>U=PV.>"#[CL<$=/>@#9HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"N/\1?\E'\%_P#;]_Z)%=A7'^(O^2C^"_\`M^_]$BMJ'Q/T?Y,3 M-C1O^0KXA_[""?\`I+!6Q6/HW_(5\0_]A!/_`$E@K8J)[_)?D-!1114`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444` M%%%%`!1110`4444`%%%%`'BOB7X8:SJ7Q;6[M8F_X1C4)[>\U$B5`OF1!OE* MD[CGZ$9DSVXZ[XJ^&]:\2>'K.WT:-;GR+Q)[FQ:?R1=Q`',>[IR<=<#OU`KO M**`/(/"_@[7-.^)]AX@/A2PT;2Y+![=[:QN8W^SMRTB\Z,^8)(0J(I?@IH M>BQ6%_NOP5'0].G/'K=%`'C7AGP'J>G#Q_%K]EI^CZ9J]LOE36D MR?9X%"OG`X(";QDE0/E/:N8\07?B6/X%7.D75OI#:39>3`FJ6FH+.MXJS*%6 M-5Z$$#)8C[IX]/HIT26-HY%5T8%65AD$'J"*XV#X2^!+?5%U&+P[;BX5]Z@R M2&,'_KF6V?I0!S/B/P-?7UYX:\46&C6.M2V>G1VMUI-\559DVY!4N"H8%CU] MJZGP+I%]9"]O+_PSH.@&<@0VNFPKYJH/^>LB_*YSTP`!^-=C10!PGQ(\/:KK M\_A9M,M?/%CK,-U/-4\3^&]+@UJ MVU>*-;FQ>Z6WDCD08#*S#:5Z\=>:JV?@37$\+>-KZ_2&3Q#XCAD_T6!QLB&Q MA'&&.`3\W)Z=/K7J=%`'D,W@KQ"S?"PKI^?[#!_M']]'^XXB_P!KYONM]W/2 MNAF\.:L_QPM_$2VN=*32#;-<>8O$F]CMVYW=".<8KO:*`///`^B>(?#7B[Q) M:W6EQOI.I7\VH1:BERO!8\1F/[V<=^G%3?%70=;\5:-IVA:7;,]I=7T9U&82 M(OE0*02?F.27:-H?BZ\^+\'BK6M(@LK-M+,`2&Z67R#G(C8Y!9NI)"[>0,G&:HZ]\- M-6O_`(JQ74"Y\,7MS!J-^/-4`3PJP"[*O#VJ:E\ M2?!FK6EKYECIQN3=2^8H\O>@"\$Y.2.P-'+@7$9F=O+D! M;]>F44`<%\//#FJZ%K?C*YU*T\B+4=7EN;5O,1O,B+,0WRDXZC@X-S44`>?(?$ MW@GPOX.TFV2UU"4W4%GJ$LK%BB,>3'EE)QD@'!X7)&*[]P3&P'4@TC0Q/*DK MQHTD>=CE02N>N#VI]`'@W_"NO%7_``H?_A&O[*_XF_\`:/G_`&?[1%]S/7=N MV_K7;^./#6KZQXU\"ZA86GG6NEW4DEY)YB+Y2DQ8."03]UNF>E>A44`>8W>B M>*_"7CK6_$'AS1H-3(6.?FW%1^08X],4`:R^`?C3D61P,XZ\*M`'H7[0&L:IHWA;2 MYM+U*\L97O=K/:SM$S#8QP2I&17>>!;F>\\`^'[FYFDGGET^%Y)96+,[%!DD MGDGWKS;]I+_D4-(_Z_\`_P!IM7HGP\_Y)QX;_P"P;!_Z`*`/+_C/K^LZ7\0_ M#=KIVK7]G;S1QF6*WN7C1_WI'(!`/''->ZU\\?'5E/Q0\+(&&X11$C/(!F./ MY'\J]M\7:]'X9\):IK+[7%IE'P8U&]U3X9Z?=ZA>7%WE5OCK_ M`,DHU+_KK!_Z,6CX%?\`)*--_P"NL_\`Z,:@#TBO`/B+XBUNQ^.NBZ=::QJ% MO8R2V8>VBNG2-@TF&RH.#D=?6O?Z^;OB?_R<-H7_`%UL?_1M`&W^T)K^LZ+? M:"NE:O?V"RQ3&06MR\0<@IC.TC/4U3B^&'Q>FA25?'A"NH89U>[S@_\``*B_ M:7_Y"'AW_KE/_-*D@^*/Q%?&'AEM3 M/BO7_P"U1<"+[/\`Z9-/Y>W?N_U@&,Y7IUQ7`_";Q%K>I?&'6[&^UC4+JTCB MN2D$]T[QJ1,H&%)P,`XKUGP%K.NZ]X5AO_$6F_V=J+2.K6_D/#A0<`[7)/(K MQ3X,_P#);]?_`.N5W_Z.2@#K_BC\5-3TG78O"/A*$2ZQ+M66;:',;,/E1%Z; MN023P`1^'/R^!OC5#&VKKXI:2Z`,GV--0D)SC[NPKY7X9Q67\/E&J_M&ZGGZC?P:5IEUJ%TX2WM86FD8]E4$G^5.MK&TLRYM;6"#>S._E1A=S, M2Q)QU)))/J37F'Q^\1G1_`:Z9"X6XU67RL!L'RE^9S[_`,*_\"H`\1N/&'CN M:UF\5IK^J16#ZD8EB6^E\M9"#($"9QM`XQZ<5]::#JT.O:!8:M!_JKN!)@/3 M(R1^!XKRY/`#?\,Z'1S$WV\VO]H[<`-YW^LV_7'R4S]G;Q"+[PC>:'(P\W39 M]\8P?]5)D_\`H0?\Q0!2UGX:?%6\US4+JQ\;>1:37,DD$7]JW2^7&6)5()/%'B$ZFTUN#:E;V:8Q%5?<1Y@&W.5Z>GM7+_L M]:_K.M7/B`:KJU_?B)(#&+JY>79DR9QN)QG`_*O9]8_Y`E__`->TG_H)KP?] MF?\`X^O$O^Y;?SDH`Z#XI_%;4M)UN/PGX2C$FKN5668()"C-]U$7H6Y!)/`R M/PPD\`_&FX5=4?Q8T5R<2_9&U*0$'@[2BKY?U&<5D_#>-=3_`&A]3N;P^9+# M/>3(6.?FW%1^08X],5],4`>)?#?XK:P?$A\'>-HRFI"0Q17#H$;S.R.!P<]F M'7CKG-5/VA/$&M:+J.A+I6KW]@LL4QD%K'3C'[B;C\4H`].^$WC8>-/!D,MQ)NU.SQ! M>9/+,!P__`AS]<^E<+XKU_6;;]HG1],@U:_BT^22V#VJ7+K$V>N4!P<_2N4T MHW?P3^+*6]U+(^BWJA6D;H\#'Y7/0;D/7_@6.M;/C!E?]IK0V5@RL]H00<@B M@#T;XN^/;GP+X9AET]$.HWLOE0-(NY8P!EFQW/0`>I[XQ7G%AX0^,GB+3[?7 MAXL>W-Q<=N]_+$2N`5S&B[!D8X/XUZ=\4_`+>/O#4=M;3)#J%I(9;9I/NL M2,%6]`>.?4"O)K/Q'\7_`(=V4>FW&BO>6-NH2$RVIGCC11@`/$1QCH&/:@#J M_A)\2];U7Q%=^$?%1#ZE!YGES%55]R'#QL%X)')!'H>M>T5XY\./B-X2\8>) M\7'AG3]*\2.6>&Y6)':<[3NQ)M#!L9X/4=^U>QT`%%%%`!1110`4444`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444` M%%%%`!7'^(O^2C^"_P#M^_\`1(KL*X_Q%_R4?P7_`-OW_HD5M0^)^C_)B9L: M-_R%?$/_`&$$_P#26"MBL?1O^0KXA_[""?\`I+!6Q43W^2_(:"BBBH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`*^9O&MCJ7PK^+\?BRUMFDTR[N6G4C.UM^?-B)[-RQ&>.A MYP17TS4%[8VFHVDEI?6T-S;R##Q3('5A[@\4`>#^.?C/%=VNEZKX/\2?9;BW MYN-*N+-]TVXKPS;2AQCLPX)PG^#W@"2]^UMX<@$FX/M6:54R/]@-MQ[8P:H>)?@EX0U][ M>6WLQI4L14,;)0BR(.S+TS_M#!]2:`*7Q]T2YUCX>K=6B&0Z?KZ#X4T'PO"T6BZ5;6090KM&OSN!TW,-6 M>,:?N",1R,^8,X/?`KCO&O@6]^$6O:%J5MJ1O\R^?'+Y!A"O&RG:?F;J"._K M7UM6+XD\)Z'XOLHK/7;$7<$,GFHOFO&5;!&A/%`'#_&/4(-5^"<^HVK! MH+K[--&1W5G4C^=N>_X4E\//^A>_P#)VX_^.4`7 M-*^+/@C6]4M]-T_6_.O+E]D4?V69=S>F2@`_$UY%\3_^3AM"_P"NMC_Z-KUW M2OA-X(T35+?4M/T3R;RV??%)]JF;:WK@N0?Q%:&J>`?#.L^(8-?U#3/.U.W, M;13^?(NTHC>`?#/A[7+C6=+TS[/J%P'66;SY'W!F#-PS$#) M`Z"@#PWQK97WPL^,<7BZ"TDETJ[N&G!0\,7!\V,GLW+,`>.F.AQZ5,_%6L:EK&J7\YT'=)Y M4,@#*TKONVHQ&[:@R.N!P/IROQ)6;XD?&VU\+6=R8X;5?LIEV;UC8`O*^`>< M=,9'*]J^C[:UM[*VCMK6"*"WB4+'%$@54`Z``<`5@:3X!\,Z'K\^N:=IGE:E M<;_-G,\KEMYRW#,0,GT%`'D?_#,O_4W?^4W_`.VUS_@>.;X8?'/^P;JY\RWG M/V-YBI02+(`T;8R`?#/A"YGN-"TS[)+.@ M21O/DDW*#G'SL<4`:^L?\@2__P"O:3_T$UX/^S/_`,?7B7_Y;0=.^R-.AYP17J$7QW\!2:>MR^HW$< MQ7<;5K20R`^F0-N?^!8KT.\LK74+22UO;:*YMY!M>*9`ZL/<'BN.?X/>`)+W M[6WAR`2;@^U9I53(_P!@-MQ[8P:`/&=*BU#XS?%Y-:^R26^D6DD99F&1'%&< MJA/0LQSQVW'L*U?VE_\`D*>'O^N,W_H25[]IVF6&D6266FV<%I;)]V*",(H] M3@=_>LCQ-X%\-^,);>37M-^UO;*RQ'SY(]H.,_<89Z#K0!B?%'P(GC?P>8X$ M7^U;-3+9OCDG'S1Y]&`Q]0#VKYV\$ZC?ZA\4_"XU)W:>UN8;4;UPP5#@*?<# MC\*^Q0```.@KEC\-_"1\3#Q'_9"C51,)_/6>0#S!_%M#;?TH`X7X])XFL-/T M_7-"U74K2U@W0W:6=S)&!D@JY"D=\C/N*T="^//@Z[T6WFU:^DL+_P`L":!K M>1_G'7:R*00>V<5ZC)&DL;1R(KHPPRL,@CT(KB;WX/\`@&_N#/-X<@5R,8@E MDA7_`+Y1@/TH`\7TRX'Q`_:!MM7\.6;V]E#=17$LFS&8X\;G8=B^,?B.^:^H M*SM'T#2/#]LUOI&FVUE$QRRP1A=Q]21U/UK1H`****`"BBB@`HHHH`****`" MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`** M**`"N/\`$7_)1_!?_;]_Z)%=A7'^(O\`DH_@O_M^_P#1(K:A\3]'^3$S8T;_ M`)"OB'_L()_Z2P5L5CZ-_P`A7Q#_`-A!/_26"MBHGO\`)?D-!1114`%%%%`! M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%% M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444 M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`! M1110`4444`%%%%`!1110`5Q_B+_DH_@O_M^_]$BNPKC_`!%_R4?P7_V_?^B1 M6U#XGZ/\F)FQHW_(5\0_]A!/_26"MBL?1O\`D*^(?^P@G_I+!6Q43W^2_(:" MBBBH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`KC_$7_)1_!?_`&_?^B1785Q_B+_D MH_@O_M^_]$BMJ'Q/T?Y,3-C1O^0KXA_[""?^DL%;%8^C?\A7Q#_V$$_])8*V M*B>_R7Y#04445`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%% M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%_R7Y#04445`!1110`4444`%%%%`!11 M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444` M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4 M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11 M10`4444`%9-\;-#M?%5]HV MHV=S:1VTLD(NVPRL4)SE>H!QQUZCI7II->`ZTUO\0[/Q-K6L7TT-G8W/V/0X M8#D22@'@)_&SY3WYZ@"JBEU)DWT+E]K^L?$K4+6SAD>PTJ^D*VEB4RT\:'YY MYC_SS&.%Z,V!ZFO9-+TFTT?28--LX]MO"FQ0>2WJ3ZDG))[DUY-\$;^*SO-5 M\/:K"8=?MF"`S,2[0H,>6OH%/.!P=V?>O9Z)=@CJKGCGA'3I/`?QFO\`P^G& MEZS`US:*#P-N6`_`"0?3%>QUPGCNS$?BKP5K"#$D.I_9&('\,J$?S7]:[RD] M=1H****0PHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@ M`HHHH`****`"N/\`$7_)1_!?_;]_Z)%=A7'^(O\`DH_@O_M^_P#1(K:A\3]' M^3$S8T;_`)"OB'_L()_Z2P5L5CZ-_P`A7Q#_`-A!/_26"MBHGO\`)?D-!111 M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`! M1110!C>*[Z;3O"NJ75O'+)<);.(4B4LS2$84`#G[Q%<1\+_A_(84 M-[`#]CMCR+0-RS8Z>8Q/)Y(``!XQ7I^*J:EJ-II.FW%_?3+#:VZ&221N@`II MZ6%;6Y\Z_$[6G\/_`!K_`+5T]3'<6@@>3!QYAV#(^A0A37T3I.J6NM:3:ZE9 M2![:YC$D;>Q['W'0CUKP+_A$M9^,>LZEXH^33M/*F*Q$BY:4J,*#CMG.6YP> M!G'&G\%O$]UHNL77@;65:&19':W63@I(.7C^AY8?CZUA$79GKWB*R^VV M]A\NXPZA;3#VVR#G\LULTF`1R*6LS0****`"BBB@`HHHH`****`"BBB@`HHH MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@ M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*X_P`1?\E'\%_]OW_HD5V% M_P`E^0T%%%%0`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`! M1110`4444`%%%%`!1110`4444`%%%&0*`$S7DOBFQOOBEXK.@V'-(F_T M^Y!QYTW>-/4J./8DD]L[VO\`BO4M2\2MX1\*>4-0C7??7\J[H[1#CH/XGYX! MX_7'5:%HMIH&E1:?9AO+3+,[G+2.3EG8]R3DFFM-27J6[*SM]/L8+.UA6*W@ M01QHHX50,`5YM\4O`DU^\7BW0$*Z[IQ24JG_`"W5#D<=V'ZCCTKU&D/-"=G< M;5S$\)>);3Q5XU8QZ1XC MG,;PG[L%W@LI7_9<;ACUQVZ>@BA@A:***0PHHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"N/\1?\E'\%_P#;]_Z)%=A7 M'^(O^2C^"_\`M^_]$BMJ'Q/T?Y,3-C1O^0KXA_[""?\`I+!6Q6/HW_(5\0_] MA!/_`$E@K8J)[_)?D-!1114`%%%%`!1110`4444`%%%%`!1110`4444`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444` M%%%%`!1110`4444`%%%%`!7!_$'Q)J=N]CX:\-D'7M4)"N/^7:$'YI#P<>Q] MCW`%=Y7'>`]-,^GCQ1J&V35]9B2>5P.(HR,I$F>B@8^IY--=Q,N^#/"-IX0T M86D+&:ZE/FW=V_WYY#U8D\X]!_4DUT8I:.](84G>EI.]`&%XQ\/+XG\,W>F[ M_+G($EM*.#%,O*,#VY_0FN?^&GCN?Q9;WECJ=L+35]/*I/&3R_&"V#T^8-D= M!Q7>FN,\8Z7)87=EXMTN`M?:<=MU'&.;BT8_O%P.I'WQ[@^M-=A-:W.THJ"T MNX+ZUBNK:5)8)4#QR(A%3TAA1110`4444`%%%%`!1110`4444`%%%%`! M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%% M%%`!1110`4444`%%%%`!1110`4444`%\^V/:0K#Y_EB/9&_167_ M`,)'I(O;>S:\5+FX4-'&ZLI.>FBT?4[71[RWM;F**YFO'G1@3C8SYVDXX)'& M<'%94O@FYO`([J:(1&ZGN"4E=F&]%"\D>OZ5VU%8RP\)))[$N"9R8\, MWDNH?:KO[-*T[PRW'[^4*KH`#M1K_B'2M2U13#:W*):R0/%)&T MC)\QZ-E0=P']W@?7I6[11["%FNX_P`E^0T%%%%0`4444`%%%%`!1110 M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`! M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%% M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444 M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%%%%`!7'^(O^2C^"_^W[_T2*["N/\`$7_)1_!?_;]_Z)%;4/B?H_R8 MF;&C?\A7Q#_V$$_])8*V*Q]&_P"0KXA_[""?^DL%;%1/?Y+\AH****@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"N/\1?\E'\%_\`;]_Z)%=A7'^(O^2C^"_^W[_T M2*VH?$_1_DQ,V-&_Y"OB'_L()_Z2P5L5CZ-_R%?$/_803_TE@K8J)[_)?D-! M1114`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%% M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`5Q_B+_DH_@O_`+?O_1(KL*X_Q%_R M4?P7_P!OW_HD5M0^)^C_`"8F;&C?\A7Q#_V$$_\`26"MBL?1O^0KXA_[""?^ MDL%;%1/?Y+\AH****@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"N/\1?\E'\%_P#; M]_Z)%=A7'^(O^2C^"_\`M^_]$BMJ'Q/T?Y,3-C1O^0KXA_[""?\`I+!6Q7,6 M>N:3IFM^((;_`%2RM)6OD<)/<)&Q7[-`,X)Z<'\JO_\`"6>&_P#H8-*_\#8_ M\:4X2;NET7Y!&_P#H8-*_\#8_\:GV M<^S'&_P#H8-*_\#8_\:/9S[,+FQ16 M/_PEGAO_`*O\`P-C_`,:/^$L\-_\`0P:5_P"!L?\`C1[.?9A&_P#H8-*_ M\#8_\:/^$L\-_P#0P:5_X&Q_XT>SGV87-BBL?_A+/#?_`$,&E?\`@;'_`(T? M\)9X;_ZO_``-C_P`:/9S[,+FQ16/_`,)9X;_ZO_`V/_&C_`(2SPW_T M,&E?^!L?^-'LY]F%S8HK'_X2SPW_`-#!I7_@;'_C1_PEGAO_`*O\`P-C_ M`,:/9S[,+FQ16/\`\)9X;_ZO_``-C_P`:/^$L\-_]#!I7_@;'_C1[.?9A M&_P#H8-*_\#8_\:/9S[,+FQ16/_PE MGAO_`*O\`P-C_`,:/^$L\-_\`0P:5_P"!L?\`C1[.?9A&_P#H8-*_\#8_ M\:/^$L\-_P#0P:5_X&Q_XT>SGV87-BBL?_A+/#?_`$,&E?\`@;'_`(T?\)9X M;_ZO_``-C_P`:/9S[,+FQ16/_`,)9X;_ZO_`V/_&C_`(2SPW_T,&E? M^!L?^-'LY]F%S8HK'_X2SPW_`-#!I7_@;'_C1_PEGAO_`*O\`P-C_`,:/ M9S[,+FQ16/\`\)9X;_ZO_``-C_P`:/^$L\-_]#!I7_@;'_C1[.?9A&_P#H8-*_\#8_\:/9S[,+FQ16/_PEGAO_ M`*O\`P-C_`,:/^$L\-_\`0P:5_P"!L?\`C1[.?9A&_P#H8-*_\#8_\:/^ M$L\-_P#0P:5_X&Q_XT>SGV87-BBL?_A+/#?_`$,&E?\`@;'_`(T?\)9X;_Z& M#2O_``-C_P`:/9S[,+FQ16/_`,)9X;_ZO_`V/_&C_`(2SPW_T,&E?^!L? M^-'LY]F%S8HK'_X2SPW_`-#!I7_@;'_C1_PEGAO_`*O\`P-C_`,:/9S[, M+FQ16/\`\)9X;_ZO_``-C_P`:/^$L\-_]#!I7_@;'_C1[.?9A&_P#H8-*_\#8_\:/9S[,+FQ16/_PEGAO_`*&# M2O\`P-C_`,:/^$L\-_\`0P:5_P"!L?\`C1[.?9A&_P#H8-*_\#8_\:/^$L\- M_P#0P:5_X&Q_XT>SGV87-BBL?_A+/#?_`$,&E?\`@;'_`(T?\)9X;_ZO_ M``-C_P`:/9S[,+FQ16/_`,)9X;_ZO_`V/_&C_`(2SPW_T,&E?^!L?^-'L MY]F%S8HK'_X2SPW_`-#!I7_@;'_C1_PEGAO_`*O\`P-C_`,:/9S[,+FQ1 M6/\`\)9X;_ZO_``-C_P`:/^$L\-_]#!I7_@;'_C1[.?9A&_P#H8-*_\#8_\:/9S[,+FQ16/_PEGAO_`*O\` MP-C_`,:/^$L\-_\`0P:5_P"!L?\`C1[.?9A&_P#H8-*_\#8_\:/^$L\-_P#0 MP:5_X&Q_XT>SGV87-BBL?_A+/#?_`$,&E?\`@;'_`(T?\)9X;_ZO_``-C M_P`:/9S[,+FQ16/_`,)9X;_ZO_`V/_&C_`(2SPW_T,&E?^!L?^-'LY]F% MS8HK'_X2SPW_`-#!I7_@;'_C1_PEGAO_`*O\`P-C_`,:/9S[,+FQ16/\` M\)9X;_ZO_``-C_P`:/^$L\-_]#!I7_@;'_C1[.?9A&_P#H8-*_\#8_\:/9S[,+FQ16/_PEGAO_`*O\`P-C_ M`,:/^$L\-_\`0P:5_P"!L?\`C1[.?9A&_P#H8-*_\#8_\:/^$L\-_P#0P:5_ MX&Q_XT>SGV87-BBL?_A+/#?_`$,&E?\`@;'_`(T?\)9X;_ZO_``-C_P`: M/9S[,+FQ16/_`,)9X;_ZO_`V/_&C_`(2SPW_T,&E?^!L?^-'LY]F%S8HK M'_X2SPW_`-#!I7_@;'_C1_PEGAO_`*O\`P-C_`,:/9S[,+FQ16/\`\)9X M;_ZO_``-C_P`:/^$L\-_]#!I7_@;'_C1[.?9A&_P#H8-*_\#8_\:/9S[,+FQ16/_PEGAO_`*O\`P-C_`,:/ M^$L\-_\`0P:5_P"!L?\`C1[.?9A'M$OKE[F[T?3[B=\;I9K9'9L#`R2,G@`5#_PB?AO_`*%_2O\` MP"C_`,***QYY+J.P?\(GX;_Z%_2O_`*/_"C_`(1/PW_T+^E?^`4?^%%%/VD^ M["P?\(GX;_Z%_2O_``"C_P`*/^$3\-_]"_I7_@%'_A111[2?=A8/^$3\-_\` M0OZ5_P"`4?\`A1_PB?AO_H7]*_\``*/_``HHH]I/NPL'_")^&_\`H7]*_P#` M*/\`PH_X1/PW_P!"_I7_`(!1_P"%%%'M)]V%@_X1/PW_`-"_I7_@%'_A1_PB M?AO_`*%_2O\`P"C_`,***/:3[L+!_P`(GX;_`.A?TK_P"C_PH_X1/PW_`-"_ MI7_@%'_A111[2?=A8/\`A$_#?_0OZ5_X!1_X4?\`")^&_P#H7]*_\`H_\*** M/:3[L+!_PB?AO_H7]*_\`H_\*/\`A$_#?_0OZ5_X!1_X444>TGW86#_A$_#? M_0OZ5_X!1_X4?\(GX;_Z%_2O_`*/_"BBCVD^["P?\(GX;_Z%_2O_``"C_P`* M/^$3\-_]"_I7_@%'_A111[2?=A8/^$3\-_\`0OZ5_P"`4?\`A1_PB?AO_H7] M*_\``*/_``HHH]I/NPL'_")^&_\`H7]*_P#`*/\`PH_X1/PW_P!"_I7_`(!1 M_P"%%%'M)]V%@_X1/PW_`-"_I7_@%'_A1_PB?AO_`*%_2O\`P"C_`,***/:3 M[L+!_P`(GX;_`.A?TK_P"C_PH_X1/PW_`-"_I7_@%'_A111[2?=A8/\`A$_# M?_0OZ5_X!1_X4?\`")^&_P#H7]*_\`H_\***/:3[L+!_PB?AO_H7]*_\`H_\ M*/\`A$_#?_0OZ5_X!1_X444>TGW86#_A$_#?_0OZ5_X!1_X4?\(GX;_Z%_2O M_`*/_"BBCVD^["P?\(GX;_Z%_2O_``"C_P`*/^$3\-_]"_I7_@%'_A111[2? M=A8/^$3\-_\`0OZ5_P"`4?\`A1_PB?AO_H7]*_\``*/_``HHH]I/NPL'_")^ M&_\`H7]*_P#`*/\`PH_X1/PW_P!"_I7_`(!1_P"%%%'M)]V%@_X1/PW_`-"_ MI7_@%'_A1_PB?AO_`*%_2O\`P"C_`,***/:3[L+!_P`(GX;_`.A?TK_P"C_P MH_X1/PW_`-"_I7_@%'_A111[2?=A8/\`A$_#?_0OZ5_X!1_X4?\`")^&_P#H M7]*_\`H_\***/:3[L+!_PB?AO_H7]*_\`H_\*/\`A$_#?_0OZ5_X!1_X444> MTGW86#_A$_#?_0OZ5_X!1_X4?\(GX;_Z%_2O_`*/_"BBCVD^["P?\(GX;_Z% M_2O_``"C_P`*/^$3\-_]"_I7_@%'_A111[2?=A8/^$3\-_\`0OZ5_P"`4?\` MA1_PB?AO_H7]*_\``*/_``HHH]I/NPL'_")^&_\`H7]*_P#`*/\`PH_X1/PW M_P!"_I7_`(!1_P"%%%'M)]V%@_X1/PW_`-"_I7_@%'_A1_PB?AO_`*%_2O\` MP"C_`,***/:3[L+!_P`(GX;_`.A?TK_P"C_PH_X1/PW_`-"_I7_@%'_A111[ M2?=A8/\`A$_#?_0OZ5_X!1_X4?\`")^&_P#H7]*_\`H_\***/:3[L+!_PB?A MO_H7]*_\`H_\*/\`A$_#?_0OZ5_X!1_X444>TGW86#_A$_#?_0OZ5_X!1_X4 M?\(GX;_Z%_2O_`*/_"BBCVD^["P?\(GX;_Z%_2O_``"C_P`*/^$3\-_]"_I7 M_@%'_A111[2?=A8/^$3\-_\`0OZ5_P"`4?\`A1_PB?AO_H7]*_\``*/_``HH MH]I/NPL'_")^&_\`H7]*_P#`*/\`PH_X1/PW_P!"_I7_`(!1_P"%%%'M)]V% M@_X1/PW_`-"_I7_@%'_A1_PB?AO_`*%_2O\`P"C_`,***/:3[L+!_P`(GX;_ M`.A?TK_P"C_PH_X1/PW_`-"_I7_@%'_A111[2?=A8/\`A$_#?_0OZ5_X!1_X M4?\`")^&_P#H7]*_\`H_\***/:3[L+!_PB?AO_H7]*_\`H_\*/\`A$_#?_0O MZ5_X!1_X444>TGW86#_A$_#?_0OZ5_X!1_X4?\(GX;_Z%_2O_`*/_"BBCVD^ M["P?\(GX;_Z%_2O_``"C_P`*/^$3\-_]"_I7_@%'_A111[2?=A8/^$3\-_\` M0OZ5_P"`4?\`A1_PB?AO_H7]*_\``*/_``HHH]I/NPL'_")^&_\`H7]*_P#` M*/\`PH_X1/PW_P!"_I7_`(!1_P"%%%'M)]V%@_X1/PW_`-"_I7_@%'_A1_PB M?AO_`*%_2O\`P"C_`,***/:3[L+!_P`(GX;_`.A?TK_P"C_PH_X1/PW_`-"_ MI7_@%'_A111[2?=A8/\`A$_#?_0OZ5_X!1_X4?\`")^&_P#H7]*_\`H_\*** M/:3[L+!_PB?AO_H7]*_\`H_\*/\`A$_#?_0OZ5_X!1_X444>TGW86#_A$_#? M_0OZ5_X!1_X4?\(GX;_Z%_2O_`*/_"BBCVD^["P?\(GX;_Z%_2O_``"C_P`* M/^$3\-_]"_I7_@%'_A111[2?=A8/^$3\-_\`0OZ5_P"`4?\`A1_PB?AO_H7] M*_\``*/_``HHH]I/NPL'_")^&_\`H7]*_P#`*/\`PJ:U\/:)8W*7-IH^GV\Z 69VRPVR(RY&#@@9'!(HHI<\GU"Q__V3\_ ` end GRAPHIC 6 taker.jpg GRAPHIC begin 644 taker.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`-5 M;FVFFR8[ZX@R,8C6,X]_F4U:HH`P)M'UQ2S6GBBZ#'HMU:02(/P1$/Z]JYC4 M?$OC_P`,EI]4\/6.KZ=&?GGTIV60+W8QMDY]AQ[UZ-2$9IW%8Y'PQ\2_#/BM M_)LK[R;K_GVN@(Y/PYPWX$UUV:\]\\*^(1X;\VY[[138Y M%E17C961@"K*<@@]"#3JDH****`"BBB@`HHHH`*,T5GZOK6FZ%9&\U2]@M+? M(423-@$GL/4^U`&AFD)'K6;I'B'2-?@:;2=1MKQ$^\89`Q7ZCJ/QKSKQS\4B M+K_A&_"!6]UBX_=M<1D&.#KG!Z%@`3GHO4^E-)BN;WC[XE:=X,MC!&%O-6=< MQ6JDX4?WG(^Z!GZG]1QEY\+M1\3>!;C6=;FEF\67`-U&2W"(!E8-O0#'8="? M;FK\.O!4>L:R;VX<7NG64_F3WKDM_:5V"?F5B.8D]_O-R?0>[#[M5?EV%ON> M"_`_QU<1WW_"(ZE)(T;!C9-)UC*C)C/M@$CT(([BO>QTKYR^,6@W'A3QQ9^* M])#1K=2B;>!E4N4(/_CP`.._S5[]HNIPZSHECJ4!!CNH$E&#TW`''X=/PHDN MJ"/8OT445!04444`%%%%`!7%_$?P99>,='A2_P!3;3H;)VG,P`*@8P=V2.,> M]=I7C?Q]\2O9:/9:!;7&V2]8RW*J>?*4\`^Q;\]IIQ5V*3LCQK49QX9U:Z7P MSK%Y):3PM`;ORO)\],X8#DY7(Z\=*Z_P#:0:MI$6@Z!!+_:VHEDUF_9<"TL] MP!2,]/F`'N?R(Z_Q!I^DZ5\)-$\+7.GM?:]=0*;2TBXECF?YF?/4*K,<^N,> MXX3P9J6H_##XE_V?JJ^3#)(+6\!/RE"?ED!]!PV?0GZ5M>Z,K69]-:7IEIH^ MFV^GV,*PVMO&(XXU[`5O298TEC:.10R,"K*1D M$&O(O@;&=.E\5Z*0X-CJ`7#=!]Y?S^2J3]VQ-M;GL%%%%24%%%%`!1110`AZ M5\R>/];M[SXT37/V4Z@-/>.W@M`N1-*O1#@=/,9L^O3O7TV>E<7X6^&^E>&] M4N]8DS>ZM`?M$6$HU31M1WQ^2T+P;=WS!@=V<>F#U]OI3@[R%/X3K?@KXU77O#@T:ZD! MU#34"+D\R0=%;\/NGZ#UKU*OB_PEXCN?"GB6SU>VY\EL2I_STC/#+^(_4`]J M^R+*\M]0L8+RUD62"=!)&Z]"I&0:)QLPA*Z+%<1X2TQ;+Q_XWG1N)[BV.ST/ ME;B<^Y`/>OF>.+6_C/X^:0JT%L,!V M!W):0#H/=C^IYZ=-SQ[K^J_$WQJGA/05WV%M,5!#?+*R\-*Q_NKSC_$BO;/" M/A+3O!VB)ING(2,[I9GQOE?NQ_H.U6O=7F0_>?D>%?%3X6+X6@36=&\R33,+ M'.C'+0M@#?GN&/7T)]#QT_P&\9">S?PI=L!)!NFLV9OO(3ED`]03GZ$^E>T7 M5K#>6LMM<1++#*I1T89#`C!!KY=\7>%]0^%?C:SU*P+R62S">SF?O@\QN1WQ MQ[@Y]:J+YE9B:Y7='U1169X>UNU\1Z#9ZO9,3!=1AP#U4]"#[@Y'X5IUD:!1 M110`4444`%%%!.*``]*\Y^*_B2_L-,M?#^A!I-;U=C%&L1^=(_XF'IG(&>W) M[4[XA_$ZV\)XTS356]UZ;:([?!98]W0MCN>R]3["K/@/P3/I+/K^OW#WWB2\ M7]]+(=P@4_P)Z>Y'T'%/;5B>NB+/P^\!V/@G1DC1$?4ID!N[CJ6;^ZOHH[#\ M:[*BBDW<=@K&\3>&M/\`%6AW.EZA&&CE7Y'Q\T;XX9?[UQ7Q%\&_\)+HXO+$F#7- M._?V-S&<.&7G9GT../0XJ[X!\6)XQ\*VVI;0ER,Q7,0_@E7K^!X(]C5-WU)2 MMH=11114E!1110`5Y]\3_B-#X+TO[-:.DFLW*9ACX(B7_GHP]."!ZGV!KJ?$ MWB*R\+:!=:M?-B*%?E4=78\*H]R<"O+/AUX.N/&.KR^/O%:),UR^^SM7&4`! MX;!_A&,*/Q]*I);LEOHC1^%_P]DAD'B_Q,&N-;O"9HA+G,(8?>8?WS^@P*]: MZ4@&`*6DW=C2L@HHHI#"BBB@!",UXCND^%WQA\M%9/#WB!A]X_*DA..#_LLW M_?+^U>WUR/Q%\(Q>+_"5U:"-3?0J9K-^ZR#M]&^Z?K[4XNVXFCK0=_"3 MQ?)XA\--8:@TG]K:8WD7`F/SN.BL<\YXP<]Q[UZ)2:MH"=PHHHH&>9ZIHMQX M\^)%U9ZHZCP_X?>(K;*3FYG>-7RWL`&/)+(WR^8![<9'J`?4UZC:W4%[:Q75M*DL$R!X MW4Y#*1D$475M#>6TMM<1I+!*I22-QE64\$$5\[Z%\5)_A_J^I^'6L3>Z/:7\ MT5NOFXDA02$8!/!'&</G$$\)# M<*6/(RO0'OVKLJEJQ2=PHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`__9 ` end GRAPHIC 7 cover3.jpg GRAPHIC begin 644 cover3.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#UZ*+4-3U; M6`-;O;2*VNEABB@C@*A?(B<\O&Q)R[=ZL_V-?_\`0S:K_P!^[7_XS1HW_(5\ M0_\`803_`-)8*V*UE)IV7ET781C_`-C7_P#T,VJ_]^[7_P",T?V-?_\`0S:K M_P!^[7_XS6Q14\[\ON0[&/\`V-?_`/0S:K_W[M?_`(S1_8U__P!#-JO_`'[M M?_C-;%%'._+[D%C'_L:__P"AFU7_`+]VO_QFC^QK_P#Z&;5?^_=K_P#&:V** M.=^7W(+&/_8U_P#]#-JO_?NU_P#C-']C7_\`T,VJ_P#?NU_^,UL44<[\ON06 M,?\`L:__`.AFU7_OW:__`!FC^QK_`/Z&;5?^_=K_`/&:V**.=^7W(+&/_8U_ M_P!#-JO_`'[M?_C-']C7_P#T,VJ_]^[7_P",UL44<[\ON06,?^QK_P#Z&;5? M^_=K_P#&:/[&O_\`H9M5_P"_=K_\9K8HHYWY?<@L8_\`8U__`-#-JO\`W[M? M_C-']C7_`/T,VJ_]^[7_`.,UL44<[\ON06,?^QK_`/Z&;5?^_=K_`/&:/[&O M_P#H9M5_[]VO_P`9K8HHYWY?<@L8_P#8U_\`]#-JO_?NU_\`C-']C7__`$,V MJ_\`?NU_^,UL44<[\ON06,?^QK__`*&;5?\`OW:__&:/[&O_`/H9M5_[]VO_ M`,9K8HHYWY?<@L8_]C7_`/T,VJ_]^[7_`.,T?V-?_P#0S:K_`-^[7_XS6Q11 MSOR^Y!8Q_P"QK_\`Z&;5?^_=K_\`&:/[&O\`_H9M5_[]VO\`\9K8HHYWY?<@ ML8_]C7__`$,VJ_\`?NU_^,T?V-?_`/0S:K_W[M?_`(S6Q11SOR^Y!8Q_[&O_ M`/H9M5_[]VO_`,9H_L:__P"AFU7_`+]VO_QFMBBCG?E]R"QC_P!C7_\`T,VJ M_P#?NU_^,T?V-?\`_0S:K_W[M?\`XS6Q11SOR^Y!8Q_[&O\`_H9M5_[]VO\` M\9H_L:__`.AFU7_OW:__`!FMBBCG?E]R"QC_`-C7_P#T,VJ_]^[7_P",T?V- M?_\`0S:K_P!^[7_XS6Q11SOR^Y!8Q_[&O_\`H9M5_P"_=K_\9H_L:_\`^AFU M7_OW:_\`QFMBBCG?E]R"QC_V-?\`_0S:K_W[M?\`XS1_8U__`-#-JO\`W[M? M_C-;%%'._+[D%C'_`+&O_P#H9M5_[]VO_P`9H_L:_P#^AFU7_OW:_P#QFMBB MCG?E]R"QC_V-?_\`0S:K_P!^[7_XS1_8U_\`]#-JO_?NU_\`C-;%%'._+[D% MC'_L:_\`^AFU7_OW:_\`QFC^QK__`*&;5?\`OW:__&:V**.=^7W(+&/_`&-? M_P#0S:K_`-^[7_XS1_8U_P#]#-JO_?NU_P#C-;%%'._+[D%C'_L:_P#^AFU7 M_OW:_P#QFC^QK_\`Z&;5?^_=K_\`&:V**.=^7W(+&/\`V-?_`/0S:K_W[M?_ M`(S1_8U__P!#-JO_`'[M?_C-;%%'._+[D%C'_L:__P"AFU7_`+]VO_QFC^QK M_P#Z&;5?^_=K_P#&:V**.=^7W(+&/_8U_P#]#-JO_?NU_P#C-']C7_\`T,VJ M_P#?NU_^,UL44<[\ON06,?\`L:__`.AFU7_OW:__`!FC^QK_`/Z&;5?^_=K_ M`/&:V**.=^7W(+&/_8U__P!#-JO_`'[M?_C-']C7_P#T,VJ_]^[7_P",UL44 M<[\ON06,?^QK_P#Z&;5?^_=K_P#&:/[&O_\`H9M5_P"_=K_\9K8HHYWY?<@L M8_\`8U__`-#-JO\`W[M?_C-']C7_`/T,VJ_]^[7_`.,UL44<[\ON06,?^QK_ M`/Z&;5?^_=K_`/&:/[&O_P#H9M5_[]VO_P`9K8HHYWY?<@L8_P#8U_\`]#-J MO_?NU_\`C-']C7__`$,VJ_\`?NU_^,UL44<[\ON06,?^QK__`*&;5?\`OW:_ M_&:/[&O_`/H9M5_[]VO_`,9K8HHYWY?<@L8_]C7_`/T,VJ_]^[7_`.,T?V-? M_P#0S:K_`-^[7_XS6Q11SOR^Y!8Q_P"QK_\`Z&;5?^_=K_\`&:/[&O\`_H9M M5_[]VO\`\9K8HHYWY?<@L8_]C7__`$,VJ_\`?NU_^,T?V-?_`/0S:K_W[M?_ M`(S6Q11SOR^Y!8Q_[&O_`/H9M5_[]VO_`,9H_L:__P"AFU7_`+]VO_QFMBBC MG?E]R"QC_P!C7_\`T,VJ_P#?NU_^,T?V-?\`_0S:K_W[M?\`XS6Q11SOR^Y! M8Q_[&O\`_H9M5_[]VO\`\9H_L:__`.AFU7_OW:__`!FMBBCG?E]R"QC_`-C7 M_P#T,VJ_]^[7_P",T?V-?_\`0S:K_P!^[7_XS6Q11SOR^Y!8Q_[&O_\`H9M5 M_P"_=K_\9H_L:_\`^AFU7_OW:_\`QFMBBCG?E]R"QC_V-?\`_0S:K_W[M?\` MXS1_8U__`-#-JO\`W[M?_C-;%%'._+[D%C'_`+&O_P#H9M5_[]VO_P`9H_L: M_P#^AFU7_OW:_P#QFMBBCG?E]R"QC_V-?_\`0S:K_P!^[7_XS1_8U_\`]#-J MO_?NU_\`C-;%%'._+[D%C'_L:_\`^AFU7_OW:_\`QFC^QK__`*&;5?\`OW:_ M_&:V**.=^7W(+&/_`&-?_P#0S:K_`-^[7_XS1_8U_P#]#-JO_?NU_P#C-;%% M'._+[D%C'_L:_P#^AFU7_OW:_P#QFC^QK_\`Z&;5?^_=K_\`&:V**.=^7W(+ M&/\`V-?_`/0S:K_W[M?_`(S1_8U__P!#-JO_`'[M?_C-;%%'._+[D%C'_L:_ M_P"AFU7_`+]VO_QFC^QK_P#Z&;5?^_=K_P#&:V**.=^7W(+&/_8U_P#]#-JO M_?NU_P#C-8]W<:II/C7PYI_]LW=W:ZA]I\^.XBA_Y9Q[EP4C4CD_I785Q_B+ M_DH_@O\`[?O_`$2*TI2YI--+9]%V8F=A1116`S'T;_D*^(?^P@G_`*2P5L5C MZ-_R%?$/_803_P!)8*V*N>_R7Y`@HHHJ`"BBB@`HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH` M*X_Q%_R4?P7_`-OW_HD5V%_P`E^0(****@ M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`" MBBB@`JKJ>GP:KI5WIURH:"ZA>&0'N&!!_G5JB@#PR/5;R]^$=KX*\PKK#ZF/ M#TFQ.51'RS8/;R@.:W_'/CO4?`TRZ=I2^'[>RL+1'6/4+DF>X`X"111G[HZEDL#'\DI4'C'?K577/A@VJ^(M8 MU*V\07-A!K-N(+^WCMHY#)A-@VNP)08Z@#GU%`&9::R=7^)6@:VD7E&Z\*/= M"-CG:6=6Q[UM""R-QKFJ6UGC7DFI>>--T7^R3&(-GFC(^?.XXX'3GZU@VOPAO;:'1K-O&%U/IFCZ ME'>V=G+9IA55BQ4L"&))/#9P`3\OH`4_&WQ7U;PKKEVB1Z`;&TF2(VU%I&^)RP8EG/S,N0#M!7IUKHI_!5VWBV M?6[?7'@BO+(6E[:?9599MJ,J,&)RN"V<#KCK0!S.C^*]4@\)>#M%\,:38#5- M3L3,BW$D@M;6)!R3RSGD@`9)]ZDOOB5K5AX7UDS:;8_\))HUY;VMS;([-#*) M67:RWNHRP#,KQLI`"`@*N%P!GC/>@"3P_XJ\1/X]N? M"_B.PTZ&4V']HVSV$CN!'OV;7+8RV<\@`<58\5^)=:MM?L/#GAFVT^75KN![ MEI=0=Q#%$A`Y"?,22<#'I6@?"^?B(OBS[9TTO^SOLOE?]-?,W[\_AC'XU7\5 M>$+C7+^RU72M9ET;6+-7CBNTA693&V-RLC<,../0T`9&H^,_$MC9Z+I3Z):0 M>*]6FFAA@EGWVRB,9:4LN3MQ@[>&Y/I5"\^(FOZ3X>\41:GIUA%XAT**&;,) M=[6X20C#*"0P[@@GT]ZU;OX=2W6DZ>#XEU$Z]I]Q)+_%=M MXG&G:]I&G"*[TZ2^LX["5WD!C`S&Y8`%CD=``/>L[P)\2=:\2Z]!:WT>A-;W M*R'R;.X9+JR*_P`,T^@\1:=J>L>*KK5HM,8M912VL:2`E=O[R4?-)QCKC MI0!3U#XB:M:_#+Q#XECM[%KW3=1DM(HRC&,JLZQ@L-V<[6SP1SVK#\37&I0: M]\3+C2Y8XKI-'M',CLR[4V-O*E>0VW.WWQFM;5_@_=ZA9:WIEMXONK;2=3NS M>_8C:)(J2EPS9;(8KQPH*X."<]^CN?`D5YJ?B:ZGOW\K7;".R>-(L-"%1EW! MB3DG=G&!T[T`FSWTUM=F.Y@:;,,8@4KC+`%BN`VX,,], M4K?$?QC'I)U^32M'_L6WU-[*?$DGGRKYWEJR+]U<9P?:/L_ M3,_G;=N[\,Y]\=J`*]_XQ\2W7B[5]-\.Z783V.AQH;Y[R1T>9W3<%A(XR!UW M=?4<&M[PEK=_XD\":?K#I;)?W=L9`JAA$'Y`XR3C('?-><>,K/7-)^(FIWFF M:;XACL-6MD2X?1[=+H7K*FT!BP'V?&<%AN)&2,'->B^`-*N]$\`Z+IU_'Y5U M!;*LL>0=K=<<>F:`/*_!&H:CX5T37O%=_96-[J6I:E]@@,,\OF33^:R[7WDJ MJ`XVD#.!SVKK)?&_BO0!JEAXFL-)&I)I-QJ5A/8-(8)#$A)C=6.[(.#D'!!_ M&M>+X=6I\'77A^ZOY7$M])?1W4*>6\,AD\Q2O)Y4\>_M52'X;WUS#JL^O^)Y M]6U2\TV738+IK584MHI%()$2G#-GDG(R!CWH`T_`.L>)M?T>/5M>M]*@M;RW MAFLX[(R&3E3O,F[@9^4@#.`<$G&:\J\167A^\^+_`(Q&N^$M<\0;19^1_944 MC^03`N=^QUQGC&<_=->X>'M)_L'PYIND>?Y_V*VC@\W9MW[5`SC)QG'3)JAI M/A?^R_&7B+Q!]L\W^V!;#R/*V^3Y4>S[V3NSUZ#'O0!PFG:KXP\(^&?"VD16 M<,NH:G>W$*0ZG,S-!%\S1AG4G[HQG@\#`Q4/BSXN:EX9U6/199-"BU.TMXI= M0:=;EHY)&7<8X=BL1P00S\?,*]%UOPY_;.MZ#J7VOR?[)N'G\OR]WF[D*XSD M;>N!;V_\`$,^M:'XDNM$N;R%+>^$,"2B=%S@C=RCX.`PZ8Z4`8A^( M?B#7-3T2T\+Z?IKC5=(:^!OW=1`X?:]=I;>#Q:^*].UL:E/,++3#I_EW&9)) MGXUFK\.MOA.UT+^U?]1JHU'SOL_WOWQDV;=W'7&<^^.U`&'-X MSMO",?CK5?[.@$D&JQ0KM:3]\[1H`TF2V,#KM`X'3-9^B?&6[U'1_$*,VD76 MIZ;IS7\$UDDXMY0#@JRRA7!!*]^<\=*["Z^'5M?0^(8KG4)1_:U['>QO"FQ[ M61`H4@Y.X@KGH.M,7P)JUUX?UJPUGQ=>:G=ZG:_9A,\"QPP+SRL*G&[GDYR< M#I0!L>$+[Q#J>D+?:_;:?;-(-?G6\01S:7#(Z1+Y2?*Q1U`.>>AKWBPM?L.G6MIOW^1"D6_&-VT`9 MQVZ5P]UX$\3Q^(=6U/0O&_\`94.I3+-);_V3'/A@@7[SMZ#T%`''VU_M^'G@ M%KQ8M3=_$L,2_:I)2]K^\DV@D,I,B#`PV5]B,5TU[XY\4WUWKEUX9TK3+C2- M!GDM[O[7+(L]R\8RXBVC`Q_M9S5UOAE$-%T6P35I3+8:TFLW%S+"&:ZE!8L" M`0%R6Z\XQWIFI_#2YN-0U1M)\3W>E:;K$C2:E8Q6\;^:S`!BCGF,MSD\YS0! MFR?$/Q)K.N)8^%M.TUX9]$CU5)-0,B^5N;!5MF=Q[`#'.3G`J'2?BAKU\GA? M5[G2M.AT+7+M=/&R5VN%G)*[N@4)N5@!R<?3&/QK,C^&NSPUX3T?^UL_\(_J$5[YOV;_CXV,S;<;OESNZ MY/3I0!QU[\>1:>(YUQIG]DP71MGMF$_VQE#[6E#!#%C&3MSGCK71:]XJ\3ZK MJ7B33?#^EZ=-IFD0-%>/=3,DL[M$6Q%@$`C/\0P?45H0?#N]LM6?[!XLU&ST M)[LWCZ7`BJ3(6W,!,/F$9/5?<\T:S\.KJ]US4[[2?$]YI%OJ\>S4;:&%)/.( M3:&5FYC..N.3ZB@#F?!%[!:S^!!+:0L1X=GD^TDOYB*I7(`#;<'W4GC@BM_P MOXJ\;>()K#6/["TW_A&M0=A&D4Y%W;QY($DFXA&''W5YY'IS>T7X?+I-UH$K MZC]H72=-DT\H8-OG!R/F^\=O3ISUZU5T7X,-2/AZRF,UKI2((R MISD(\RG%=7+ M$2."&DZD#D8SG!K7U3PQK&DP>+-3\/ZJT>JZQ+!);;;17\ED`7:=Q((;NQ'R M@DX.*`-CQ_\`\DZ\2_\`8+N?_1;5PVB>)?$UO9>$?#?AZSTN9[CPU%=>9?/( MHC90JY)7.5Z#;@')ZBO2M?TK^W/#NI:3YWD?;;62W\W;NV;U*YQD9QGID5A: M)X'_`+'UC1;_`/M'SO[,T5=)V>1M\S!4^9G< MEVA\1W^HOI:0F0BW29&8-(?XM@VYP#GWKK?"]UXFG@N8?%&G6=O=0R8CN+&7 M=!<*1G*ACO7'0[NO45AR_#5)/#G]GIJ\T%]#J0B*,[I)$ M.^0N1N`1FC&`?ZUUWB3X@Z9X:U1=,>PU;4;WR?M,L6FVAF,,62-[\@`9!K@[ M7X+WE_X(N(]5U_6X-6OEDNKFPCNU^Q_:6)8;HP"&P0N3NYQD$<8DUKPWXJU& MTT74;WP?#J&J0Z>MM(]KJOV*[@E&0Q,BN4=#U`ZC@#UG2]3M-9TNUU*PE M\VTN8Q+$^",J?8\CZ5R4_P`5O#MOJ3P/%J7V".;R)-6%H?L229V[3+]>^,>] M;7@[3M8TSPAI]CK]\;[4XXR)YRQ8MDD@%CRQ`(&3R<9KS>/P9XRM?"$WPZAT MJR?1Y)FVZVUVORPF7?@Q;=QDQWZ>_>@#7;Q?KNH?&A?#UM_:5II-H@,R+IJN MDQ(8[GE)RB'`"L.IXQ4WQ,\0:MI?B/PMING^)H/#UMJ)N_M-[/!%(B^6J,N? M,X')(ZC[W>MO2M"OK+XD:KJ;0$:=+IMM;PS%U.YD+9&,YZ$%9O$7C MKP==2Z9!?:18F\^W"<(R+OC4)E&^]\R]@<8SQ0`:)KRZ'X;O=5UGQM;^)[=9 MECCFLK6)2KG`$2K$3N8EAQUYJIK7Q$%YX#\0WNDQ:AI.L:=;B0VVHVHCFBW' MY6*-D$'!QUJ;QW\/+36/!@TK0=+L+8Q7L=[]DC46T5P5^5E8H!C*DC/L.1UK MD[/X:A:+;VUC'J+W,K88$[Y'?R\$@$8`([F@#M_#OQ&T MK6M4M=(:WU*UNKB#S;::]M##'>@+EC$3R<=>@]JI:;\7M&U71[O5K?2-=%A: M6KW,EQ):*L?R,%,8?=M+\AL`XQWR"*JV.C^+M;\7^';C7=(L],L_#\;MYT%V M)OMDCQA/E``*`=2"/IGK4/AOP3K47P)G\*WD"6NJRP7""-Y%90S.S+EE)'(( MH`[:;Q-90:YI&DM%/]HU6&6>!@HV*L:ACN.<@X88P#6%9?%+0K[78--CM-56 M"YG-M:ZE):%;2XE!QM23/)R".G8UB:7IOC;4_%WAK4]6T(--L;BW9EO4G M8.R!0S`=B0,`;L1G`SG@Y`XST$ MGBS35O="M(?-N)-:1I+4P@,HC";R['/"X(Y&>2*P/!&B7'A[2/%G_"0Q16EK M=ZS=W@>69-AMG5?G8@X48#=<$=ZY[X/Z9<3ZA?ZA<7D=[8Z.&T;2+A#E9(`Y M=GR.&R#&N1_=QZY`.U\6KXLN[C3]/\-31:?!,SM>:K(B2FV50"JK$Q^8LC<97)H`WOASKFK:O%J]OJ.H0:M#8W0AMM6MXEC2[ M7:"2`I*_*>,KQ75:Q-?V^C7DVEVJW6H)"QMX&<*'DQ\H))``S[UYOH4'B#P1 MH7BGQ++X<@MDN)(IK;PY;7:!8%4;78.HVY8'=M4C:U/J%MHMY-I-H M+S4%B)MX"X0._8$D@`?C0!P&F:_XIT#Q=%I7B+5[75A&-1UC4+6ZTOQ/O"6D=L(S8ML+IM?J^0,'=^%1> M`=%\46LM_;^(?"*SJ?AC3M M8L+6UTOPP'*7D=P)#?-L*)M3JF`X)/3@:Y;>HV(8F4'!.3R0.,T`=11110`4444`%%%%`!1110`4444` M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4 M444`%%%%`!1110`4444`%"".U M-M+.UL+6.UL[:&VMXQA(H4"(H]`!P*FHH`****`&2Q1S*%EC210P8!E!&0<@ M_4$`T^BB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`*X_Q%_P`E'\%_]OW_`*)%=A7'^(O^2C^"_P#M^_\`1(K:A\3]'^3$ MSL****Q&8^C?\A7Q#_V$$_\`26"MBL?1O^0KXA_[""?^DL%;%7/?Y+\@0444 M5`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%% M%`!1110`4444`%%%%`!1110`4444`%_ MR7Y`@HHHJ`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**PDDUS_A("K!?[/SQP M,8QZXSFMV@2=PHHI#0,6BO+/&/B_7=*\3W5G97WE6Z!-J>2C8RH)Y*D]36%_ MPL#Q1_T$_P#R7B_^)KLA@JDHJ2:U,W52=CW"BO#_`/A8'BC_`*"?_DO%_P#$ MT?\`"P/%'_03_P#)>+_XFJ_L^KW7]?(/:H]PHKP__A8'BC_H)_\`DO%_\31_ MPL#Q1_T$_P#R7B_^)H_L^KW7]?(/:H]PHKP__A8'BC_H)_\`DO%_\31_PL#Q M1_T$_P#R7B_^)H_L^KW7]?(/:H]PHKP__A8'BC_H)_\`DO%_\31_PL#Q1_T$ M_P#R7B_^)H_L^KW7]?(/:H]PHKP__A8'BC_H)_\`DO%_\31_PL#Q1_T$_P#R M7B_^)H_L^KW7]?(/:H]PHKP__A8'BC_H)_\`DO%_\31_PL#Q1_T$_P#R7B_^ M)H_L^KW7]?(/:H]PHKP__A8'BC_H)_\`DO%_\31_PL#Q1_T$_P#R7B_^)H_L M^KW7]?(/:H]PHKP__A8'BC_H)_\`DO%_\31_PL#Q1_T$_P#R7B_^)H_L^KW7 M]?(/:H]PHKP__A8'BC_H)_\`DO%_\31_PL#Q1_T$_P#R7B_^)H_L^KW7]?(/ M:H]PHKP__A8'BC_H)_\`DO%_\31_PL#Q1_T$_P#R7B_^)H_L^KW7]?(/:H]P MHKP__A8'BC_H)_\`DO%_\31_PL#Q1_T$_P#R7B_^)H_L^KW7]?(/:H]PHKP_ M_A8'BC_H)_\`DO%_\31_PL#Q1_T$_P#R7B_^)H_L^KW7]?(/:H]PHKP__A8' MBC_H)_\`DO%_\31_PL#Q1_T$_P#R7B_^)H_L^KW7]?(/:H]PHKP__A8'BC_H M)_\`DO%_\31_PL#Q1_T$_P#R7B_^)H_L^KW7]?(/:H]PHKP__A8'BC_H)_\` MDO%_\31_PL#Q1_T$_P#R7B_^)H_L^KW7]?(/:H]PHKP__A8'BC_H)_\`DO%_ M\35[1?''B.[UW3K:?4=\,US'&Z^1&,J6`(R%]*3P%1*]U_7R#VJ/8J***XC0 M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"N/\1?\E'\%_P#;]_Z)%=A7'^(O^2C^"_\`M^_]$BMJ'Q/T?Y,3 M.PHHHK$9CZ-_R%?$/_803_TE@K8K'T;_`)"OB'_L()_Z2P5L5<]_DOR!!111 M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%%%%`!1110`444A('6@!:*JG4;-6VFYCS_`+U2M,IMVEC(M4X-*Y*DF8FH:=K\NL/); MW6V$G*'?@*/3%=:N=HR M1U/K0T3%6;-.D-9NE1WZ6TGVHY8_<#'D4:<-2$LGVW;L_AQCK2L7<\D^(7_( MZ7O^['_Z`*Y>NG^(/_(Z7O\`NQ_^@"N8KWZ'\*/HCEE\3"BE4[6!P#@YYKJ- M4,=M#HIMM,MW>XLTED&PG>Q8CU]JJ4^5I6W!*YRU%=3K_A]9/$)M-'M^?LZR MRPAL^4V"6&?P%8\NAZA#VQ@W1JRSG$3QN&5CW&1QFK3>%=83S@;8;X5W/&'&_&,Y`SD]:KVD%U"S,:B MM&XT+4+;3_MTL(\@$*Q#`E">FX=1^-/N[6:/0[!VT]8@\CA;@-EING&/:CGB M[6"QET5I'0=06"23RE)B7?)$'!D1?4KU`I]IX;U2]B@E@MLQSDA&+``X^M'M M(;W"S,JBI8B8;M=RJQ5L%6Y!KMY;"W7QO/8-I4`TM&P[E2-B;KM:V0NK9$;;,[8,2@\-[G%4[32KJ\B\U`B1%MH>5PBL?0$]33 MYUU%8I45HIH6I2:I_9RVS?:O[AX_'Z5*_AK55MOM`MMR;@C!&#%"?[P'(_&G M[2'<+,R:*OZAH][IB0OV5FEY(B-;LVW?&XM+VBNDNH6.;HHKH;R*'_A#M,N$MHEN)YY8WD`Y8+C'\Z< MI1`Z!Y%7<#TQD\FLY;&Y:[>U$+^=&2'4C[N.N? M2A3B]F%F5Z*NWNEW-A%%+-Y31RDA&CD#@D8R.#[BJ5--/5`%:?AS_D9])_Z_ M8?\`T,5F5I^'/^1GTG_K]A_]#%*?PL%N?0=%%%?.'6%%%%`!1110`4444`%% M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!7'^(O^2C M^"_^W[_T2*["N/\`$7_)1_!?_;]_Z)%;4/B?H_R8F=A1116(S'T;_D*^(?\` ML()_Z2P5L5CZ-_R%?$/_`&$$_P#26"MBKGO\E^0(****@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"LCQ"\RV*^42%+?.1Z5JNZQH7<@*HR2>PK%E\1VI8IY,CITS@<_A3C>]Q,YF MN@\-&4F9>3#@=>F:NP:=I=X@N(X05;T)`_*M&*&.!`D2!%'8"KE.ZL3&/4HR MZ'8RR%S&5)ZA3@51UW4U\/V$<=I"-\A(7/0>I/K6O>:A:Z?$)+J98E)P,]ZQ M+O6/#^LQ&UN)^"?E9E*X/J#CBHN^HIM)63LSGK?QEJ<4H:;RY4[KMQ^M>@PR M":".4`@.H89]ZP+7P;I<,HE9I9AU"NPQ^@YKH@`H``P!P*'85*,U\3%I#2TA MI&IXE\0O^1TO?]V/_P!`%"2:#_B7HCE"5YW,<'WYKE:,54H\S3[`G8Z;P3YK> M())@6)%M-E_I(DST M_.K]J4M-!\+S7:$0PWTCR[A]U2PP3[5Q.!2XINE=[_U:PK&^T_Q1-JEEI4,ZN3) M'>;F9"I7!R.XCC&620G.2/0^M/\06LWG^&U4>9MM(HRT9W#<&.1D5R*NR9"L5SP<'&: M;Q35)I[]_P`0N>CF)+CQ3XJLMZQW-Y`5MF8XW],@'WX_*N:2I2BK)]/TL#=SL6@EB\%:O" MUBMHWGPD0@DO@$\L"?UP*B\0V5QU6(#IABW`/IUKD6)=BS$DG MJ3SFK%E>RZ?]"I-:IZ[_A8+W&W5NUI=RVSLC/$Q1BA MR,CT-=!?6\Q\"Z2HB?(N9B1MY`.,?G7,]>328'I6DHMV\A'5^)%E34M"SN7; M96Z@^C#J/K6Q<6PO-;\6V$>U;NZ1&MP3CS`""P!]^*\]P*!E3E3@^HK-T=$K M_P!7N/FUN:D>A:K)=Q6#VTD4DA8HDQV`D#D\^P%9A!5BIZ@X-#,SG+L6/J3F MDK97ZB"M/PY_R,^D_P#7[#_Z&*S*T_#G_(SZ3_U^P_\`H8I3^%@MSZ#HHHKY MPZPHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`*X_Q%_R4?P7_`-OW_HD5V%!\*T97^]FK\YU;_A&">/[0V<[>O7G\<5S? MA\:XNJQX$XC)_>^;G;M[]>]5%M$2FKI6.H$UKX=TU1=3.1CA1(,;C53Q5HESJBPS6OS/$""A.,@^E<_IWA74Y;N-IHO(C5P69C MS^%+P]1]:YK&>!7L4D,*UZ**1T)65@I#2TAH& M>)?$+_D=+W_=C_\`0!7+UU'Q"_Y'2]_W8_\`T`5R]?04/X4?1')+XF%%%%:B M"BBB@`HHHH`****`"BBB@#6L[ZW&GW"SQ0>8JJL6(UW-R<\E3[58,&@JK(MP MS;V&&).4&X_[/H5S]#6#14.'9CN;QM=`4QC[6YSRQ!)`.U>/NCN7Y]A5:U.G M/:&&Y=4^=BK*/F)[;CMX'T/X5E44F><5C44^3S"YT"PZ$8DB^U`1F4 M,793YFW:<@X'K5&Y-K9Q*MNBR231_/Y@SL'3C/_R7Y`@HHHJ`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`CFWB%S&`7"G:#Z]JR-+GU*2[ M872$1XYR,O7_$/P\_M[6I]1_M3R/-"CR_L^[&%`Z[AZ5E M_P#"I/\`J-_^2G_V=>Q2Q5&-.*;V2[G.X2NV>:45Z7_PJ3_J-_\`DI_]G1_P MJ3_J-_\`DI_]G6GURC_-^#%[.1YI17I?_"I/^HW_`.2G_P!G1_PJ3_J-_P#D MI_\`9T?7*/\`-^##VSD>:45Z7_`,*D M_P"HW_Y*?_9T?\*D_P"HW_Y*?_9T?7*/\WX,/9R/-**]+_X5)_U&_P#R4_\` MLZ/^%2?]1O\`\E/_`+.CZY1_F_!A[.1YI17I?_"I/^HW_P"2G_V='_"I/^HW M_P"2G_V='URC_-^##VSD>:45Z7_`,*D_P"HW_Y*?_9T M?\*D_P"HW_Y*?_9T?7*/\WX,/9R/-**]+_X5)_U&_P#R4_\`LZ/^%2?]1O\` M\E/_`+.CZY1_F_!A[.1YI6GX<_Y&?2?^OV'_`-#%=Q_PJ3_J-_\`DI_]G5G3 MOAA_9^J6E[_;'F?9YDEV?9L;MK`XSOXZ5,L71<6D_P`QJ$KGH5%%%>*=`444 M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%_R7Y`@HHHJ` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`*X_Q%_P`E'\%_]OW_`*)%=A7'^(O^2C^" M_P#M^_\`1(K:A\3]'^3$SL****Q&8^C?\A7Q#_V$$_\`26"MBL?1O^0KXA_[ M""?^DL%;%7/?Y+\@04445`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%% M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%_R7Y`@HHHJ`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*X_ MQ%_R4?P7_P!OW_HD5V%[; MW;C..^<5NCQ%8V>F6%SKMU9:1/=1JWD7-VJ[7(!*!FQN(Z<"O(/[/NO^%@R_ M#GRIO[,DUD:V6^4K]FV^88_]WS<#_/*_%.:WNO&NI6$]C:PW3:6$LYY=+DOI M[S"LQ2`9V1E22"V`1DDGB@#UBY\2K!XQT[0!;!UO;26Z%R)>%"%1C;CG.[KF MKZ:YI,MA#?QZI9/93N(X;A;A#'(Y;:%5LX)R",#OQ7E7@T^9K7P]VMN_XIJ9 M$9(;I=9T_78!>0FW<"W!N6=2[$;><@`9S0![_ M`'>N:387L-G>:I96]U-_JH)KA$>3_=4G)_"LG_A-])/B^Z\-+<0?;K>W$V'N M$7S&.3Y:C.=P`R?0$&O#OB7-;WVJ^,(6L;6TU&.19!'_`&7)<)V) M6&/']W'`QU-=Q&=#LOBM*UY;0"\U'1(FL)S:[C+*$?S&5PIPVS&3D<8%`'H> MD>(X+SPK;:YJ;6>G1R(7D_TZ.:*/DC_7*=K#CJ*N/K>DQZ5_:KZI9+IV`?M; M7""'!.!\^<]>&64=O#X,^&VI:[:O=>%[1;DWZ>298XW.X1O(@!RH.?\ M\&KKL44GP[^(>I:-;M:^%KRZL6TV+R#"K,&C$LB*0,*3C'T]J`/H"UU;3;Z[ MN+6TU"TN+FV($\,,RN\6>FX`Y7\:P_&'C'_A%VTVSM=-EU/5=3E:*SLXY%CW ME0"Q+MPH&1S[USMKH&D^'_C1IL>D:?;V,67N&5(=>&4@'GVK5C\0:9=V5[<:=?VE_]D5C(MO<*^UE&=IV MDX/UKQ2&Y\0Z[X'\:Z=X?U75=1Z`5TWA MN_\``M_+='PKHD\5[%I,L5U54/?'!(]\5J-K&F+J8TQM1M!J!7>+4SKYI7UV9SC\* M\7TK1=,L?#'PNU.UL8(M0N-2@6:Z1`)9%*/D,W4C@<'CBN7DT2>X\2W6GWVM M75KXCDU``!X(H`^B=6U_3M(1TGO+5;PPO+ M#:R3JDDVU22%!Y/3L#5;PUXGM?$.BZ7>L8;6ZU"V^TI9F<,X7N1T+`9'..]> M4>(?^$?L?&'C6'Q=I$MY?ZA"K:0QM&F,L:PD$0D`["IZGC'KQ1H.M6GAC_A7 M>KZIYT6GR:++:>>D#R`2LRE5PH)R<<"@#T[Q#XSM-&L+2[M!#J*S:G%IL@AN M!B)V;:V2`>5[KP?I6S-K&F6^HPZ=/J-I%?3?ZJV>=5DD_P!U2:JS6-K!H"75 MQ(YPIP1RV>>* M]CTZ75I_`UI+9V<-GJS6*&*WO7=DBDV#"N?OD#OW_&@#>KG?&GB:;PIHD=]; M:;_:,\MU%;1V_GB',U'\7;?[7X5T^V\Z6'SM7M(_-A;:Z9DQN4]B.H/K0!/;>+/%J6FHW6L> M"(]+@M;1YXY)=;@999%(Q&6P`@().X\#'O701^)=*CM87O\`4=/L[AK1+N2& M2\C/EQG`W9SRF3C?T-<9XB\)_P#"-?#KQ8__``D&O:KY^G2#;JM[YXCPIY7@ M8SGGZ"L/2=%TS7/BGHMOJMA;7L$?@N"18KB,2*&\T+G!XSAC^=`'K3ZMIL>F M#4WU"T73R@<733*(BIZ'?G&/?-8GB3QI9Z+X4_M^P\C5;'K:ZLK5M-BUF[!NKZ"6Y@L]LD@4M$A^?.X@;LCD\9JK:1 M?9_AIXNM\D;?$5NRJ;3[+\I>(JPA_P"68(Y`],4`?2-%%%`!1110`4444`%% M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444 M4`%%%%`!1110`4444`%%%%`!7'^(O^2C^"_^W[_T2*["N/\`$7_)1_!?_;]_ MZ)%;4/B?H_R8F=A1116(S'T;_D*^(?\`L()_Z2P5L5CZ-_R%?$/_`&$$_P#2 M6"MBKGO\E^0(****@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"N/\1?\`)1_!?_;] M_P"B1785Q_B+_DH_@O\`[?O_`$2*VH?$_1_DQ,["BBBL1F/HW_(5\0_]A!/_ M`$E@K8K'T;_D*^(?^P@G_I+!6Q5SW^2_($%%%%0`4444`%%%%`!1110`4444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1145S_P`>LW^XW\J`):*^7/#VAV>H>#=- M_P"$=\&^)(_%KE3#K:"2.U#!^6\PN5V[&T^)>M3^+/#FJZW! M;Z?:MYFGH^VWX;[N1:ZQ:B1+=)!*VT^9Y@4;1P?EZC\: M](^)%S;7%KX4\(:]J5O;1W\BRZG<32K&ICA7-?TXW45S-HR2:>TL1RDBHPV,I!((*;<$'M61H]AH%QXET>R\&>%]#=?\0.L]OY3Z7#( MXA'DKD-L=<$\8SGI6OKOAOP_J!^'.B)HEW9:+<7-T3IUXTD;Z+HMKX'^)5GHNAM-#I&I:=+,]D\SR)%+&RX=-Q)&0YS5/XR0V$] MYX3BU/2[S5;)KV7S;*R5FFE'E'`4*0>N#P1P#0!ZI17BG@33=&G\::OH]CI& MIZ'H5WI.V71=6219+B0OAIE#LW`7"Y!SS3;73=;U&_M_A5?>8VE:9*+FYO2P MS@Z);V5M87'B;4Y$B$+J_DA@A M>5@`V[:,8ZGJ*SM5^(]XGP=MO&6DP6LM[*L*F%U9T$A<(ZX!!X.<<^G6@#TB MBN%'Q`:^T_PC?:;%%Y6LWPM;E)E)>$[&+J,$88,N.<_2L/6O%'Q+TOQCIF@) M%X29M6>)K^XALX MHE61K=IF/S$#(;8%#')/''TI="\=Q77PX?Q1JT0MY;-)!?01C&R6,E64`D]2 M!@$]Q0!V5-E3S(G3.-RD9]*\Z7Q#\3%MH-9;PUH\VG3;&&FV]Q(;U%;'5B`A M(SD\?R-3Z[XB\9R^.V\.^&(="58].CO9&U02YRSLI`,9QV';UYH`Z7PCX?\` M^$5\*:?H?VK[5]D0IYWE[-^6)SMR<=?6F6OAI;?Q=J^N/<"5=1MH;<[NF!^-3>&_^$E^P2?\)1_9/VWS3Y?]E^9Y?EX&,^9SNSN]L8KCKKQ' MX^U'Q;XATWP['X:6STB2)"VHB<2-OC#]4./7T[4`/?X6RIX1U;PS9Z\8-.NK MM+JQ5K3>UEB0.4'S@.I(&.!CGKFM31_#GC6RU:WN-3\??VC9(29;3^QX8?,& M"`-ZG(YP>/2LJW^)UQ?^#=#U"QTA9M9UBY:TM[,S@1AT)#N7_N`+GCU`]ZM6 M/BCQ5HVOZ9I?C*QTGRM4D:&VO=*DDV)*%R$=9.M#6TD02V&OF;S&D!+H$B+@#!`!##!R#TH`IWOPLM6/B2'2KR'3 M+#7+2.%[2&T&R&1#Q(H#`VO/)\P M%<89&7<,JP[9%GV'VS M^SK;^T?(^W>4GVC[/GR_,P-VS/.W.<9YQ0!P]YX#\2KXGU?6-"\;?V2FIO&\ ML']E1S\H@0?,[>QZ`=:=JW@/Q%JUIHRCT._>ZBTFX3=YDS0,`VXY*D$;B,8Z4ESXG\>:GX[ M\0Z%X:A\."VTCR,MJ*SAW\V/=U0X/(;L.U`&_P"'/!UUIFL2:WKFNSZYK#0? M9TN)($@2*/.2$C7@$G&3GG%.\9>$[_Q)-I-UIFN?V1>Z;,\T4_V1;C)9=I^5 MB!T)ZYKG;OXEZC;^&8M7>PMK:33]873M<@FW-Y"[@&>-@1D?,I!((YKHM;\3 M7MKXTT+P_IL-O*;N.6ZO7DR?*@0<%<$:`(?#_@W4['7AK?B'Q++KE_% M`UO;M]D2V2)&(+?*F>(_M>[[391VGV?R\;=C%MV[/.<], M?C7"1?%35F^&>@:X;*P.KZU>M91;BT=M$WF.H9\DMMPHSSZ]*Z30/%&NPIK$ M?C#38+7^S8!<_P!H6(/[W2%\46F@Z/_ M`&"T1N$LI+B3[;)#@D,&`\L$C!QSZ58U7QGX@U/4/#MOX,32&75[&2]WZJLN M%5=O'R'@_-Z'I0!Z)17`Z-XSURVO-?TWQ18V#7ND6(OR^DL[1RH0QV[7^8-\ MOXY_/,\.>/?%^J'1]5N=%TZZT'5IA$O]EM+-/99R-TW!7`(Y/&.^.E`'J-%% M<-K7C/4=-U;Q7:0PVK1Z1HHU"W+JQ+283CXM7=S\'K MSQ3:VUJNM6+11W%K*C^6&=T`8#<&VLK;AS^)Q72:]XFU^7Q,_AKPG8Z?+?P6 MRW-U=:C(P@A#'"IM3YF8@$]@..M`':45@>%-2U[4+&=?$6D)I]];RF(M"^Z& MX`_Y:1YY"GT/-;]`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%-R`XBWA#F+.,?ZS!VYZ#./3V M>B@#R_7M$\3>*?B@]QI>HSZ%;Z)9K';WLNFB99I)]44`>0:YX M2U72OBIHL^E6LLN@7VIC4;E8HBRVMR$*.Q(^ZK@@Y/<=JZ'Q3I][P M6=Q+:VRWOGSI$S)%NBPNY@,+D\#/6N^HH`\S\7:)XC\5?$G3HM+O9]&M=%M& MN(]1>S\Z-YY#MVJK85B$[Y.,FL6S\%:]%_PF?@V^N9+R+6;<:A!J@L?(@-R3 MAU;;E58E4.!V!/>O9J*`/%/$NH>*?$>FVNFV^A>-])\16D!3.GSI#8R2$+\S MS;L.!CC!&,D9J/QIHEG+\0(+CQ+X0U_Q!9KHL$*OID$LFV<.V[+*RYX]SU'% M>WT4`+X;Z+XH^( M/B^]\2Z'--'Y]O\`8YG>6)77R0&VE6`;D8[XKU:B@#@/&'AFXL9?"^L>&]*2 M8^'IWQI\!$>^"1=KA,\;A@'!Z\]ZS[BXU/XC>(O#VWPUJVDZ3I-\+^XFU6(0 M.\B#]VB)DDC)R3TX/TKT^B@#Q3^P]7_X1+R?[*OO-_X37[5L^SON\GS<^9C' MW,<[NE6I?"FK:'\8M"2QM9Y?#3W5Q?JZ1LRVDLD3+(I;HJDX(!QRQQ7L-%`' M$ZC8W;_&+1;Y+6=K2/2KB-[@1DQJQ<84MT!/I6OXVO[[3?!FJW&EVMQ=7_D, MEO%;PM*Y=OE!"J"3C.3]*WZ*`/#=0^'OC/PWX4TB]M->;53H,L5U;:1!IB1O MG(WJ)%)9N&;.0<^F:T[;7KWPO\3/%VI3>$_$U]:ZHMDUO)8Z$+[5O!WBN+6K<6MSXBN9KA;8X8VP*A8@QR06&U6/O5+ MX5:=KM[+J'B+Q-I\]KJ(M8=+MTN(BC^5$@+-R`<.YSZ9'M7J=%`'B6B:9K>G M_!;P_97?A+^U+:.XF.IZ9I^#=`UJPEO].L-)GC MGFC\Q(UFRA'SJ1CG=@$\XZ5Z_10!Y7X,T75?!LGB/PO8Z/`T@C-SI6I2VK>3 M=*<[8IW4`%E/'7)!)QZ\G:Z)=SZWI$N@>!]8\.>)4N8CJ5U$K0Z>8@1Y@7YB MK*>#M&.G?'/T!10!GZ?J\>HWNHVJVUU"]C,(7,\>T294,&3GE>>O'(->?^)= M*U&?7_'LD-A=21W7AL06[)"Q$LFV3Y%('S-R.!SS7I-O9V]J\[PQ!'GD\V5N MI=L`9)^@`]@*GH`^>_&O@G74^&^C7FBZ==27-WI5G8ZO8QP,TI\L(R/L'.Y6 M7:>.A]J]!U9M3\(>/M0\1Q:'J&KZ7JEG#%,-.02SPRQD@?NR02I#=0>,'->A MT4`-L#>\>?EQGD9R`#QQSU]%%`! M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%% M%%`!1110`4444`%%%%`!1110`4444`%_R7Y`@HHHJ`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`***HZEK>E:,B/JFIV5BCG"-=7"Q!CZ#<1F@"]138Y$EC62-U= M&&0RG((^M*S!%+,0%`R23P!0`M%-1TEC62-E=&`964Y!!Z$&HKN]M-/@\^]N MH;:'<$\R:0(NXG`&3W)X%`$]%%%`!115+4-7TS25C;4M1M+,2MLC-S.L>]O0 M;B,GVH`NT4TR1K$96=1&%W%R>`/7/I4=K=6]]:QW5I<17%O*NZ.6)PZ./4$< M$4`345'//%;0O-/*D42#+O(P55'J2>E06.J:?J=G]LL+ZUN[7G]]!,LB<=?F M!QQ0!;HJIIVJZ=J]N;C3+^UO8`=IDMIED7/IE214D5[:3W<]I#=0R7-OM,\* M2`O%N!*[E'(R`<9ZXH`GHJ#[;:?;_L'VJ'[88O.^S^8/,\O.-^WKMR0,],U/ M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5Q_B+_ M`)*/X+_[?O\`T2*["N/\1?\`)1_!?_;]_P"B16U#XGZ/\F)G84445B,Q]&_Y M"OB'_L()_P"DL%;%8^C?\A7Q#_V$$_\`26"MBKGO\E^0(****@`HHHH`**** M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"O+O"FBZ7XJ\7^,]0\0Z9;7 M][;:F;*&.\C$PAMT4;-JMD*&Y;@>M>HUR.O?#O2];U6358;_`%;1]0F54GN= M)NS`TZJ,`/P0<>N,\#F@#@[;7;KP/:>.['0H(S9V6IV\.FK*Q,4,LX`D7V56 M.<=,FM;Q/I/CBR^'_BFWU?Q-9ZC;'3VECNELEBF&!F2(H!MVLH(#9W`GITKK MX?`/AR'PK<^'!8;]/NF+S^8Y:260G.]G/);('/;`JAI?PRT33X-06ZN]4U6> M_M3927.I71EE6`CF-&`&U<\_6@#F[2^\5P:9X0\)Z?KD"7VHV+74FJRV:$PP MHJE8TBSM9@&`R>PS61XIUW6KWP9KVA:G-;W6K:+JMC$MZ(O*BN-[JR,P'`/] MX#I7=2?#'2)=!T[3)-2UEIM-9C9ZE]KQ=P!N"JR``!<8&,8P!3Y?AEH,WA.? MP[(]\]OXD4@[G<@YS@`X`]L4`84OB;Q/X,UZ^M?$.HV^M6SZ5 M<:G"T-J+=H6BZQ``G*\C!))K(\!^.?&FJ^(=-;4;+5KK3-33=(TFB_9[>TRN MY6BF5F,B$X&7QP0:[G1OAWHVCW][>O-J&I7%W`UJ7U*Y,YC@)YB4GD)]( MM6RSYX&,(_AM9>(_$B:])KVO6%['"(8SI]VL(1><@?(2,Y.>>:`.-UZX&A^ M!]%^'>H:U;6-W+IIDU"XDG1`D"@_ND+=69OD'^RK&NT^%%Y:W?PST-;:YAF: M"V6*81R!C&X&2K8Z'!'!YYJ]_P`()H,^F0VFJ6B:O/%"8!?ZG''<717)/,C+ MG@L<55L/!D/AZWT#3]!,]O:65P9;ETD6/[0/+*YF"J/,8G;V'3/8`@%WQIHV MD:SH.->NY+;2[29+NXPRJDBQ\[),@Y0G&0,$X'->.ZI;M'\/?&_B33+0Z)H. MLRVD-E;I%L!@#JCS;!PH<,>`!D?4$^Q^,O!]EXWT4:3J%W>V]KYJRM]D=5+D M9P&W*W&3GZ@51T[X>6-II>HZ;?ZSKNLV5_$(I(=4O?."`9^Y@#:??V%`'.Z? MI46D?%_5=$\/Q1:7:W?AM96>UA4"*<2E$DVXVE@&)YZ_G1\-M,71_B/\0+$7 M-Q=&-K`M/U6M-\-6>E^(]:UR"6=KG5S";A'8%%\I2J[0`".#SDG\*`.!\.Z-)H MOQYGBGU*ZU&YF\-F:>YN2-SN;A1PH`"J`H`4=*]7K&'AJS'C,^*/-G^W&P_L M_P`O_ MR7Y`@HHHJ`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*X_Q%_R4?P7_P!OW_HD5V%< M?XB_Y*/X+_[?O_1(K:A\3]'^3$SL****Q&8^C?\`(5\0_P#803_TE@K8K'T; M_D*^(?\`L()_Z2P5L5<]_DOR!!1114`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`5SU]X)T#4<&XLB6"D*PF<%<_CB MNAHH`XBYT?Q9X>1I/#U_#JULIS_9^HQI&V._ERH%&?\`>!'O5KPK\0-+\37$ MFGM'+IVL0<3Z?=#;(I[[?[P_7U`KI+_4+32[&:^OKA+>U@4O)*YP%%>.:WH] M[\3A=>*M"MSILNF';IL^W;/>LARQ8Y^4`C"]\Y!QT%+7&P]T`NIV9$-VF,9;L^.V<=.Q!%=M2:L-.X4444AA1110`4444`%%%%`!11 M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%^'?$MW;:[X:O M;714E:*#4`C8D*@X(R-K;L<8/'YUZ@3CK7SU<26/CX^(M9U875TLUQ_9_AVU MB?#;QSN0=.FPL>@!.>U5%+J3)]B^;O6?BCK-@UP'M+)W\^PM8W!,$2G#74O' M)R"J#^][*=WMFGV%OI>FV]A:IL@@C$<:^@`Q^=>-?"*9_!WB[5O!6LQP17SX MD@G7_EK@9VANZ[3N`XQ\_P1[GD=I9'PA\>VCA;;8^([>20+G`$HRS M?CE3_P!]UZX*X/XBV!.I^$-6B!\ZTUN"$MV$#I2;O8%H%%%%(H* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`KC_$7_`"4?P7_V_?\`HD5V%)3[$Y8]S^)/HE9NO:Y8^'-&N=4U&7R[>!-Q]6/91ZDG@4[]!-+<^?_`(SZ MI<:7\6+._LP(;FSMH'C?'WF#,V3ZCG'T%>\^%O$%MXH\.6>KVK#9<1@LN?\` M5N.&4_0Y%>.:/X0U+XPW][XI\0R26-D\1@T^*+G&,X//5022>FXD]!Q3?A;J MU[X$\;7G@K7B8DN9!Y))RHEQ\I!]'7`^H`]:MJZMU1";3OW/9/$]C]OTZU0? M>BU&SG4\\;+B,G]`:VJ`_R7Y`@HHHJ`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHH)Q0`5Y3K5C*=0\7>()O"OA24QP0G&I:N@R(5Y!2/MO/3/;G'3([K M2M*M-%TV#3[&+RK>%=JC.2?4D]R3R2>II[$[EF&&*WA2&&-(XXU"HB+@*!P` M`.@K@?BC\/QXMTV._P!.VQ:W8J6@<<&51SL)^O(/8_4UZ%10G8;5SEO`/BG_ M`(2KPQ!=3#9J$!-O?1%=ICF7@\=L]?QQVKJ:X+65A\%>,;;Q!%F+3=7E6SU- M0/E64_ZJ;VYRK'I@YZUW@.:&"%HHHI#"BBB@`HHHH`****`"BBB@`HHHH`** M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH MH`****`"BBB@`HHHH`****`"BBB@`HHHH`*X_P`1?\E'\%_]OW_HD5V%'&/\`;&I(3-,I(%G! MWD)'3/('?\<5W]Z3=*#'X.#^%<]\./$%Q?Z5-HFK$KKFC,+6[5B27`R$D![A@ M.OKSW%=M7$>+[#^PM3@\;6("R6:E-3C7C[3:]S[LG##UQCTIKL)]SMZ*CAF2 M>".:-LI(H93C&0>E24AA1110`4444`%%%%`!1110`4444`%%%%`!1110`444 M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%%%%`!1110`4444`%_R7Y`@HHHJ`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`JEI&F1:-I%IID$DLD-I$L,;2D%MJC`!P`.``.E7:ANXYYK M26.VN/L\S+A)=@?8?7!X-#>@$U%<=H5]K(_M*\O]1GOX;*ZDM/LL%FF^5E(` M8;>G7IT'K1J'C*."_L)=TMO:)+=6N=C17/S>+K&VO([6>VO(W.SS6\H%;U76$TF/S)+.[ MG0(TCM!&"L:KU))('X=?:M?:PLW?8?,C2J&[M8[VSGM921'-&T;%>N",&N;D M\6V]E?71D:\NHWD@2"&*W7*%X]P`.[+9]^AXJUI7C#3]7O8;6&&[B>96*--% MM5BOWE!SR14K$4V^6^HN9%/P_P"!AX:B$%CXEUY[<#:L%S-%*BCMMW1Y7Z`@ M5UE%%;%!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`! M1110`4444`%_R7Y`@H MHHJ`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`YX^&'_LW4K1-09&O+YKS>J$;Z)Y$03RNL0N'FLUD9R@QE2Q. MPD``\'UJUX@\-OKLJM]M\J,0M$8GC\Q[]?:EA\)RVWV)H-2V2VGVHH_D`_-,.#@G M^$\^_M7344?5Z?;^M_T#E0R%72"-)9/,D50&?;C<<_R7 MY`@HHHJ`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*X_Q%_P`E'\%_]OW_`*)%=A7' M^(O^2C^"_P#M^_\`1(K:A\3]'^3$SL****Q&8^C?\A7Q#_V$$_\`26"MBL?1 MO^0KXA_[""?^DL%;%7/?Y+\@04445`!1110`4444`%%%%`!1110`4444`%%% M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%PL@_P"%6^#/^@-_Y-3? M_%T?\*M\&?\`0&_\FIO_`(NBBCZQ6_G?WL+(/^%6^#/^@-_Y-3?_`!='_"K? M!G_0&_\`)J;_`.+HHH^L5OYW]["R#_A5O@S_`*`W_DU-_P#%T?\`"K?!G_0& M_P#)J;_XNBBCZQ6_G?WL+(/^%6^#/^@-_P"34W_Q='_"K?!G_0&_\FIO_BZ* M*/K%;^=_>PL@_P"%6^#/^@-_Y-3?_%T?\*M\&?\`0&_\FIO_`(NBBCZQ6_G? MWL+(/^%6^#/^@-_Y-3?_`!='_"K?!G_0&_\`)J;_`.+HHH^L5OYW]["R#_A5 MO@S_`*`W_DU-_P#%T?\`"K?!G_0&_P#)J;_XNBBCZQ6_G?WL+(/^%6^#/^@- M_P"34W_Q='_"K?!G_0&_\FIO_BZ**/K%;^=_>PL@_P"%6^#/^@-_Y-3?_%T? M\*M\&?\`0&_\FIO_`(NBBCZQ6_G?WL+(/^%6^#/^@-_Y-3?_`!='_"K?!G_0 M&_\`)J;_`.+HHH^L5OYW]["R#_A5O@S_`*`W_DU-_P#%T?\`"K?!G_0&_P#) MJ;_XNBBCZQ6_G?WL+(/^%6^#/^@-_P"34W_Q='_"K?!G_0&_\FIO_BZ**/K% M;^=_>PL@_P"%6^#/^@-_Y-3?_%T?\*M\&?\`0&_\FIO_`(NBBCZQ6_G?WL+( M/^%6^#/^@-_Y-3?_`!='_"K?!G_0&_\`)J;_`.+HHH^L5OYW]["R#_A5O@S_ M`*`W_DU-_P#%T?\`"K?!G_0&_P#)J;_XNBBCZQ6_G?WL+(/^%6^#/^@-_P"3 M4W_Q='_"K?!G_0&_\FIO_BZ**/K%;^=_>PL@_P"%6^#/^@-_Y-3?_%T?\*M\ M&?\`0&_\FIO_`(NBBCZQ6_G?WL+(/^%6^#/^@-_Y-3?_`!='_"K?!G_0&_\` M)J;_`.+HHH^L5OYW]["R#_A5O@S_`*`W_DU-_P#%T?\`"K?!G_0&_P#)J;_X MNBBCZQ6_G?WL+(/^%6^#/^@-_P"34W_Q='_"K?!G_0&_\FIO_BZ**/K%;^=_ M>PL@_P"%6^#/^@-_Y-3?_%T?\*M\&?\`0&_\FIO_`(NBBCZQ6_G?WL+(/^%6 M^#/^@-_Y-3?_`!='_"K?!G_0&_\`)J;_`.+HHH^L5OYW]["R#_A5O@S_`*`W M_DU-_P#%T?\`"K?!G_0&_P#)J;_XNBBCZQ6_G?WL+(/^%6^#/^@-_P"34W_Q M='_"K?!G_0&_\FIO_BZ**/K%;^=_>PL@_P"%6^#/^@-_Y-3?_%T?\*M\&?\` M0&_\FIO_`(NBBCZQ6_G?WL+(/^%6^#/^@-_Y-3?_`!='_"K?!G_0&_\`)J;_ M`.+HHH^L5OYW]["R#_A5O@S_`*`W_DU-_P#%T?\`"K?!G_0&_P#)J;_XNBBC MZQ6_G?WL+(/^%6^#/^@-_P"34W_Q='_"K?!G_0&_\FIO_BZ**/K%;^=_>PL@ M_P"%6^#/^@-_Y-3?_%T?\*M\&?\`0&_\FIO_`(NBBCZQ6_G?WL+(/^%6^#/^ M@-_Y-3?_`!='_"K?!G_0&_\`)J;_`.+HHH^L5OYW]["R#_A5O@S_`*`W_DU- M_P#%T?\`"K?!G_0&_P#)J;_XNBBCZQ6_G?WL+(/^%6^#/^@-_P"34W_Q='_" MK?!G_0&_\FIO_BZ**/K%;^=_>PL@_P"%6^#/^@-_Y-3?_%T?\*M\&?\`0&_\ MFIO_`(NBBCZQ6_G?WL+(/^%6^#/^@-_Y-3?_`!='_"K?!G_0&_\`)J;_`.+H MHH^L5OYW]["R#_A5O@S_`*`W_DU-_P#%T?\`"K?!G_0&_P#)J;_XNBBCZQ6_ MG?WL+(/^%6^#/^@-_P"34W_Q='_"K?!G_0&_\FIO_BZ**/K%;^=_>PL@_P"% M6^#/^@-_Y-3?_%T?\*M\&?\`0&_\FIO_`(NBBCZQ6_G?WL+(/^%6^#/^@-_Y M-3?_`!='_"K?!G_0&_\`)J;_`.+HHH^L5OYW]["R#_A5O@S_`*`W_DU-_P#% MT?\`"K?!G_0&_P#)J;_XNBBCZQ6_G?WL+(/^%6^#/^@-_P"34W_Q='_"K?!G M_0&_\FIO_BZ**/K%;^=_>PL@_P"%6^#/^@-_Y-3?_%T?\*M\&?\`0&_\FIO_ M`(NBBCZQ6_G?WL+(/^%6^#/^@-_Y-3?_`!='_"K?!G_0&_\`)J;_`.+HHH^L M5OYW]["R#_A5O@S_`*`W_DU-_P#%T?\`"K?!G_0&_P#)J;_XNBBCZQ6_G?WL M+(/^%6^#/^@-_P"34W_Q='_"K?!G_0&_\FIO_BZ**/K%;^=_>PL@_P"%6^#/ M^@-_Y-3?_%T?\*M\&?\`0&_\FIO_`(NBBCZQ6_G?WL+(/^%6^#/^@-_Y-3?_ M`!='_"K?!G_0&_\`)J;_`.+HHH^L5OYW]["R#_A5O@S_`*`W_DU-_P#%T?\` M"K?!G_0&_P#)J;_XNBBCZQ6_G?WL+(/^%6^#/^@-_P"34W_Q='_"K?!G_0&_ M\FIO_BZ**/K%;^=_>PL@_P"%6^#/^@-_Y-3?_%UJU9R?WA9'24445D,_]D_ ` end